
<html lang="en"     class="pb-page"  data-request-id="4881a287-d4e5-4b12-99ce-fa2816dd7cad"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm5004599;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders" /></meta><meta name="dc.Creator" content="Roger B.  Clark" /></meta><meta name="dc.Creator" content="Diana  Lamppu" /></meta><meta name="dc.Creator" content="Lyn  Libertine" /></meta><meta name="dc.Creator" content="Amy  McDonough" /></meta><meta name="dc.Creator" content="Anjali  Kumar" /></meta><meta name="dc.Creator" content="Greg  LaRosa" /></meta><meta name="dc.Creator" content="Roger  Rush" /></meta><meta name="dc.Creator" content="Daniel  Elbaum" /></meta><meta name="dc.Description" content="Herein we report the design, synthesis, and structure–activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)pipera..." /></meta><meta name="Description" content="Herein we report the design, synthesis, and structure–activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)pipera..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 9, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5004599" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5004599" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5004599" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5004599" /></link>
        
    
    

<title>Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5004599" /></meta><meta property="og:title" content="Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0011.jpeg" /></meta><meta property="og:description" content="Herein we report the design, synthesis, and structure–activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)piperazine scaffold. The oxazolo[4,5-b]pyridine, (R)-18, and 4-methoxyphenylurea, (R)-47, were identified as potent and selective modulators of the α7 nAChR with favorable in vitro safety profiles and good oral bioavailability in mouse. Both compounds were shown to significantly inhibit cellular infiltration in a murine model of allergic lung inflammation. Despite the structural and in vivo functional similarities in the compounds, only (R)-18 was shown to be an agonist. Compound (R)-47 demonstrated silent agonist activity. These data support the hypothesis that the anti-inflammatory activity of the α7 nAChR is mediated by a signal transduction pathway that is independent of ion current." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5004599"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5004599">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5004599&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5004599&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5004599&amp;href=/doi/10.1021/jm5004599" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 3966-3983</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401742r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500018m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger+B.++Clark">Roger B. Clark</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Lamppu">Diana Lamppu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lyn++Libertine">Lyn Libertine</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++McDonough">Amy McDonough</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anjali++Kumar">Anjali Kumar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Greg++LaRosa">Greg LaRosa</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger++Rush">Roger Rush</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Elbaum">Daniel Elbaum</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-817-5502. E-mail: <a href="/cdn-cgi/l/email-protection#197d7d7c757b786c74597e74787075377a7674"><span class="__cf_email__" data-cfemail="026666676e6063776f42656f636b6e2c616d6f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5004599&amp;href=/doi/10.1021%2Fjm5004599" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 3966–3983</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 9, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2013</li><li><span class="item_label"><b>Published</b> online</span>9 May 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 May 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5004599" title="DOI URL">https://doi.org/10.1021/jm5004599</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3966%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRoger%2BB.%2BClark%252C%2BDiana%2BLamppu%252C%2BLyn%2BLibertine%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D10%26contentID%3Djm5004599%26title%3DDiscovery%2Bof%2BNovel%2B2-%2528%2528Pyridin-3-yloxy%2529methyl%2529piperazines%2Bas%2B%25CE%25B17%2BNicotinic%2BAcetylcholine%2BReceptor%2BModulators%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BDisorders%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3983%26publicationDate%3DMay%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5004599"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1340</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5004599" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;B. Clark&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Lamppu&quot;},{&quot;first_name&quot;:&quot;Lyn&quot;,&quot;last_name&quot;:&quot;Libertine&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;McDonough&quot;},{&quot;first_name&quot;:&quot;Anjali&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Greg&quot;,&quot;last_name&quot;:&quot;LaRosa&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;Rush&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Elbaum&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;3966-3983&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5004599&quot;},&quot;abstract&quot;:&quot;Herein we report the design, synthesis, and structure–activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)piperazine scaffold. The oxazolo[4,5-b]pyridine, (R)-18, and 4-methoxyphenylurea, (R)-47, were identified as potent and selective modulators of the α7 nAChR with favorable in vitro safety profiles and good oral bioavailability in mouse. Both compounds were shown to significantly inhibit cellular infiltration in a murine model of allergic lung inflammation. Despite the structural and in vivo functional similarities in the compounds, only (R)-18 was shown to be an agonist. Compound (R)-47 demonstrated silent agonist activity. These data support the hypothesis that the anti-inflammatory activity of the α7 nAChR is mediated by a signal transduction pathway that is independent of ion current.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004599&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004599" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004599&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004599" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004599&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004599" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5004599&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004599&amp;href=/doi/10.1021/jm5004599" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5004599" /></input><a href="/doi/pdf/10.1021/jm5004599" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (687 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5004599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5004599%26sid%3Dliteratum%253Aachs%26pmid%3D24814197%26genre%3Darticle%26aulast%3DClark%26date%3D2014%26atitle%3DDiscovery%2Bof%2BNovel%2B2-%2528%2528Pyridin-3-yloxy%2529methyl%2529piperazines%2Bas%2B%25CE%25B17%2BNicotinic%2BAcetylcholine%2BReceptor%2BModulators%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D10%26spage%3D3966%26epage%3D3983%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jmcmar.2014.57.issue-10/production/jmcmar.2014.57.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we report the design, synthesis, and structure–activity relationships for a new class of α7 nicotinic acetylcholine receptor (nAChR) modulators based on the 2-((pyridin-3-yloxy)methyl)piperazine scaffold. The oxazolo[4,5-<i>b</i>]pyridine, (<b><i>R</i></b>)-<b>18</b>, and 4-methoxyphenylurea, (<b><i>R</i></b>)-<b>47</b>, were identified as potent and selective modulators of the α7 nAChR with favorable in vitro safety profiles and good oral bioavailability in mouse. Both compounds were shown to significantly inhibit cellular infiltration in a murine model of allergic lung inflammation. Despite the structural and in vivo functional similarities in the compounds, only (<b><i>R</i></b>)-<b>18</b> was shown to be an agonist. Compound (<b><i>R</i></b>)-<b>47</b> demonstrated silent agonist activity. These data support the hypothesis that the anti-inflammatory activity of the α7 nAChR is mediated by a signal transduction pathway that is independent of ion current.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The neuronal nicotinic acetylcholine receptors (nAChRs) are a family of calcium-permeable, ligand-gated ion channels that have received significant attention over the past few years due to their proposed involvement in a variety of disorders. In particular, the α4β2 and α7 subtypes are highly expressed in the brain, and consequently most of this interest has been focused on disorders of the central nervous system (CNS).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The α7 nAChR has been implicated in diseases associated with cognitive impairment such as Alzheimer’s disease<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and schizophrenia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Indeed, several α7 agonists, including the partial agonist <b>1</b> (GTS-21)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and <b>2</b> (EVP-6124)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), have advanced into the clinic for the treatment of these disorders.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Recent examples of α7 nAChR agonists and design rational.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recent reports have found that the α7 nAChR is expressed on non-neuronal cells,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> including lymphocytes,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> macrophages,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and intestinal and lung endothelial and epithelial cells.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It has been suggested that α7 is an essential regulator of the inflammatory process<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and that agonists of the receptor may be useful in the treatment of inflammatory conditions such as sepsis,<a onclick="showRef(event, 'cit10a cit10b ref11'); return false;" href="javascript:void(0);" class="ref cit10a cit10b ref11">(10a, 10b, 11)</a> postoperative ileus,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and ulcerative colitis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Nicotine has been shown to inhibit the lipopolysaccharide (LPS)-induced production of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), in human or murine monocytes.<a onclick="showRef(event, 'cit10a ref14'); return false;" href="javascript:void(0);" class="ref cit10a ref14">(10a, 14)</a> Additionally, both lung expression data and studies with smokers provide a link to the potential utility of α7 nAChR agonists in the treatment of asthma and chronic obstructive pulmonary disease (COPD). While smokers have an increased risk of developing lung cancer, few smokers develop COPD.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It has been suggested that the inflammatory response to tobacco smoke is dampened by the anti-inflammatory effects of nicotine.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> While the original literature data linking the α7 nAChR to inflammation is based on nicotine, a nonselective agonist, more recent work has shown that compound <b>3</b> (AR-R17779), a highly selective α7 agonist,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> is an effective therapy in the collagen induced arthritis model in mice.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Furthermore, a group in The Netherlands conducted a phase 1 clinical trial (Clinical Trial Register no. NCT 00783068) with compound <b>1</b> in LPS-induced endotoxemia. Although this study showed that at the highest safe dose (150 mg) the reduction in TNF-α, IL-6, IL-1RA, and IL-10 was not statistically significant, there was a correlation between plasma levels of <b>1</b> and the levels of TNF-α, IL-6, and IL-1RA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Furthermore, Targacept has conducted a clinical trial using TC-5987 (structure not disclosed) in asthma. A post-trial press release reported a positive effect on pulmonary function as measured by forced expiratory volume in one second (FEV1), but the full set of results from this study have yet to be published.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Here we detail our efforts to develop a new series of selective α7 nAChR modulators to further explore the involvement of this receptor in inflammation.</div><div class="NLM_p last">Several reviews have appeared recently outlining the large number of α7 ligands that have been reported over the past decade.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Early compounds include the highly selective α7 agonist <b>3</b> (AR-R17779),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the partial agonist <b>1</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and the potent α4β2 agonist <b>4</b> (A-85380, <i>K</i><sub>i</sub> = 0.052 nM), which also exhibits a reasonable level of α7 affinity (<i>K</i><sub>i</sub> = 148 nM).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Many of the more recent compounds have been based on the quinuclidine scaffold <b>5</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with variations in the linker and aromatic regions. In comparing these compounds, several structural features are evident, including a basic amine that is protonated at physiological pH, a hydrogen bond acceptor, and a hydrophobic group.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Additionally, compounds <b>1</b>, <b>4</b>, and <b>6</b><a onclick="showRef(event, 'cit24d'); return false;" href="javascript:void(0);" class="ref cit24d">(24d)</a> have a 3-pyridyl moiety that is also found in nicotine. While the 3-alkoxypyridine portion of compound <b>4</b> may serve as the hydrogen bond acceptor and/or the hydrophobic region, the pyridine groups in <b>1</b> and <b>6</b> appear to occupy an additional region within the ligand binding site. In designing a new class of α7 modulators, we chose to combine all four of these structural features on the piperazine core, leading to the generic compounds <b>7</b> and <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The N-4 nitrogen of the piperazine would serve as the basic amine, while the N-1 nitrogen allows for convenient introduction of the hydrogen bond acceptor and hydrophobic groups via benzoxazoles and benzothiazoles without the addition of a stereocenter. The 3-pyridyl moiety is readily introduced at the 2-position from piperazine-2-carboxylic acid.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the <i>N</i>-1 benzoxazole- and benzothiazole-substituted 2-((pyridin-3-yloxy)methyl)piperazines is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. We have previously reported the synthesis of 2-(phenoxymethyl)piperazines by phenoxide ring-opening of the bicyclic oxazolidinone <b>10</b> and utilized this methodology as an efficient method to introduce the 3-alkoxypyridine group while simultaneously unmasking the <i>N</i>-1 nitrogen of the piperazine.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>10</b> was readily prepared from piperazine-2-carboxylic acid, <b>9</b>, in three steps, and serves as an orthogonally protected precursor without the need for selective protection of the two piperazine nitrogens. Oxazolidinone ring-opening with the in situ generated potassium salt of 3-hydroxypyridine in DMF gave the key piperazine intermediate <b>11</b>. The benzoxazole substituents were introduced by treating compound <b>11</b> with the benzoxazole-2-thiones <b>12</b>. The benzothiazole compounds were prepared via a palladium mediated coupling with <b>11</b> and the 2-chlorobenzothiazoles <b>13</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In both cases, the Boc group was removed with HCl and the compounds were free-based on work-up. While compounds <b>14</b>, <b>15</b>, and <b>23</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were isolated as the free-base forms, the remaining compounds were converted to the monohydrochloride salts by the addition of one equivalent of HCl. In general, compounds were prepared as racemic mixtures for initial biological evaluation. The individual enantiomers of selected compounds were then prepared as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> starting from the commercially available enantiomers of piperazine-2-carboxylic acid.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 equiv Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 50 °C, 96% yield; (b) BH<sub>3</sub>–THF, THF, 50 °C; (c) 0.1 equiv NaH, THF, reflux, 80% yield for 2 steps; (d) 10 equiv 3-hydroxypyridine, 10 equiv KOtBu, DMF, 90 °C, 50–80% yield; (e) <b>12</b>, toluene, DMSO, 110 °C; (f) <b>13</b>, Pd(OAc)<sub>2</sub>, Ph<sub>3</sub>P, NaOtBu, toluene, 110 °C; (g) 4 M HCl in 1,4-dioxane, MeOH; (h) 1 equiv HCl.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro α7 nAChR Binding Affinity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">α7<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> IC<sub>50</sub> (nM) ± SEM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">106</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">22 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">71 ± 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="center">75 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>R</b></i>)-<b>17</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="center">67 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>S</b></i>)-<b>17</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="center">3200 ± 370</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>R</b></i>)-<b>18</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">5.5 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>S</b></i>)-<b>18</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1580 ± 50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">490 ± 160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">79 ± 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>R</b></i>)-<b>20</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">46 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i><b>S</b></i>)-<b>20</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">5100 ± 1100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">107 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">85 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">153 ± 45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">270 ± 110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">338 ± 48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">132 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">17 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">19 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">32 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Rat PC-12 cell binding assay, fluorescently labeled α-bungarotoxin, average of three experiments except for <b>14</b>, which is the average of two.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">All compounds were assayed as the mono-HCl salts except for <b>14</b>, <b>19</b>, and <b>23</b>, which were assayed as the free-bases.</p></div></div></div><div class="NLM_p">Amides, carbamates, and ureas were synthesized as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Amide and urea substituents were introduced by reaction of the key piperazine intermediate <b>11</b> with either acid chlorides or isocyanates, respectively. The carbamates were prepared by conversion of <b>11</b> to the <i>N</i>-acylimidazole <b>31</b>, followed by displacement with phenols under basic conditions. In general, the Boc group was removed with HCl and the final compounds were isolated as the dihydrochloride salts. Compound <b>36</b> was isolated as the free-base upon treatment with aqueous NaOH. As with the benzoxazoles and benzothiazoles, the compounds were first prepared as racemates. Selected active compounds were then constructed as single enantiomers.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArCOCl or ArOCH<sub>2</sub>COCl, CH<sub>2</sub>Cl<sub>2</sub>; (b) ArNCO, CH<sub>2</sub>Cl<sub>2</sub>; (c) 4 M HCl in 1,4-dioxane, MeOH; (d) <i>N</i>,<i>N</i>-carbonyldiimidazole, CH<sub>2</sub>Cl<sub>2</sub>; (e) ArOH, Et<sub>3</sub>N, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 70 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gratifyingly, our design strategy yielded compounds with very good binding affinity in the α7 nAChR assay as exhibited by the parent benzoxazole and benzothiazole analogues <b>14</b> and <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Moreover, the acylated analogues also showed good binding affinity for the α7 nAChR (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro α7 nAChR Binding Affinity<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">α7<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> IC<sub>50</sub> (nM) ± SEM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">bond</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1080 ± 190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">bond</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">6100 ± 2200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">560 ± 70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">110 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2340 ± 110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">680 ± 200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">70 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">9.5 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Rat PC-12 cell binding assay, fluorescently labeled α-bungarotoxin, average of at least two experiments.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">All compounds were assayed as the di-HCl salts except for <b>36</b>, which was assayed as the free-base.</p></div></div></div><div class="NLM_p">In general, the benzoxazole compounds were somewhat more potent than the corresponding benzothiazoles (compounds <b>14</b>–<b>16</b> vs <b>19</b>–<b>21</b>). Substitution at the 5- or 6-position led to improved activity in both of the bicyclic ring series, with substitution at the 6-position favored slightly (compounds <b>15</b>, <b>16</b>, <b>20</b>, and <b>21</b>). This improvement in binding affinity is also dependent on the electronics of the substituent as exemplified by compounds <b>20</b> and <b>22</b>–<b>25</b>. In these examples, activity decreases as the electron withdrawing ability of the substituent increases (OMe > CH<sub>3</sub> > Cl > OCF<sub>3</sub> > CF<sub>3</sub>). There also appears to be a steric component because the strongly electron withdrawing compounds <b>24</b> and <b>26</b> still exhibit improved binding affinity over the unsubstituted compound <b>19</b>. These results fit nicely into the α7 nAChR pharmacophore model discussed previously wherein the oxazole and thiazole portions of the bicycles act as the hydrogen bond acceptor and the phenyl rings act as the hydrophobic region. Electron donating substituents enhance the hydrogen bonding ability of the benzoxazole and benzothiazole rings, leading to improved potency. The opposite effect on hydrogen bonding ability is true for electron withdrawing groups, leading to reduced affinity, yet this is counterbalanced to some extent by the added hydrophobicity of these substituents. The fact that both heteroatoms in the benzoxazole and benzothiazole rings are capable of hydrogen bonding may also explain why substituents at either the 5- or 6-position are tolerated. The 6-position is slightly favored, probably because the electron donating group is <i>para</i> to the nitrogen atom, which has greater hydrogen bonding ability relative to the other heteroatom.</div><div class="NLM_p">In exploring other substitution on the benzothiazole ring, the 4-fluoro substituted compounds <b>27</b> and <b>28</b> were found to have significantly improved binding affinities relative to their unsubstituted counterparts, compounds <b>19</b> and <b>26</b>. On the hypothesis that the aromatic C–F bond might also be involved in a hydrogen bond, the oxazolo[4,5-<i>b</i>]pyridine and thiazolo[4,5-<i>b</i>]pyridine derivatives <b>18</b>, <b>29</b>, and <b>30</b> were prepared. Once again, these compounds were found to be more than an order of magnitude more potent than the corresponding benzoxazole and benzothiazoles. As before, the oxygen analogue <b>18</b> was more potent than the sulfur compound <b>29</b> and a substituent at the 6-position led to improved binding affinity.</div><div class="NLM_p">The single enantiomers of compounds <b>17</b>, <b>18</b>, and <b>20</b> were prepared in order to explore the effects of the stereocenter on α7 nAChR activity. The <i>R</i>-enantiomers were found to be between 50- and 400-fold more potent than the corresponding <i>S</i>-enantiomers. That the <i>R</i>-enantiomers are more potent is not surprising, as this enantiomer overlaps better than the <i>S</i>-enantiomer with literature compounds <b>4</b> and <b>6</b> (based on examination of physical models).</div><div class="NLM_p">To establish that compound (<b><i>R</i></b>)-<b>18</b> is a selective agonist of α7 nAChR, it was evaluated in a voltage clamp electrophysiology study in <i>Xenopus</i> oocytes independently expressing either human α7 or human α4β2 nAChR. These experiments showed that compound (<b><i>R</i></b>)-<b>18</b> is a potent agonist of α7 nAChR with an EC<sub>50</sub> of 200 nM and an efficacy equivalent to 85% of the maximal acetylcholine response observed at 300 μM.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In contrast, no agonist activity on the α4β2 nAChR was observed.</div><div class="NLM_p">In the amide series (compounds <b>32</b>–<b>36</b>), the spacer length between the carbonyl and the phenyl ring had a profound impact on binding affinity, with the phenylacetamides <b>34</b> and <b>35</b> favored over the benzamides <b>32</b> and <b>33</b> and the phenoxyacetamide <b>36</b>. This is particularly pronounced, with a 4-chloro substituent on the phenyl ring where the phenylacetamide is favored by 60-fold over the corresponding benzamide. The urea analogues <b>37</b> and <b>38</b> have almost identical binding affinities to the phenylacetamides. In contrast, the carbamate analogues (compounds <b>39</b>–<b>41</b>) are an order of magnitude more potent than both the phenylacetamides and the ureas. As is the case in the benzoxazole and benzothiazole series, a substituent at the 4-position of the phenyl ring leads to a 4–10-fold improvement in binding affinity. Thus, the 4-substituted phenylcarbamates <b>40</b> and <b>41</b> have IC<sub>50</sub>s of 9.5 and 11 nM, respectively, and are in the same potency range as the most potent benzoxazole compound, (<b><i>R</i></b>)-<b>18</b> (IC<sub>50</sub> = 5.5 nM). Despite their superior potency profiles, we had concerns about possible chemical and metabolic instability of the carbamate group and the possible generation of free phenol in vivo. Ureas are generally more stable than carbamates, and given the sub-100 nM potency of compound <b>38</b>, this series was selected for further SAR exploration.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> provides a summary of the SAR of substitution on the phenyl ring in the urea series. As observed in the benzoxazole and benzothiazole series, substituents at either the 3- or 4-position of the phenyl ring led to improved binding affinity (compounds <b>38</b>, <b>42</b>, <b>47</b>, and <b>48</b> vs <b>37</b>). This effect was especially pronounced at the 4-position, leading to a 10-fold improvement over the unsubstituted compound. While a substituent at the 2-position was tolerated (compound <b>49</b>), no improvement was observed relative to the parent compound. This observation was confirmed with the 2,4-disubstituted compound <b>50</b>, which is equipotent to the corresponding 4-substituted compound <b>47</b>. Although somewhat small (2–3-fold), there does appear to be a trend toward improved α7 nAChR activity for the 3,4-disubstituted compounds (compounds <b>43</b>, <b>51</b>, and <b>54</b>). With the 3,4-disubstituted bicyclic compound <b>58</b>, though, binding affinity was no better than the unsubstituted compound <b>37</b>. This was a trend we observed in a number of similar bicyclic compounds (data not shown) and indicates that the constraint locks the two substituents into a sterically unfavorable conformation. We also explored the possibility that a hydrogen bond acceptor at the 2-position might lead to a significant improvement in binding affinity as observed in the benzoxazole and benzothiazole series. In the urea series, however, the 2-fluoro compound <b>55</b> was equipotent to its unsubstituted counterpart, compound <b>53</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro α7 nAChR Binding Affinity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="±">α7<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">680 ± 200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">70 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">210 ± 50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">74 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">220 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">i-Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">280 ± 25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">60 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>S</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">18000 ± 5700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">340 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">850 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">80 ± 30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">152 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">42 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">COPh</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">41 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" colspan="2" align="center">–OCH<sub>2</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">630 ± 90</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Rat PC-12 cell binding assay, fluorescently labeled α-bungarotoxin, average of at least two experiments.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">All compounds were assayed as the di-HCl salts.</p></div></div></div><div class="NLM_p">In looking at a variety of substituents at the 4-position of the phenyl ring, we found that smaller, electron-donating (compounds <b>44</b> and <b>47</b>) to mildly electron-withdrawing (compounds <b>38</b> and <b>53</b>) groups were equipotent in α7 nAChR binding affinities, with IC<sub>50</sub>s in the 50–75 nM range. Compounds with strongly electron-withdrawing substituents (compounds <b>45</b> and <b>52</b>), however, were 3–5-fold less potent. Whereas the bulky isopropyl group of compound <b>46</b> also resulted in a decrease in binding affinity, the planar phenyl substituent of compound <b>56</b> provided the most potent compound in the urea series with an IC<sub>50</sub> of 13 nM. A number of known α7 modulators also have phenyl groups in this region, indicating that there is a fairly large hydrophobic pocket in the ligand binding site. The benzophenone moiety of compound <b>57</b>, with an IC<sub>50</sub> of 41 nM, also benefits from this added lipophilic interaction and is able to overcome some of the electronic liability of the electron withdrawing carbonyl group. These results again fit nicely into the α7 nAChR pharmacophore discussed earlier wherein the urea carbonyl acts as a hydrogen bond acceptor and the phenyl ring and its substituents occupy a hydrophobic region of the binding pocket.</div><div class="NLM_p">The single enantiomers of compound <b>47</b> were prepared, with the majority of the α7 nAChR activity found in the <i>R</i>-enantiomer. Whereas in the benzoxazole and benzothiazole series, the <i>S</i>-enantiomers generally bound to α7 in the low micromolar range, compound (<b><i>S</i></b>)-<b>47</b> had an IC<sub>50</sub> of 18 μM, about 1000-fold less potent than (<b><i>R</i></b>)-<b>47</b> (IC<sub>50</sub> = 19 nM).</div><div class="NLM_p">Compound (<b><i>R</i></b>)-<b>47</b> was also evaluated in two voltage clamp experiments using <i>Xenopus</i> oocytes independently expressing either α7 or α4β2 nAChRs. As with compound (<b><i>R</i></b>)-<b>18</b>, no agonist activity was observed in cells expressing α4β2 nAChRs. To our surprise, compound (<b><i>R</i></b>)-<b>47</b> did not elicit a current from α7 nAChRs on its own. However, when the oocytes were pretreated with PNU-120596, a type 2 positive allosteric modulator of nAChRs,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> a current was observed.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This type of behavior is consistent with a silent agonist. Thus, compound (<b><i>R</i></b>)-<b>47</b> appears to bypass the open channel state proceeding directly to a desensitized state without the passage of ions.</div><div class="NLM_p">On the basis of α7 nAChR binding affinities and structural diversity, several compounds were selected for further profiling in selectivity assays against the α4β2 nAChR, the muscle type nAChR, α1β1γδ, and the 5-HT<sub>3</sub> receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The benzoxazole and oxazolo[4,5-<i>b</i>]pyridine compounds <b>14</b>, (<b><i>R</i></b>)-<b>17</b>, and (<b><i>R</i></b>)-<b>18</b> all showed nearly complete inhibition of the α4β2 nAChR at a concentration of 10 μM. An IC<sub>50</sub> of 58 nM was found for (<b><i>R</i></b>)-<b>18</b>, corresponding to a modest 11-fold binding selectivity for the α7 nAChR. This stands in contrast to the functional data showing no agonist activity and indicates that the compound might be an antagonist of the α4β2 nAChR. The benzothiazole compounds (<b><i>R</i></b>)-<b>20</b>, <b>27</b>, and <b>28</b>, on the other hand, had improved selectivity over the α4β2 nAChR, especially in the latter two cases. In contrast to the benzoxazoles and benzothiazoles, none of the ureas showed significant binding to the α4β2 nAChR at 10 μM. Indeed, compound (<b><i>R</i></b>)-<b>47</b> was found to have an IC<sub>50</sub> of >100 μM for α4β2, consistent with its lack of functional activity in the voltage clamp experiment. The carbamate analogue, <b>41</b>, was less selective for the α4β2 nAChR, exhibiting 90% inhibition at 10 μM. None of the compounds profiled showed any significant inhibition of the muscle-type receptor at 10 μM. For the 5-HT<sub>3</sub> receptor, the ureas and carbamates showed lower inhibition in general than the benzoxazoles and benzothiazoles. Compound (<b><i>R</i></b>)-<b>18</b> was the only urea that exhibited less than 50% inhibition at 10 μM, while compound (<b><i>R</i></b>)-<b>47</b> was the most selective compound, with only 7% inhibition at 10 μM.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Selectivity and Safety Profiling<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">% inhibition at 10 μM</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">Cyp % inhibition at 10 μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">α7 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">α1β1γδ</th><th class="colsep0 rowsep0" align="center">5-HT<sub>3</sub></th><th class="colsep0 rowsep0" align="center">hERG % Inhibition at 1 μM</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">106</td><td class="colsep0 rowsep0" align="center">89</td><td class="colsep0 rowsep0" align="center">–2</td><td class="colsep0 rowsep0" align="center">95</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="center">87</td><td class="colsep0 rowsep0" align="center">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>17</b></td><td class="colsep0 rowsep0" align="center">67</td><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>18</b></td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="center">58 nM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">72 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>20</b></td><td class="colsep0 rowsep0" align="center">46</td><td class="colsep0 rowsep0" align="center">83</td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="center">99</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">63</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">78</td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">53</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">99</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">63</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">91</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">67</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="center">72</td><td class="colsep0 rowsep0" align="center">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">90</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">39</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">–8</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)<b>-47</b></td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">31 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" colspan="5" align="center">>100 μM all isoforms<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">47</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">80</td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">48</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">51</td><td class="colsep0 rowsep0" align="center">85</td><td class="colsep0 rowsep0" align="center">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">47</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">41</td><td class="colsep0 rowsep0" align="center">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">41</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">49</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">All assays. except α7, performed at Cerep in duplicate.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">IC<sub>50</sub> based on a 5 concentration titration curve. Data reduction performed in SigmaPlot</p></div></div></div><div class="NLM_p">In vitro safety was assessed for this set of compounds including human ether-à-go-go-related gene (hERG) and cytochrome P450 (Cyp) inhibition assays. Inhibition of the hERG potassium channel is believed to cause prolongation of the QT interval and to increase the risk of cardiac arrhythmia.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Because this class of compounds loosely fits the pharmacophore of known hERG inhibitors, compounds were routinely assessed in a whole-cell voltage-clamp assay at 1 μM. Compounds <b>14</b>, (<b><i>R</i></b>)-<b>20</b>, <b>27</b>, and <b>28</b> showed moderate inhibition, with the benzothiazole compounds having somewhat higher inhibition than the benzoxazole. The oxazolo[4,5-<i>b</i>]pyridine (<b><i>R</i></b>)-<b>18</b> was found to have a hERG IC<sub>50</sub> of 72 μM, indicating a good margin of safety relative to both the α7 nAChR activity (5.5 nM) and the efficacious plasma levels (≤2.5 μM, see below). The urea compounds, <b>47</b>, (<i><b>R</b></i>)-<b>47</b>, <b>51</b>, <b>54</b>, <b>55</b>, and <b>57</b>, showed modest inhibition of hERG, with the more lipophilic compounds <b>54</b>, and <b>55</b> inhibiting 27% and 40% of the channel activity, respectively. Compound (<b><i>R</i></b>)-<b>47</b> was further assessed in a five-point assay and was found to have a hERG IC<sub>50</sub> of 31 μM. This corresponds to a good margin of safety relative to both the α7 nAChR activity (19 nM) and the efficacious plasma levels (≤1 μM, see below).</div><div class="NLM_p">The compounds were also assayed for inhibition of the five main Cyp isoforms at a concentration of 10 μM. Here, a clear distinction between the benzoxazole and benzothiazole classes was seen. The benzothiazole compounds (<b><i>R</i></b>)-<b>20</b>, <b>27</b>, and <b>28</b> all showed 50% or greater inhibition of all of the isoforms except 2C9. The benzoxazole <b>14</b> only showed significant inhibition of 2D6 (87%), while the oxazolo[4,5-<i>b</i>]pyridine (<b><i>R</i></b>)-<b>18</b> was again the cleanest compound with no significant inhibition of any of the five isoforms. In the urea series, compound <b>54</b> inhibited 80% of the activity of Cyps 2D6 and 3A4, while compounds <b>51</b> and <b>55</b> were both fairly clean with only moderate inhibition of Cyp 3A4. Compound <b>47</b> separated itself from these two compounds with less than 20% inhibition at all of the five isoforms. (<b><i>R</i></b>)-<b>47</b> was found to have IC<sub>50</sub>s greater than 100 μM across the profiled Cyps. These differences correlate fairly well with the lipophilicity of the compounds, with improved Cyp profiles observed with decreasing lipophilicity.</div><div class="NLM_p">On the basis of the initial in vitro ADMET properties, compounds (<b><i>R</i></b>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b> were assayed in a panel of 55 receptors, ion channels, and transporters (<a class="ref internalNav" href="#notes-8" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>) as well as 11 enzymes (<a class="ref internalNav" href="#notes-8" aria-label="Supporting Information Table S2">Supporting Information Table S2</a>). Compound (<b><i>R</i></b>)-<b>18</b> showed some activity in the A<sub>2a</sub> binding assay (50% inhibition at 10 μM). No other activity was >40%. Compound (<b><i>R</i></b>)-<b>47</b> showed activity in the histamine H<sub>3</sub> receptor (86% at 10 μM) and the sodium channel site 2 (48% at 10 μM). Thus, the off-target activity demonstrated by these compounds was limited and nonoverlapping. Given their favorable activity, selectivity, and in vitro safety profile, compounds (<b><i>R</i></b>)-<b>18</b>, and (<b><i>R</i></b>)-<b>47</b> were selected for in vivo profiling. Compound (<b><i>R</i></b>)-<b>18</b> was found to have acceptable pharmacokinetic (PK) properties upon oral administration in mouse at a 5 mg/kg dose (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Good oral bioavailability of 50% was observed, with a <i>C</i><sub>max</sub> of 787 ng/mL (2.53 μM). Despite the moderate oral half-life of 98 min, plasma concentrations were still well above the α7 nAChR IC<sub>50</sub> of 5.5 nM after 6 h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of Compound (<b><i>R</i></b>)-<b>18</b> in Mouse after Oral Administration</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>18</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>18</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">787</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">103</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">324</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">(<b><i>R</i></b>)-<b>47</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">141</td><td class="colsep0 rowsep0" align="char" char=".">751</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div><div class="NLM_p">Compound (<b><i>R</i></b>)-<b>47</b> also demonstrated acceptable PK properties upon oral administration in mouse and rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) typified by very good oral bioavailability of 76% and 89% in mouse and rat, respectively. The compound is rapidly cleared in both species, leading to fairly short half-lives, although the values are somewhat better upon oral administration. The <i>C</i><sub>max</sub> of 324 ng/mL (0.95 μM) in mouse corresponds to an approximately 50-fold excess over the α7 IC<sub>50</sub>. In a separate experiment, it was found that (<b><i>R</i></b>)-<b>47</b> has no significant brain penetration in mouse, with mean brain/plasma ratios of ≤0.06 at 5, 15, and 30 min postintravenous administration. It has been shown that effects mediated by α7 nAChRs in the periphery may be independent of channel current.<a onclick="showRef(event, 'cit10c ref32'); return false;" href="javascript:void(0);" class="ref cit10c ref32">(10c, 32)</a> For example, NS-6740, a silent agonist of α7,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> has been shown to inhibit LPS-induced TNF in microglial cells<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> while having no effect on cognition.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In addition, after this work was completed, ASM-024, a silent agonist of α7 nAChR (structure not disclosed), has shown efficacy in the murine ovalbumin challenge model of asthma.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Given this data, both compounds (<b><i>R</i></b>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b> were evaluated in a murine model of allergic lung inflammation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this model, Balb/c mice were sensitized to ovalbumin on days 1 and 14 via intraperitoneal (IP) injection. On days 29, 30, and 31, the sensitized animals received intranasal ovalbumin challenges. Compound (<b><i>R</i></b>)-<b>18</b> was administered orally 30 min prior to each challenge on days 29–31 at doses of 1 and 5 mg/kg. Eight hours after the third ovalbumin challenge, bronchoalveolar lavage (BAL) fluid was collected and analyzed for cellular infiltration. As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, the ovalbumin sensitization and challenge leads to a large, mainly neutrophilic cellular infiltration in the BAL fluid at the 8 h time point (vehicle control vs saline/saline control). Although smaller, there is also a statistically significant influx of eosinophils. Compound (<b><i>R</i></b>)-<b>18</b> exhibited statistically significant inhibition of both total cells (60 ± 11%, <i>p</i> < 0.001 at 5 mg/kg; 60 ± 23%, <i>p</i> < 0.01 at 1 mg/kg) and neutrophils (78 ± 12%, <i>p</i> < 0.001 at 5 mg/kg; 90 ± 8%, <i>p</i> < 0.001 at 1 mg/kg) at both doses. While the 5 mg/kg dose did not show statistically significant inhibition of eosinophils, the 1 mg/kg dose inhibited 64 ± 9% (<i>p</i> < 0.001) of the eosinophilic infiltration. These data suggest that α7 modulators may have efficacy in various phenotypes of asthma, including those involving infiltration of eosinophils and/or neutrophils.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of (<b><i>R</i></b>)-<b>18</b> (QD) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (**) <i>p</i> < 0.01 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound (<b><i>R</i></b>)-<b>47</b> was similarly evaluated in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation in two separate experiments.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In the first experiment, compound (<b><i>R</i></b>)-<b>47</b> was administered orally, twice a day, at doses of 0.2, 1, 5, and 30 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For the two intermediate doses, statistically significant inhibition of total cells (63 ± 6%, <i>p</i> < 0.001 at 5 mg/kg; 53 ± 7%, <i>p</i> < 0.001 at 1 mg/kg), neutrophils (70 ± 5%, <i>p</i> < 0.001 at 5 mg/kg; 61 ± 1%, <i>p</i> < 0.001 at 1 mg/kg), and eosinophils (74 ± 8%, <i>p</i> < 0.001 at 5 mg/kg; 48 ± 9%, <i>p</i> < 0.001 at 1 mg/kg) was observed. The 5 mg/kg dose results are comparable to those observed with compound (<b><i>R</i></b>)-<b>18</b> dosed at 1 mg/kg, while the 1 mg/kg dose of (<b><i>R</i></b>)-<b>47</b> was somewhat less efficacious in inhibiting both neutrophils and eosinophils. This is consistent with the 5-fold difference in potency between the two compounds. No significant inhibition was observed at the lowest dose, likely due to insufficient plasma levels of compound. Similarly, no significant inhibition of cellular infiltration was observed for the 30 mg/kg dose. A possible explanation for this is discussed below.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of (<b><i>R</i></b>)-<b>47</b> (BID) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (**) <i>p</i> < 0.005 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further demonstrate that the in vivo efficacy results were mediated through the α7 nAChR, the racemic compound <b>47</b> and its two enantiomers, (<b><i>R</i></b>)-<b>47</b> and (<b><i>S</i></b>)-<b>47</b>, were dosed in the ovalbumin sensitization and challenge model (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In this experiment, both the racemate dosed at 10 mg/kg and (<b><i>R</i></b>)-<b>47</b> dosed at 1 mg/kg showed statistically significant inhibition of total cells, neutrophils, and eosinophils comparable to the efficacy observed in the previous study. The very weak α7 modulator (<b><i>S</i></b>)-<b>47</b>, on the other hand, showed no significant inhibition of neutrophils or eosinophils at 1 mg/kg relative to vehicle. This finding further supports the theory that the anti-inflammatory effects of (<b><i>R</i></b>)-<b>47</b> are mediated through the α7 nAChR.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>47</b>, (<b><i>R</i></b>)-<b>47</b>, and (<b><i>S</i></b>)-<b>47</b> (BID) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (*) <i>p</i> < 0.05 vs vehicle control; (**) <i>p</i> < 0.005 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The question remains as to why (<b><i>R</i></b>)-<b>47</b> showed reduced efficacy when dosed at 30 mg/kg in the ovalbumin model. Papke and co-workers<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> have shown that α7 nAChRs have at least two distinct desensitized states, D<sub>s</sub> and D<sub>i</sub>. Furthermore, high agonist concentrations appear to stabilize the D<sub>i</sub> state. We can thus hypothesize that (<b><i>R</i></b>)-<b>47</b> at low concentrations induces a desensitized state that is competent to initiate the anti-inflammatory effect. However, at high concentrations, the compound stabilizes a distinct desensitized state that is incompetent with respect to anti-inflammatory activity. Although we cannot rigorously exclude an unknown mechanism of action, the close structural similarity, selectivity profile, and in vivo efficacy of these compounds supports the hypothesis that α7 nAChRs are important mediators of the anti-inflammatory response in the murine ovalbumin challenge model of asthma, in an ion current independent manner.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The design, synthesis, SAR, and in vitro and in vivo profiles of N-1 substituted 2-((pyridin-3-yloxy)methyl)piperazines as α7 nAChR modulators have been described. Of these compounds, the oxazolo[4,5-<i>b</i>]pyridine (<b><i>R</i></b>)-<b>18</b> and methoxyphenyl urea (<b><i>R</i></b>)-<b>47</b> were found to be potent modulators of the α7 nAChR with good selectivity over other nAChRs. These compounds also exhibited a favorable in vitro safety profile and good oral bioavailability. Additionally, both compounds were shown to significantly decrease cellular infiltration in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation at oral doses down to 1 mg/kg with no associated adverse effects. Despite the similarity in these compounds, only (<b><i>R</i></b>)-<b>18</b> is a true agonist, while (<b><i>R</i></b>)-<b>47</b> is a silent agonist. These results provide added support to the theory that the α7 nAChR is an essential regulator of the inflammatory process and that this effect is likely independent of ion current. Nonetheless, a selective agonist of the receptor may be useful in the treatment of inflammatory conditions.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div class="NLM_p">Air and moisture sensitive liquids and reagents were transferred via syringe or cannula and were introduced into oven-dried glassware under a positive pressure of dry nitrogen through rubber septa. All reactions were stirred magnetically. Commercial reagents were used without further purification. Analytical thin-layer chromatography was performed on EM Science precoated glass-backed silica gel 60 Å F-254 250 μm plates. Visualization of the plates was effected by one or more of the following techniques: (a) ultraviolet illumination, (b) exposure to iodine vapor, and/or (c) immersion of the plate in a 10% solution of phosphomolybdic acid (PMA) in ethanol followed by heating. Column chromatography was performed on a FlashMaster Personal or FlashMaster Personal Plus system using ISOLUTE Flash Si II silica gel prepacked cartridges (available from Biotage). Preparative reversed-phase HPLC chromatography (HPLC) was accomplished using an Agilent 1100 series system and an Agilent Prep-C18 (21.2 mm I.D. × 150 mm) column equipped with an Agilent Prep-C18 (21.2 mm I.D.) guard column. The mobile phase used was a mixture of H<sub>2</sub>O (A) and MeCN (B) containing 0.1% TFA. <sup>1</sup>H NMR spectra were recorded on a Varian Gemini 2400 (400 MHz) spectrometer and are reported in ppm using residual solvent as the internal standard (CDCl<sub>3</sub> at 7.24 ppm or DMSO-<i>d</i><sub>6</sub> at 2.50 ppm). <sup>13</sup>C NMR spectra were recorded on a Varian Gemini 2400 (100 MHz) spectrometer and are reported in ppm using residual solvent as the internal standard (CDCl<sub>3</sub> at 77.2 ppm or DMSO-<i>d</i><sub>6</sub> at 39.5 ppm). High performance liquid chromatography–electrospray mass spectra (LC-MS) were obtained using an Agilent 1100 series HPLC equipped with a binary pump, a diode array detector monitored at 254 and 214 nm, an Agilent Eclipse XDB-C8 (4.6 mm I.D. × 150 mm, 5 μm) column, and an Agilent 1100 series LC/MSD mass spectrometer with electrospray ionization. Spectra were scanned from 100 to 1000 amu. The eluent was a mixture of H<sub>2</sub>O (A) and MeCN (B) containing 0.1% AcOH at a flow rate of 1 mL/min. A typical gradient was: (a) time = 0, 90% A, 10% B; (b) time = 9 min, 10% A, 90% B; (c) time = 9.5 min, 90% A, 10% B; (d) time = 12 min, 90% A, 10% B. Purity of the final compounds was assessed by two orthogonal HPLC methods using the Agilent 1100 series HPLC described above. Method A: Agilent Eclipse XDB-C8 (4.6 mm I.D. × 150 mm, 5 μm) column, gradient elution of H<sub>2</sub>O with 0.1% AcOH (A) and MeOH (B) at 1.5 mL/min, (a) time = 0, 95% A, 5% B; (b) time = 11 min, 100% B; (c) time =12 min, 95% A, 5% B; (d) time = 14.5 min, 95% A, 5% B. Method B: Agilent Zorbax Eclipse XDB-C18 (4.6 mm I.D. × 150 mm, 5 μm) column, gradient elution of H<sub>2</sub>O with 0.1% TFA (A) and MeCN with 0.1% TFA (B) at 1.5 mL/min, (a) time = 0, 95% A, 5% B; (b) time = 11 min, 100% B; (c) time = 12 min, 95% A, 5% B; (d) time = 14.5 min, 95% A, 5% B. All compounds submitted for biological assays showed ≥95% purity. Elemental analysis (C, H, N) for select compounds was performed by Atlantic Microlab, Inc. (Norcross, Georgia).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 1,4-Bis(<i>tert</i>-butoxycarbonyl)piperazine-2-carboxylic Acid</h4><div class="NLM_p last">According to the literature procedure,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> a solution of di-<i>tert</i>-butyldicarbonate (63 g, 290 mmol) in MeOH (100 mL) was added portionwise to a solution of piperazine-2-carboxyilc acid dihydrochloride (25.0 g, 123 mmol) and triethylamine (48 mL, 340 mmol) in MeOH (150 mL) over 30 min. Upon complete addition, the reaction mixture was heated to 50 °C for 2 h. Upon cooling to rt, the reaction mixture was concentrated under reduced pressure. The material was dissolved in water (300 mL), and the solution was brought to pH 2 with 1 M aqueous HCl. This was extracted with EtOAc (4 × 200 mL), and the combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure until ∼100 mL EtOAc remained. The solution was diluted with hexanes (150 mL) and cooled to 0 °C. The resulting solid was collected by filtration, washed with hexanes (2×), and air-dried. This gave 38.9 g (96%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.02–12.80 (br, 1H), 4.50–4.24 (m, 2H), 3.94–3.72 (br, 1H), 3.66 (d, <i>J</i> = 12.8 Hz, 1H), 3.22–2.92 (m, 2H), 2.90–2.68 (br, 1H), 1.42–1.34, (m, 18H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>tert</i>-Butyl 3-Oxotetrahydro-1<i>H</i>-oxazolo[3,4-<i>a</i>]pyrazine-7(3<i>H</i>)-carboxylate (<b>10</b>)</h4><div class="NLM_p last">Borane–THF complex (1.0 M solution in THF, 200 mL, 200 mmol) was added slowly to a solution of 1,4-bis(<i>tert</i>-butoxycarbonyl)piperazine-2-carboxylic acid (30.3 g, 91.7 mmol) in THF (100 mL). Upon complete addition, the reaction mixture was heated to 50 °C for 2 h. Upon cooling to rt, the reaction mixture was carefully quenched by the dropwise addition of MeOH. After gas evolution ceased, the reaction mixture was concentrated under reduced pressure. The material was dissolved in EtOAc (300 mL) and washed with 1 N NaOH (2 × 200 mL) and brine (200 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The material was twice dissolved in THF (50 mL) and concentrated under reduced pressure. The material was dissolved in THF (200 mL), and NaH (60% dispersion in mineral oil, 0.366 g, 0.916 mmol) was added portionwise. The reaction mixture was heated to reflux. After 1 h, the reaction mixture was allowed to cool to rt and was concentrated under reduced pressure. The material was dissolved in EtOAc (300 mL), washed with water (2 × 200 mL) and brine (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting solid was dissolved in EtOAc (200 mL) with heating, diluted with hexanes (200 mL), and allowed to cool to rt. The white, crystalline solid was collected by filtration after 5 h, washed with hexanes (2×), and dried in the fritted funnel under vacuum. This gave 13.29 g (60%) of the product. The filtrate was concentrated under reduced pressure, dissolved in EtOAc (50 mL) with heating, and diluted with hexanes (200 mL). This was allowed to cool to rt and sit over the weekend. The white, crystalline solid was collected by filtration, washed with hexanes (2×), and dried in the fritted funnel under vacuum. This gave an additional 4.49 g (20%) of the product. <i>R</i><sub>f</sub> = 0.43 in 80% EtOAc/hexanes. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.41 (t, <i>J</i> = 8.4 Hz, 1H), 4.35–3.98 (br, 2H), 3.92 (dd, <i>J</i> = 5.6 and 8.8 Hz, 1H), 3.80–3.72 (m, 2H), 2.98 (dt, <i>J</i> = 3.6 and 12.4 Hz, 1H), 2.86–2.70 (br, 1H), 2.70–2.55, (br, 1H), 1.45 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.7, 154.2, 81.1, 65.5, 52.9, 47.7 (br), 43.4 (br), 41.1, 28.7. LC-MS: RT = 6.46 min; [M + Na]<sup>+</sup> = 264.9. Anal. Calcd for C<sub>11</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>: C, 54.53; H, 7.49; N, 11.56. Found: C, 54.38; H, 7.44; N, 11.35.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>tert</i>-Butyl 3-((Pyridin-3-yloxy)methyl)piperazine-1-carboxylate (<b>11</b>)</h4><div class="NLM_p last">Potassium <i>tert</i>-butoxide (1.18 g, 10.5 mmol) was added to a solution of 3-hydroxypyridine (0.979 g, 10.3 mmol) in DMF (10 mL). After 30 min, compound <b>10</b> (0.500 g, 2.06 mmol) was added, and the reaction mixture was heated to 90 °C. After 48 h, a second batch of 3-hydroxypyridine potassium salt was prepared by adding potassium <i>tert</i>-butoxide (1.18 g, 10.5 mmol) to a solution of 3-hydroxypyridine (0.979 g, 10.3 mmol) in DMF (5 mL). This was added to the reaction mixture, and heating was continued at 90 °C for 3 days. Upon cooling to rt, water (50 mL) was added, and the reaction mixture was extracted with EtOAc (3 × 500 mL). The combined extracts were washed with 1 N NaOH (2 × 100 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by column chomatography (0–4% MeOH in CH<sub>2</sub>Cl<sub>2</sub> with 0.5% NH<sub>4</sub>OH gradient) gave 0.487 g (80%) of the desired product as a white solid. <i>R</i><sub>f</sub> = 0.32 in 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> (faint UV, visualized with PMA). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25 (dd, <i>J</i> = 2.4 and 0.8 Hz, 1H), 8.17 (dd, <i>J</i> = 4.2 and 1.4 Hz, 1H), 7.18–7.10 (m, 2H), 3.96–3.80 (m, 4H), 3.09–3.3.0 (m, 1H), 2.96 (br d, <i>J</i> = 11.6 Hz, 1H), 2.87 (br t, <i>J</i> = 12.0 Hz, 1H), 2.80–2.56 (m, 2H), 2.40–2.20 (br, 1H), 1.41 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.1, 154.7, 142.5, 138.0, 123.8, 121.0, 80.0, 69.9, 54.0, 46.0 (br), 45.1, 44.4 (br), 28.7. LC-MS: RT = 3.81 min; [M + H]<sup>+</sup> = 294.1.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole (<b>14</b>)</h4><div class="NLM_p last">Palladium(II) acetate (18 mg, 0.082 mmol) was added to a mixture of compound <b>11</b> (478 mg, 1.63 mmol), 2-chlorobenzoxazole (378 mg, 2.45 mmol), sodium <i>tert</i>-butoxide (172 mg, 1.79 mmol), and triphenylphosphine (21 mg, 0.082 mmol) in toluene (5 mL). The reaction mixture was heated to 110 °C overnight. Upon cooling to rt, the reaction mixture was diluted with EtOAc (50 mL) and washed with water (30 mL) and brine (30 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The material was purified by column chromatography (0–4% MeOH in CH<sub>2</sub>Cl<sub>2</sub> gradient), yielding 121 mg (18%) of a thick oil. <i>R</i><sub>f</sub> = 0.40 in 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>. LC-MS: RT = 8.43 min, [M + H]<sup>+</sup> = 411.2. Then 4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of the intermediate in MeOH (1 mL). After 2 h, the reaction mixture was concentrated under reduced pressure. The material was dissolved in EtOAc, washed with 1 N NaOH (25 mL) and brine (25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. This gave 69.7 mg (76%) of the title compound as a sticky solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22–8.18 (br, 1H), 8.17–8.13 (br, 1H), 7.42–7.27 (m, 4H), 7.15 (t, <i>J</i> = 7.6 Hz, 1H), 7.02 (t, <i>J</i> = 7.8 Hz, 1H), 4.53–4.45 (m, 2H), 4.42–4.34 (m, 1H), 3.97–3.90 (m, 1H), 3.35–3.25 (m, 1H), 3.22–3.15 (m, 1H), 3.06–2.99 (m, 1H), 2.95 (dd, <i>J</i> = 12.8 and 2.8 Hz, 1H), 2.76 (dt, <i>J</i> = 12.8 and 3.2 Hz, 1H). LC-MS: RT = 3.98 min, [M + H]<sup>+</sup> = 311.1. Purity >95% by HPLC method A, RT = 3.63 min. Purity >95% by HPLC method B, RT = 4.71 min.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 6-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole Hydrochloride (<b>15</b>)</h4><div class="NLM_p last">A solution of 6-methoxybenzo[<i>d</i>]oxazole-2(3<i>H</i>)-thione<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (222 mg, 1.23 mmol) and compound <b>11</b> (300 mg, 1.02 mmol) in toluene (3 mL) and DMSO (0.3 mL) was heated to 110 °C overnight. Upon cooling to rt, the reaction mixture was concentrated under reduced pressure. The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 151 mg (22%, di-TFA salt) of a thick oil. LC-MS: RT = 8.29 min, [M + H]<sup>+</sup> = 441.2. Then 4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of the intermediate in MeOH (1 mL). After 1 h, the reaction mixture was concentrated under reduced pressure and purified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). The fractions containing the desired product were combined, brought to pH 12 with 1 N NaOH, and were extracted with EtOAc (3×). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The material was dissolved in MeOH (1 mL), and 4 M HCl in 1,4-dioxane (1 equiv HCl) was added. The mixture was concentrated under reduced pressure to give 37.4 mg (44%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.60–9.46 (br, 1H), 9.20–9.06 (br, 1H), 8.28 (d, <i>J</i> = 3.2 Hz, 1H), 8.22 (dd, <i>J</i> = 4.6 and 1.4 Hz, 1H), 7.48–7.36 (m, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 1H), 7.10 (d, <i>J</i> = 2.4 Hz, 1H), 6.80 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.80–4.72 (m, 1H), 4.58–4.49 (m, 2H), 4.20–4.13 (m, 1H), 3.75 (s, 3H), 3.60–3.34 (m, 4H), 3.24–3.12 (m, 1H). LC-MS: RT = 4.00 min, [M + H]<sup>+</sup> = 341.1. Purity >95% by HPLC method A, RT = 3.73 min. Purity >95% by HPLC method B, RT = 4.88 min.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 5-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole Hydrochloride (<b>16</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>15</b> from 5-methoxybenzo[<i>d</i>]oxazole-2(3<i>H</i>)-thione<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (370 mg, 2.05 mmol) and compound <b>11</b> (200 mg, 0.682 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (30–50% EtOAc in hexanes gradient), yielding 243 mg (81%) of a thick oil. <i>R</i><sub>f</sub> = 0.31 in 70% EtOAc in hexanes. LC-MS: RT = 8.37 min, [M + H]<sup>+</sup> = 441.2. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 120 mg (58%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.55 (br, 1H), 9.42–9.26 (br, 1H), 8.15 (d, <i>J</i> = 2.8 Hz, 1H), 8.07 (dd, <i>J</i> = 4.6 and 1.0 Hz, 1H), 7.38–7.33 (m, 1H), 7.27 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.13 (d, <i>J</i> = 8.8 Hz, 1H), 6.77 (d, <i>J</i> = 2.8 Hz, 1H), 6.46 (dd, <i>J</i> = 8.8 and 2.8 Hz, 1H), 4.67–4.59 (m, 1H), 4.50–4.38 (m, 2H), 4.08–4.00 (m, 1H), 3.58 (s, 3H), 3.48–3.34 (m, 2H), 3.26–3.17 (m, 2H), 3.06–2.93 (m, 1H). LC-MS: RT = 4.09 min, [M + H]<sup>+</sup> = 341.1. Purity >95% by HPLC method A, RT = 3.69 min. Purity >95% by HPLC method B, RT = 4.88 min.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 5-Bromo-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole Hydrochloride (<b>17</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>15</b> from 5-bromobenzo[<i>d</i>]oxazole-2(3<i>H</i>)-thione<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (784 mg, 3.41 mmol) and compound <b>11</b> (200 mg, 0.682 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 310 mg (63%, di-TFA salt) of an off-white solid. LC-MS: RT = 9.49 min, [M + H]<sup>+</sup> = 489.0. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 103 mg (56%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80–9.66 (br, 1H), 9.48–9.34 (br, 1H), 8.32 (d, <i>J</i> = 2.4 Hz, 1H), 8.25 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.56–7.50 (m, 2H), 7.45 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (dd, <i>J</i> = 8.4 and 2.4 Hz, 1H), 4.86–4.79 (m, 1H), 4.68–4.54 (m, 2H), 4.26–4.18 (m, 1H), 3.67–3.52 (m, 2H), 3.46–3.34 (m, 2H), 3.24–3.12 (m, 1H). LC-MS: RT = 4.74 min, [M + H]<sup>+</sup> = 388.9. Purity >95% by HPLC method A, RT = 4.47 min. Purity >95% by HPLC method B, RT = 6.00 min.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-5-Bromo-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole Hydrochloride ((<i><b>R</b></i>)-<b>17</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>17</b> from (<i><b>R</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68–9.44 (br, 2H), 8.22 (d, <i>J</i> = 2.4 Hz, 1H), 8.18 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.42–7.36 (m, 2H), 7.33 (dd, <i>J</i> = 4.4 and 3.6 Hz, 1H), 7.22 (dd, <i>J</i> = 8.6 and 2.2 Hz, 1H), 4.85–4.78 (m, 1H), 4.67–4.50 (m, 2H), 4.26–4.18 (m, 1H), 3.66–3.51 (m, 2H), 3.43–3.34 (m, 2H), 3.16 (dt, <i>J</i> = 12.4 and 3.6 Hz, 1H). LC-MS: RT = 4.71 min, [M + H]<sup>+</sup> = 388.9. Purity >95% by HPLC method A, RT = 4.41 min. Purity >95% by HPLC method B, RT = 6.72 min.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>S</i>)-5-Bromo-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]oxazole Hydrochloride ((<i><b>S</b></i>)-<b>17</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>17</b> from (<i><b>S</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80–9.66 (br, 1H), 9.48–9.28 (br, 1H), 8.25 (d, <i>J</i> = 2.4 Hz, 1H), 8.20 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.54 (d, <i>J</i> = 1.6 Hz, 1H), 7.44–7.39 (m, 2H), 7.36 (dd, <i>J</i> = 4.4 and 3.6 Hz, 1H), 7.22 (dd, <i>J</i> = 8.6 and 2.2 Hz, 1H), 4.86–4.78 (m, 1H), 4.66–4.50 (m, 2H), 4.26–4.18 (m, 1H), 3.66–3.52 (m, 2H), 3.46–3.34 (m, 2H), 3.23–3.10 (m, 1H). LC-MS: RT = 4.67 min, [M + H]<sup>+</sup> = 388.9. Purity >95% by HPLC method A, RT = 4.25 min. Purity >95% by HPLC method B, RT = 6.53 min.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)oxazolo[4,5-<i>b</i>]pyridine Hydrochloride (<b>18</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>15</b> from oxazolo[4,5-<i>b</i>]pyridine-2(3<i>H</i>)-thione<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (369 mg, 2.42 mmol) and compound <b>11</b> (237 mg, 0.808 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (30–100% EtOAc in hexanes gradient), yielding 273 mg (82%) of an off-white solid. <i>R</i><sub>f</sub> = 0.30 in 10% MeOH in EtOAc. LC-MS: RT = 6.59 min, [M + H]<sup>+</sup> = 412.7. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 148 mg (64%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.10–9.55 (br, 2H), 8.29 (d, <i>J</i> = 2.8 Hz, 1H), 8.21 (dd, <i>J</i> = 4.6 and 1.2 Hz, 1H), 8.18 (dd, <i>J</i> = 5.2 and 1.2 Hz, 1H), 7.78 (dd, <i>J</i> = 7.8 and 1.6 Hz, 1H), 7.48 (ddd, <i>J</i> = 8.4, 2.8, and 1.6 Hz, 1H), 7.39 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.07 (dd, <i>J</i> = 7.8 and 5.2 Hz, 1H), 4.92–4.85 (m, 1H), 4.72 (dd, <i>J</i> = 9.8 and 7.4 Hz, 1H), 4.60 (dd, <i>J</i> = 10.6 and 7.0 Hz, 1H), 4.29 (dd, <i>J</i> = 14.8 and 3.2 Hz, 1H), 3.72–3.62 (m, 1H), 3.60–3.54 (m, 1H), 3.46–3.36 (m, 2H), 3.24–3.13 (m, 1H). LC-MS: RT = 2.18 min, [M + H]<sup>+</sup> = 312.5. Purity >95% by HPLC method A, RT = 1.62 min. Purity >95% by HPLC method B, RT = 4.10 min.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)oxazolo[4,5-<i>b</i>]pyridine Hydrochloride ((<i><b>R</b></i>)-<b>18</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>18</b> from (<i><b>R</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92–9.74 (br, 1H), 9.60–9.44 (br, 1H), 8.30 (d, <i>J</i> = 2.8 Hz, 1H), 8.22 (dd, <i>J</i> = 4.6 and 1.2 Hz, 1H), 8.19 (dd, <i>J</i> = 5.2 and 1.2 Hz, 1H), 7.78 (dd, <i>J</i> = 7.8 and 1.6 Hz, 1H), 7.52–7.46 (m, 1H), 7.40 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.07 (dd, <i>J</i> = 7.8 and 5.2 Hz, 1H), 4.92–4.85 (m, 1H), 4.70 (dd, <i>J</i> = 10.4 and 7.2 Hz, 1H), 4.58 (dd, <i>J</i> = 10.4 and 7.2 Hz, 1H), 4.29 (dd, <i>J</i> = 14.8 and 3.2 Hz, 1H), 3.72–3.62 (m, 1H), 3.60–3.54 (m, 1H), 3.46–3.35 (m, 2H), 3.24–3.13 (m, 1H). LC-MS: RT = 3.15 min, [M + H]<sup>+</sup> = 312.1. Purity >95% by HPLC method A, RT = 2.67 min. Purity >95% by HPLC method B, RT = 4.14 min.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)oxazolo[4,5-<i>b</i>]pyridine Hydrochloride ((<i><b>S</b></i>)-<b>18</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>18</b> from (<i><b>S</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.00–9.82 (br, 1H), 9.70–9.50 (br, 1H), 8.36 (d, <i>J</i> = 2.8 Hz, 1H), 8.26 (dd, <i>J</i> = 4.6 and 1.2 Hz, 1H), 8.19 (dd, <i>J</i> = 5.2 and 1.2 Hz, 1H), 7.79 (dd, <i>J</i> = 7.8 and 1.6 Hz, 1H), 7.62–7.56 (m, 1H), 7.48 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.08 (dd, <i>J</i> = 7.8 and 5.2 Hz, 1H), 4.94–4.86 (m, 1H), 4.72 (dd, <i>J</i> = 10.4 and 7.2 Hz, 1H), 4.62 (dd, <i>J</i> = 10.4 and 7.2 Hz, 1H), 4.30 (dd, <i>J</i> = 14.8 and 3.2 Hz, 1H), 3.74–3.62 (m, 1H), 3.62–3.54 (m, 1H), 3.46–3.36 (m, 2H), 3.26–3.14 (m, 1H). LC-MS: RT = 2.92 min, [M + H]<sup>+</sup> = 312.1. Purity >95% by HPLC method A, RT = 2.50 min. Purity >95% by HPLC method B, RT = 4.04 min.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole (<b>19</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>14</b> using 2-chlorobenzothiazole (87 mg, 0.51 mmol) and compound <b>11</b> (100 mg, 0.341 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 116 mg (52%, di-TFA salt) of a thick oil. LC-MS: RT = 9.14 min, [M + H]<sup>+</sup> = 427.1. The material was deprotected as described for <b>14</b> to gave 41.7 mg (59%) of the title compound as a sticky solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (d, <i>J</i> = 3.2 Hz, 1H), 8.17 (d, <i>J</i> = 4.4 Hz, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.52–7.42 (m, 2H), 7.34 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.27 (t, <i>J</i> = 7.4 Hz, 1H), 7.06 (t, <i>J</i> = 7.4 Hz, 1H), 4.54 (t, <i>J</i> = 9.0 Hz, 1H), 4.42–4.34 (m, 1H), 4.26 (dd, <i>J</i> = 9.6 and 5.6 Hz, 1H), 3.76–3.66 (m, 1H), 3.42–3.28 (m, 1H), 3.15 (d, <i>J</i> = 12.4 Hz, 1H), 3.02–2.95 (m, 1H), 2.85 (dd, <i>J</i> = 12.6 and 3.4 Hz, 1H), 2.71 (dt, <i>J</i> = 12.4 and 3.6 Hz, 1H). LC-MS: RT = 4.38 min, [M + H]<sup>+</sup> = 327.1. Purity >95% by HPLC method A, RT = 3.98 min. Purity >95% by HPLC method B, RT = 5.23 min.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>20</b>)</h4><div class="NLM_p last">The compound was prepared as for compound <b>14</b> using 2-chloro-6-methoxybenzo[<i>d</i>]thiazole (1.02 g, 5.12 mmol) and compound <b>11</b> (1.00 g, 3.41 mmol). The material was purified by column chromatography (20–60% EtOAc in hexanes gradient), yielding 1.145 g (73%) of a tan solid. <i>R</i><sub>f</sub> = 0.29 in 70% EtOAc in hexanes. LC-MS: RT = 8.90 min, [M + H]<sup>+</sup> = 457.0. The material was deprotected and converted to the HCl salt as described for compound <b>15</b>, yielding 828.6 mg (88%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78–9.62 (br, 1H), 9.46–9.30 (br, 1H), 8.39 (d, <i>J</i> = 2.8 Hz, 1H), 8.24 (d, <i>J</i> = 4.8 Hz, 1H), 7.62–7.55 (m, 1H), 7.50–7.38 (m, 3H), 6.91 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.76–4.69 (m, 1H), 4.62 (t, <i>J</i> = 9 Hz, 1H), 4.52 (dd, <i>J</i> = 10.0 and 6.0 Hz, 1H), 4.08–4.00 (m, 1H), 3.76 (s, 3H), 3.67–3.34 (m, 4H), 3.24–3.10 (m, 1H). LC-MS: RT = 4.37 min, [M + H]<sup>+</sup> = 357.0. Purity >95% by HPLC method A, RT = 4.02 min. Purity >95% by HPLC method B, RT = 5.28 min.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-6-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride ((<i><b>R</b></i>)-<b>20</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>20</b> from (<i><b>R</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82–9.70 (br, 1H), 9.54–9.38 (br, 1H), 8.39 (br, 1H), 8.24 (d, <i>J</i> = 3.6 Hz, 1H), 7.60–7.55 (m, 1H), 7.50–7.38 (m, 3H), 6.91 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.76–4.68 (m, 1H), 4.62 (t, <i>J</i> = 9 Hz, 1H), 4.56–4.48 (m, 1H), 4.08–3.98 (m, 1H), 3.76 (s, 3H), 3.68–3.52 (m, 2H), 3.42–3.32 (m, 2H), 3.22–3.10 (m, 1H). LC-MS: RT = 4.80 min, [M + H]<sup>+</sup> = 357.0. Purity >95% by HPLC method A, RT = 4.03 min. Purity >95% by HPLC method B, RT = 6.05 min.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-6-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride ((<i><b>S</b></i>)-<b>20</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>20</b> from (<i><b>S</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78–9.65 (br, 1H), 9.45–9.29 (br, 1H), 8.36 (br, 1H), 8.24–8.19 (m, 1H), 7.56–7.50 (m, 1H), 7.48–7.36 (m, 3H), 6.94–6.88 (m, 1H), 4.76–4.68 (m, 1H), 4.60 (t, <i>J</i> = 9 Hz, 1H), 4.54–4.46 (m, 1H), 4.08–3.99 (m, 1H), 3.76 (s, 3H), 3.67–3.54 (m, 2H), 3.42–3.31 (m, 2H), 3.22–3.10 (m, 1H). LC-MS: RT = 4.58 min, [M + H]<sup>+</sup> = 357.0. Purity >95% by HPLC method A, RT = 4.02 min. Purity >95% by HPLC method B, RT = 6.09 min.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-Methoxy-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>21</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-5-methoxybenzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (202 mg, 1.01 mmol) and compound <b>11</b> (198 mg, 0.675 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (20–50% EtOAc in hexanes gradient), yielding 159 mg (52%) of an off-white solid. <i>R</i><sub>f</sub> = 0.20 in 70% EtOAc in hexanes. LC-MS: RT = 8.97 min, [M + H]<sup>+</sup> = 457.8. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 99 mg (72%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.55 (br, 1H), 9.36–9.20 (br, 1H), 8.36 (d, <i>J</i> = 2.0 Hz, 1H), 8.22 (d, <i>J</i> = 4.4 Hz, 1H), 7.68 (dd, <i>J</i> = 8.4 and 1.2 Hz, 1H), 7.56–7.50 (m, 1H), 7.40 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.08 (d, <i>J</i> = 2.0 Hz, 1H), 6.75 (dt, <i>J</i> = 8.8 and 0.8 Hz, 1H), 4.81–4.73 (m, 1H), 4.59 (t, <i>J</i> = 9.0 Hz, 1H), 4.48 (dd, <i>J</i> = 10.2 and 6.2 Hz, 1H), 3.76 (s, 3H), 3.68–3.54 (m, 2H), 3.44–3.34 (m, 2H), 3.24–3.12 (m, 1H). LC-MS: RT = 4.28 min, [M + H]<sup>+</sup> = 357.5. Purity >95% by HPLC method A, RT = 4.07 min. Purity >95% by HPLC method B, RT = 5.47 min.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-Methyl-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>22</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-6-methylbenzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (262 mg, 1.43 mmol) and compound <b>11</b> (175 mg, 0.953 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 269 mg (42%, di-TFA salt) of a thick oil. LC-MS: RT = 9.60 min, [M + H]<sup>+</sup> = 441.8. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 75 mg (49%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76–9.60 (br, 1H), 9.42–9.26 (br, 1H), 8.35 (d, <i>J</i> = 3.6 Hz, 1H), 8.21 (d, <i>J</i> = 4.4 Hz, 1H), 7.62 (s, 1H), 7.54–7.48 (m, 1H), 7.44–7.34 (m, 2H), 7.12 (d, <i>J</i> = 8.0 Hz, 1H), 4.79–4.71 (m, 1H), 4.59 (t, <i>J</i> = 9.0 Hz, 1H), 4.50 (dd, <i>J</i> = 10.0 and 6.4 Hz, 1H), 4.10–4.02 (m, 1H), 3.68–3.54 (m, 2H), 3.44–3.32 (m, 2H), 3.24–3.10 (m, 1H), 2.34 (s, 3H). LC-MS: RT = 4.66 min, [M + H]<sup>+</sup> = 341.5. Purity >95% by HPLC method A, RT = 4.43 min. Purity >95% by HPLC method B, RT = 6.01 min.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-Chloro-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole (<b>23</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2,6-dichlorobenzo[<i>d</i>]thiazole (104 mg, 0.511 mmol) and compound <b>11</b> (100 mg, 0.341 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 93 mg (40%, di-TFA salt) of a thick oil. LC-MS: RT = 10.1 min, [M + H]<sup>+</sup> = 461.2. Deprotection gave 30 mg (52%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (d, <i>J</i> = 2.8 Hz, 1H), 8.16 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.49–7.44 (m, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 1H), 7.32 (dd, <i>J</i> = 8.6 and 4.6 Hz, 1H), 7.28 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.52 (t, <i>J</i> = 8.8 Hz, 1H), 4.40–4.32 (m, 1H), 4.28 (dd, <i>J</i> = 9.6 and 5.6 Hz, 1H), 3.76–3.67 (m, 1H), 3.40–3.28 (m, 1H), 3.13 (d, <i>J</i> = 12.0 Hz, 1H), 3.01–2.94 (m, 1H), 2.84 (dd, <i>J</i> = 12.8 and 4.0 Hz, 1H), 2.69 (dt, <i>J</i> = 12.4 and 3.2 Hz, 1H). LC-MS: RT = 5.00 min, [M + H]<sup>+</sup> = 361.1. Purity >95% by HPLC method A, RT = 4.77 min. Purity >95% by HPLC method B, RT = 6.30 min.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)-6-(trifluoromethoxy)benzo[<i>d</i>]thiazole Hydrochloride (<b>24</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-6-(trifluoromethoxy)benzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (250 mg, 0.985 mmol) and compound <b>11</b> (193 mg, 0.657 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (20–40% EtOAc in hexanes gradient), yielding 184 mg (55%) of the intermediate. <i>R</i><sub>f</sub> = 0.33 in 70% EtOAc in hexanes. LC-MS: RT = 10.3 min, [M + H]<sup>+</sup> = 511.9. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 109 mg (68%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.36–8.96 (br, 2H), 8.31 (d, <i>J</i> = 2.8 Hz, 1H), 8.19 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.98 (d, <i>J</i> = 2.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.46 (ddd, <i>J</i> = 4.4, 2.8, and 1.2 Hz, 1H), 7.34 (dd, <i>J</i> = 8.8 and 4.8 Hz, 1H), 7.32–7.27 (m, 1H), 4.76–4.68 (m, 1H), 4.60–4.48 (m, 2H), 4.10–4.02 (m, 1H), 3.62 (dd, <i>J</i> = 12.8 and 2.8 Hz, 1H), 3.52 (d, <i>J</i> = 13.2 Hz, 1H), 3.38–3.28 (m, 2H), 3.11 (dt, <i>J</i> = 12.8 and 4.0 Hz, 1H). LC-MS: RT = 5.25 min, [M + H]<sup>+</sup> = 411.6. Purity >95% by HPLC method A, RT = 5.25 min. Purity >95% by HPLC method B, RT = 7.57 min.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)-6-(trifluoromethyl)benzo[<i>d</i>]thiazole Hydrochloride (<b>25</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-6-(trifluoromethyl)benzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (215 mg, 0.905 mmol) and compound <b>11</b> (177 mg, 0.603 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (20–40% EtOAc in hexanes gradient), yielding 97 mg (32%) of the intermediate. <i>R</i><sub>f</sub> = 0.35 in 75% EtOAc in hexanes. LC-MS: RT = 10.2 min, [M + H]<sup>+</sup> = 495.8. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 62 mg (74%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74–9.63 (br, 1H), 9.44–9.28 (br, 1H), 8.38 (d, <i>J</i> = 2.8 Hz, 1H), 8.34 (s, 1H), 8.25 (dd, <i>J</i> = 4.8 and 1.4 Hz, 1H), 7.62 (d, <i>J</i> = 1.4 Hz, 2H), 7.56 (dd, <i>J</i> = 8.4 and 2.8 Hz, 1H), 7.44 (dd, <i>J</i> = 8.4 and 4.8 Hz, 1H), 4.88–4.82 (m, 1H), 4.64–4.55 (m, 2H), 4.20–4.12 (m, 1H), 3.74–3.64 (m, 1H), 3.59 (d, <i>J</i> = 13.2 Hz, 1H), 3.46–3.36 (m, 2H), 3.24–3.14 (m, 1H). LC-MS: RT = 5.17 min, [M + H]<sup>+</sup> = 395.6. Purity >95% by HPLC method A, RT = 5.10 min. Purity >95% by HPLC method B, RT = 7.25 min.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-Fluoro-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>26</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-6-fluorobenzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (165 mg, 0.880 mmol) and compound <b>11</b> (172 mg, 0.587 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 88 mg (22%, di-TFA salt) of the intermediate. LC-MS: RT = 9.27 min, [M + H]<sup>+</sup> = 445.7. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 35 mg (72%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78–9.62 (br, 1H), 9.44–9.28 (br, 1H), 8.35 (d, <i>J</i> = 2.8 Hz, 1H), 8.22 (dd, <i>J</i> = 4.8 and 1.2 Hz, 1H), 7.78 (dd, <i>J</i> = 8.8 and 2.8 Hz, 1H), 7.54–7.46 (m, 2H), 7.39 (dd, <i>J</i> = 8.6 and 4.2 Hz, 1H), 7.16 (dt, <i>J</i> = 9.2 and 2.8 Hz, 1H), 4.79–4.72 (m, 1H), 4.62–4.50 (m, 2H), 4.12–4.04 (m, 1H), 3.69–3.58 (m, 2H), 3.44–3.34 (m, 2H), 3.24–3.12 (m, 1H). LC-MS: RT = 4.47 min, [M + H]<sup>+</sup> = 345.5. Purity >95% by HPLC method A, RT = 4.20 min. Purity >95% by HPLC method B, RT = 5.93 min.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-Fluoro-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>27</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-4-fluorobenzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (144 mg, 0.767 mmol) and compound <b>11</b> (150 mg, 0.511 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 92 mg (27%, di-TFA salt) of the intermediate. LC-MS: RT = 9.35 min, [M + H]<sup>+</sup> = 445.8. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 37 mg (71%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78–9.64 (br, 1H), 9.44–9.28 (br, 1H), 8.36 (d, <i>J</i> = 3.2 Hz, 1H), 8.23 (dd, <i>J</i> = 4.8 and 0.8 Hz, 1H), 7.67 (dd, <i>J</i> = 7.6 and 0.8 Hz, 1H), 7.57 (dd, <i>J</i> = 8.4 and 1.6 Hz, 1H), 7.40 (dd, <i>J</i> = 8.4 and 4.8 Hz, 1H), 7.22–7.10 (m, 2H), 4.84–4.77 (m, 1H), 4.63–4.53 (m, 2H), 4.16–4.08 (m, 1H), 3.72–3.56 (m, 2H), 3.44–3.34 (m, 2H), 3.24–3.14 (m, 1H). LC-MS: RT = 4.35 min, [M + H]<sup>+</sup> = 345.5. Purity >95% by HPLC method A, RT = 4.08 min. Purity >95% by HPLC method B, RT = 5.96 min.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4,6-Difluoro-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)benzo[<i>d</i>]thiazole Hydrochloride (<b>28</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chloro-4,6-difluorobenzo[<i>d</i>]thiazole<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (158 mg, 0.767 mmol) and compound <b>11</b> (150 mg, 0.511 mmol). The <i>N</i>-Boc intermediate was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 85 mg (24%, di-TFA salt) of the intermediate. LC-MS: RT = 9.63 min, [M + H]<sup>+</sup> = 463.8. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 31 mg (63%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.64–9.54 (br, 1H), 9.30–9.14 (br, 1H), 8.37 (d, <i>J</i> = 2.8 Hz, 1H), 8.24 (d, <i>J</i> = 3.2 Hz, 1H), 7.69 (dd, <i>J</i> = 8.0 and 1.6 Hz, 1H), 7.60–7.55 (m, 1H), 7.42 (dd, <i>J</i> = 8.0 and 4.4 Hz, 1H), 7.28 (dt, <i>J</i> = 10.6 and 2.8 Hz, 1H), 4.82–4.75 (m, 1H), 4.60–4.53 (m, 2H), 4.14–4.07 (m, 1H), 3.72–3.56 (m, 2H), 3.44–3.34 (m, 2H), 3.25–3.14 (m, 1H). LC-MS: RT = 4.65 min, [M + H]<sup>+</sup> = 363.5. Purity >95% by HPLC method A, RT = 4.36 min. Purity >95% by HPLC method B, RT = 6.39 min.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(2-((Pyridin-3-yloxy)methyl)piperazin-1-yl)thiazolo[4,5-<i>b</i>]pyridine Hydrochloride (<b>29</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2-chlorothiazolo[4,5-<i>b</i>]pyridine<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (260 mg, 1.53 mmol) and compound <b>11</b> (300 mg, 1.02 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (50–100% EtOAc in hexanes gradient) and repurified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 62 mg (14%) of the intermediate. LC-MS: RT = 6.45 min, [M + H]<sup>+</sup> = 428.7. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 12 mg (22%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.86–9.76 (br, 1H), 9.54–9.40 (br, 1H), 8.42 (d, <i>J</i> = 2.8 Hz, 1H), 8.40–8.34 (m, 2H), 8.28 (d, <i>J</i> = 4.4 Hz, 1H), 7.68–7.62 (m, 1H), 7.50 (dd, <i>J</i> = 8.4 and 4.8 Hz, 1H), 7.17 (dd, <i>J</i> = 7.4 and 5.0 Hz, 1H), 4.93–4.85 (m, 1H), 4.63 (d, <i>J</i> = 6.8 Hz, 2H), 4.24–4.15 (m, 1H), 3.76–3.40 (m, 4H), 3.26–3.14 (m, 1H). LC-MS: RT = 2.86 min, [M + H]<sup>+</sup> = 328.5. Purity >95% by HPLC method A, RT = 2.35 min. Purity >95% by HPLC method B, RT = 4.59 min.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-Chloro-2-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)thiazolo[4,5-<i>b</i>]pyridine Hydrochloride (<b>30</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>14</b> from 2,6-dichlorothiazolo[4,5-<i>b</i>]pyridine<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (366 mg, 1.79 mmol) and compound <b>11</b> (262 mg, 0.893 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (50–75% EtOAc in hexanes gradient), yielding 88 mg (21%) of the intermediate. <i>R</i><sub>f</sub> = 0.39 in EtOAc. LC-MS: RT = 8.27 min, [M + H]<sup>+</sup> = 462.7. The material was deprotected and converted to the hydrochloride salt as described for <b>15</b>, yielding 74 mg (98%) of the title compound as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80–9.67 (br, 1H), 9.52–9.35 (br, 1H), 8.45 (d, <i>J</i> = 2.4 Hz, 1H), 8.39–8.35 (m, 2H), 8.24 (dd, <i>J</i> = 4.6 and 1.0 Hz, 1H), 7.55 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H), 7.43 (dd, <i>J</i> = 8.4 and 4.8 Hz, 1H), 4.88–4.81 (m, 1H), 4.66–4.56 (m, 2H), 4.24–4.15 (m, 1H), 3.74–3.56 (m, 2H), 3.46–3.37 (m, 2H), 3.26–3.14 (m, 1H). LC-MS: RT = 4.16 min, [M + H]<sup>+</sup> = 362.5. Purity >95% by HPLC method A, RT = 3.87 min. Purity >95% by HPLC method B, RT = 5.81 min.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Phenyl(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)methanone Dihydrochloride (<b>32</b>)</h4><div class="NLM_p last">Benzoyl chloride (36 mg, 0.26 mmol) was added to a solution of <b>11</b> (72 mg, 0.25 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL). After stirring overnight, the material was concentrated under reduced pressure and purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 90 mg (71%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.45 min, [M + H]<sup>+</sup> = 398.2. Then 4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of the intermediate in MeOH (1 mL). After stirring overnight, the reaction mixture was concentrated under reduced pressure, yielding 64 mg (98%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.86–9.74 (br, 1H), 9.68–9.54 (br, 1H), 8.64–8.54 (m, 1H), 8.48–8.42 (m, 1H), 8.02–7.90 (br m, 1H), 7.86–7.74 (br m, 1H), 7.50–7.40 (m, 5H), 4.82–4.60 (br m, 2H), 4.60–4.24 (br m, 2H), 3.50–3.18 (m, 4H), 3.14–3.02 (m, 1H). LC-MS: RT = 3.05 min, [M + H]<sup>+</sup> = 298.1. Purity >95% by HPLC method A, RT = 2.79 min. Purity >95% by HPLC method B, RT = 3.26 min.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (4-Chlorophenyl)(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)methanone Dihydrochloride (<b>33</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>32</b> from 4-chlorobenzoyl chloride (61 mg, 0.35 mmol) and <b>11</b> (85 mg, 0.29 mmol). The <i>N</i>-Boc intermediate was purified by column chromatography (40–60% EtOAc in hexanes gradient), yielding 84 mg (67%) of the intermediate. <i>R</i><sub>f</sub> = 0.31 in 100% EtOAc. LC-MS: RT = 9.18 min, [M + H]<sup>+</sup> = 432.1. The material was deprotected as described for <b>32</b>, yielding 78 mg (100%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.84–9.74 (br, 1H), 9.66–9.52 (br, 1H), 8.68–8.48 (br m, 1H), 8.48–8.40 (m, 1H), 8.04–7.70 (br m, 2H), 7.58–7.46 (m, 4H), 4.84–4.56 (br m, 2H), 4.56–4.24 (br m, 2H), 3.54–3.15 (m, 4H), 3.14–3.02 (m, 1H). LC-MS: RT = 5.03 min, [M + H]<sup>+</sup> = 332.1. Purity >95% by HPLC method A, RT = 5.16 min. Purity >95% by HPLC method B, RT = 4.32 min.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Phenyl-1-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)ethanone Dihydrochloride (<b>34</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>32</b> from phenylacetyl chloride (40 mg, 0.26 mmol) and <b>11</b> (72 mg, 0.25 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 96 mg (74%) of the <i>N</i>-Boc intermediate TFA salt as a thick oil. LC-MS: RT = 7.75 min, [M + H]<sup>+</sup> = 412.2. The material was deprotected as described for <b>32</b>, yielding 63 mg (90%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.66–9.42 (br, 2H), 8.63–8.40 (m, 2H), 7.88–7.74 (m, 2H), 7.33–7.18 (m, 5H), 5.06–4.98 (m, 1H), 4.82–4.74 (m, 1H), 4.64–4.53 (m, 1H), 4.52–4.39 (m, 2H), 3.83–3.76 (m, 1H), 3.50–3.42 (m, 2H), 3.32–3.10 (m, 2H), 2.86–2.64 (m, 1H). LC-MS: RT = 3.61 min, [M + H]<sup>+</sup> = 312.1. Purity >95% by HPLC method A, RT = 3.35 min. Purity >95% by HPLC method B, RT = 3.74 min.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(4-Chlorophenyl)-1-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)ethanone Dihydrochloride (<b>35</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>32</b> from 2-(4-chlorophenyl)acetyl chloride (69 mg, 0.37 mmol) and <b>11</b> (90 mg, 0.31 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 159 mg (93%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.46 min, [M + H]<sup>+</sup> = 446.1. The material was deprotected as described for <b>32</b> and was purified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 99 mg (83%) of the title compound as a white solid upon conversion to the dihydrochloride salt. The <sup>1</sup>H NMR indicates a 1.5:1 mixture of rotomers. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80–9.50 (br, 2H), 8.68–8.63 (br, 0.6H), 8.61–8.56 (br, 0.4H), 8.47 (d, <i>J</i> = 5.2 Hz, 1H), 8.07–8.01 (m, 0.6H), 7.96–7.90 (m, 0.4H), 7.88–7.79 (m, 1H), 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 7.24 (appt. t, <i>J</i> = 9.2 Hz, 2H), 5.04–4.96 (m, 0.6H), 4.82–4.74 (m, 0.6H), 4.73–4.60 (m, 1.4H), 4.56–4.42 (m, 2.4H), 3.85–3.74 (m, 1H), 3.52–3.42 (m, 2H), 3.32–3.10 (m, 2H), 3.00–2.84 (m, 1H). LC-MS: RT = 4.28 min, [M + H]<sup>+</sup> = 346.1. Purity >95% by HPLC method A, RT = 4.06 min. Purity >95% by HPLC method B, RT = 4.81 min.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Phenoxy-1-(2-((pyridin-3-yloxy)methyl)piperazin-1-yl)ethanone (<b>36</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>32</b> from 2-phenoxyacetyl chloride (68 mg, 0.37 mmol) and <b>11</b> (90 mg, 0.31 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 138 mg (84%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.85 min, [M + H]<sup>+</sup> = 428.2. The material was deprotected as described for <b>5</b> and was purified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 14 mg (16%) of the title compound as a thick oil upon free-basing with 1 N NaOH. The <sup>1</sup>H NMR indicates a 1:1 mixture of rotomers. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34–8.27 (m, 1H), 8.22–8.15 (m, 1H), 7.46–7.39 (m, 1H), 7.38–7.32 (m, 1H), 7.30–7.23 (m, 2H), 6.96–6.86 (m, 3H), 5.02–4.72 (m, 2H), 4.66–4.58 (m, 0.5H), 4.63 (t, <i>J</i> = 10 Hz, 0.5H), 4.38 (t, <i>J</i> = 11 Hz, 0.5H), 4.34–4.22 (m, 1H), 4.19–4.04 (m, 1H), 3.69–3.62 (m, 0.5H), 3.30–3.18 (m, 1H), 3.14–3.04 (m, 1H), 2.99–3.90 (m, 1H), 2.89–2.78 (m, 1H), 2.76–2.62 (m, 1H). LC-MS: RT = 3.66 min, [M + H]<sup>+</sup> = 328.1. Purity >95% by HPLC method A, RT = 3.42 min. Purity >95% by HPLC method B, RT = 3.86 min.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-Phenyl-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>37</b>)</h4><div class="NLM_p last">Phenylisocyanate (41 mg, 0.34 mmol) was added to a solution of <b>11</b> (101 mg, 0.34 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After 1 h, the material was concentrated under reduced pressure and purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). The desired fractions were combined, brought to pH 12 with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure, yielding 115 mg (81%) of the <i>N</i>-Boc intermediate as a white solid. LC-MS: RT = 8.79 min, [M + H]<sup>+</sup> = 413.2. Then 4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of the intermediate in MeOH (1 mL). After stirring overnight, the reaction mixture was concentrated under reduced pressure, yielding 105 mg (98%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82–9.73 (br, 1H), 9.70–9.58 (br, 1H), 8.96 (s, 1H), 8.69 (d, <i>J</i> = 2.4 Hz, 1H), 8.48 (d, <i>J</i> = 4.8 Hz, 1H), 8.11 (dd, <i>J</i> = 8.6 and 2.4 Hz, 1H), 7.88 (dd, <i>J</i> = 8.6 and 4.8 Hz, 1H), 7.44 (dd, <i>J</i> = 8.4 and 1.2 Hz, 2H), 7.24 (t, <i>J</i> = 7.8 Hz, 2H), 6.96 (dd, <i>J</i> = 7.8 and 1.2 Hz, 1H), 4.82–4.76 (m, 1H), 4.73 (t, <i>J</i> = 9.0 Hz, 1H), 4.58 (dd, <i>J</i> = 10.4 and 6.8 Hz, 1H), 4.22 (d, <i>J</i> = 14 Hz, 1H), 3.54–3.47 (m, 1H), 3.40–3.28 (m, 2H), 3.28–3.16 (m, 1H), 3.05–2.93 (m, 1H). LC-MS: RT = 5.28 min, [M + H]<sup>+</sup> = 313.1. Purity >95% by HPLC method A, RT = 4.89 min. Purity >95% by HPLC method B, RT = 3.57 min.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(4-Chlorophenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>38</b>)</h4><div class="NLM_p last">4-Chlorophenylisocyanate (53 mg, 0.34 mmol) was added to a solution of <b>11</b> (101 mg, 0.34 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After 1 h, the material was concentrated under reduced pressure. LC-MS: RT = 9.54 min, [M + H]<sup>+</sup> = 447.1. Trifluoroacetic acid (1 mL) was added to a solution of the intermediate in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After stirring overnight, the reaction mixture was concentrated under reduced pressure and was purified by HPLC (5–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 75 mg (52%) of the title compound as a white solid upon conversion to the dihydrochloride salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.62 (br, 1H), 9.58–9.45 (br, 1H), 9.10 (s, 1H), 8.64 (d, <i>J</i> = 2.8 Hz, 1H), 8.45 (d, <i>J</i> = 5.6 Hz, 1H), 8.02 (dd, <i>J</i> = 8.8 and 2.8 Hz, 1H), 7.82 (dd, <i>J</i> = 8.8 and 5.6 Hz, 1H), 7.49 (d, <i>J</i> = 6.8 Hz, 2H), 7.29 (d, <i>J</i> = 6.8 Hz, 2H), 4.82–4.74 (m, 1H), 4.67 (t, <i>J</i> = 9.0 Hz, 1H), 4.55 (dd, <i>J</i> = 10 and 6.8 Hz, 1H), 4.21 (br d, <i>J</i> = 14 Hz, 1H), 3.54–3.47 (m, 1H), 3.40–3.28 (m, 2H), 3.28–3.16 (m, 1H), 3.06–2.93 (m, 1H). LC-MS: RT = 4.38 min, [M + H]<sup>+</sup> = 347.1. Purity >95% by HPLC method A, RT = 4.19 min. Purity >95% by HPLC method B, RT = 4.92 min.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3-Chlorophenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>42</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 3-chlorophenylisocyanate (25 mg, 0.16 mmol) and <b>11</b> (45 mg, 0.15 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 83 mg (97%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.32 min, [M + H]<sup>+</sup> = 446.9. The material was deprotected as described for <b>37</b>, yielding 62 mg (100%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68–9.59 (br, 1H), 9.55–9.42 (br, 1H), 9.17 (s, 1H), 8.63 (d, <i>J</i> = 2.4 Hz, 1H), 8.43 (d, <i>J</i> = 5.2 Hz, 1H), 8.02–7.95 (m, 1H), 7.79 (dd, <i>J</i> = 8.8 and 4.8 Hz, 1H), 7.63 (t, <i>J</i> = 2.4 Hz, 1H), 7.40 (ddd, <i>J</i> = 8.0, 2.0, and 0.8 Hz, 1H), 7.27 (t, <i>J</i> = 8.0 Hz, 1H), 7.01 (ddd, <i>J</i> = 8.0, 2.0, and 0.8 Hz, 1H), 4.92–4.84 (m, 1H), 4.65 (dd, <i>J</i> = 10.4 and 8.0 Hz, 1H), 4.55 (dd, <i>J</i> = 10.4 and 7.0 Hz, 1H), 4.25–4.18 (m, 1H), 3.54–3.47 (m, 1H), 3.38–3.28 (m, 2H), 3.28–3.18 (m, 1H), 3.06–2.94 (m, 1H). LC-MS: RT = 4.20 min, [M + H]<sup>+</sup> = 346.9. Purity >95% by HPLC method A, RT = 4.15 min. Purity >95% by HPLC method B, RT = 4.95 min.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(3,4-Dichlorophenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>43</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 3,4-dichlorophenylisocyanate (96 mg, 0.51 mmol) and <b>11</b> (150 mg, 0.51 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 295 mg (97%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.96 min, [M + H]<sup>+</sup> = 481.1. The material was deprotected as described for <b>37</b>, yielding 208 mg (93%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.68–9.59 (br, 1H), 9.55–9.44 (br, 1H), 9.35 (s, 1H), 8.63 (d, <i>J</i> = 2.4 Hz, 1H), 8.44 (d, <i>J</i> = 4.4 Hz, 1H), 8.02–7.97 (m, 1H), 7.83 (d, <i>J</i> = 2.0 Hz, 1H), 7.80 (dd, <i>J</i> = 8.6 and 5.0 Hz, 1H), 7.52–7.45 (m, 2H), 4.93–4.85 (m, 1H), 4.65 (dd, <i>J</i> = 10.0 and 8.0 Hz, 1H), 4.56 (dd, <i>J</i> = 10.0 and 7.0 Hz, 1H), 4.26–4.18 (m, 1H), 3.54–3.47 (m, 1H), 3.39–3.28 (m, 2H), 3.28–3.18 (m, 1H), 3.06–2.94 (m, 1H). LC-MS: RT = 4.87 min, [M + H]<sup>+</sup> = 381.0. Purity >95% by HPLC method A, RT = 4.76 min. Purity >95% by HPLC method B, RT = 6.16 min.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-((Pyridin-3-yloxy)methyl)-<i>N</i>-<i>p</i>-tolylpiperazine-1-carboxamide Dihydrochloride (<b>44</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from <i>p</i>-tosylisocyanate (43 mg, 0.32 mmol) and <b>11</b> (86 mg, 0.29 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 149 mg (94%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.87 min, [M + H]<sup>+</sup> = 427.2. The material was deprotected as described for <b>37</b>, yielding 109 mg (98%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.71–9.62 (br, 1H), 9.59–9.46 (br, 1H), 8.80 (s, 1H), 8.65 (d, <i>J</i> = 2.4 Hz, 1H), 8.45 (d, <i>J</i> = 4.4 Hz, 1H), 8.05–8.00 (m, 1H), 7.82 (dd, <i>J</i> = 8.8 and 5.6 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 2H), 4.88–4.81 (m, 1H), 4.68 (dd, <i>J</i> = 10.0 and 8.0 Hz, 1H), 4.52 (dd, <i>J</i> = 10.0 and 6.6 Hz, 1H), 4.23–4.15 (m, 1H), 3.54–3.46 (m, 1H), 3.38–3.27 (m, 2H), 3.26–3.16 (m, 1H), 3.05–2.92 (m, 1H), 2.23 (s, 3H). LC-MS: RT = 3.95 min, [M + H]<sup>+</sup> = 327.1. Purity >95% by HPLC method A, RT = 3.81 min. Purity >95% by HPLC method B, RT = 4.36 min.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-((Pyridin-3-yloxy)methyl)-<i>N</i>-(4-(trifluoromethyl)phenyl)piperazine-1-carboxamide Dihydrochloride (<b>45</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-(trifluoromethyl)phenylisocyanate (47 mg, 0.25 mmol) and <b>11</b> (74 mg, 0.25 mmol). The material was purified by trituration with 1:1 CH<sub>2</sub>Cl<sub>2</sub>/hexanes, yielding 93 mg (77%) of the <i>N</i>-Boc intermediate as a white solid. LC-MS: RT = 8.78 min, [M + H]<sup>+</sup> = 481.9. The material was deprotected as described for <b>37</b>, yielding 86 mg (98%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67–9.58 (br, 1H), 9.54–9.42 (br, 1H), 9.37 (s, 1H), 8.61 (d, <i>J</i> = 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 5.2 Hz, 1H), 7.99–7.94 (m, 1H), 7.77 (dd, <i>J</i> = 8.6 and 5.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 2H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 4.94–4.86 (m, 1H), 4.65 (dd, <i>J</i> = 10.0 and 7.6 Hz, 1H), 4.57 (dd, <i>J</i> = 10.0 and 7.2 Hz, 1H), 4.27–4.19 (m, 1H), 3.55–3.48 (m, 1H), 3.40–3.30 (m, 2H), 3.30–3.20 (m, 1H), 3.08–2.96 (m, 1H). LC-MS: RT = 4.85 min, [M + H]<sup>+</sup> = 381.6. Purity >95% by HPLC method A, RT = 4.68 min. Purity >95% by HPLC method B, RT = 5.79 min.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(4-Isopropylphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>46</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-isopropylphenylisocyanate (67 mg, 0.42 mmol) and <b>11</b> (122 mg, 0.42 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 232 mg (98%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.89 min, [M + H]<sup>+</sup> = 455.9. The material was deprotected as described for <b>37</b>, yielding 135 mg (78%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.60 (br, 1H), 9.56–9.44 (br, 1H), 8.80 (s, 1H), 8.64 (d, <i>J</i> = 2.8 Hz, 1H), 8.43 (d, <i>J</i> = 5.4 Hz, 1H), 8.04–7.98 (m, 1H), 7.80 (dd, <i>J</i> = 8.8 and 5.4 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 4.86–4.80 (m, 1H), 4.67 (dd, <i>J</i> = 10.0 and 8.4 Hz, 1H), 4.51 (dd, <i>J</i> = 9.6 and 6.8 Hz, 1H), 4.21–4.14 (m, 1H), 3.54–3.46 (m, 1H), 3.36–3.27 (m, 2H), 3.26–3.16 (m, 1H), 3.04–2.91 (m, 1H), 2.80 (hept, <i>J</i> = 6.8 Hz, 1H), 1.15 (d, <i>J</i> = 6.8 Hz, 6H). LC-MS: RT = 4.94 min, [M + H]<sup>+</sup> = 355.6. Purity >95% by HPLC method A, RT = 4.88 min. Purity >95% by HPLC method B, RT = 6.22 min.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(4-Methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>47</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-methoxyphenylisocyanate (76 mg, 0.51 mmol) and <b>11</b> (150 mg, 0.51 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 251 mg (88%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.18 min, [M + H]<sup>+</sup> = 443.2. The material was deprotected as described for <b>37</b>, yielding 187 mg (99%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.83–9.73 (br, 1H), 9.69–9.58 (br, 1H), 8.79 (s, 1H), 8.70 (d, <i>J</i> = 2.4 Hz, 1H), 8.48 (d, <i>J</i> = 5.2 Hz, 1H), 8.11 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 7.88 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.33 (d, <i>J</i> = 6.8 Hz, 2H), 6.83 (d, <i>J</i> = 6.8 Hz, 2H), 4.88–4.82 (m, 1H), 4.73 (dd, <i>J</i> = 10.0 and 8.4 Hz, 1H), 4.54 (dd, <i>J</i> = 9.6 and 6.4 Hz, 1H), 4.24–4.16 (m, 1H), 3.70 (s, 3H), 3.54–3.46 (m, 1H), 3.38–3.28 (m, 2H), 3.26–3.15 (m, 1H), 3.04–2.91 (m, 1H). LC-MS: RT = 3.40 min, [M + H]<sup>+</sup> = 343.1. Purity >95% by HPLC method A, RT = 5.09 min. Purity >95% by HPLC method B, RT = 3.79 min.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-<i>N</i>-(4-Methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride ((<b><i>R</i></b>)-<b>47</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>47</b> from (<i><b>R</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88–9.78 (br, 1H), 9.74–9.60 (br, 1H), 8.81 (s, 1H), 8.71 (d, <i>J</i> = 2.4 Hz, 1H), 8.48 (d, <i>J</i> = 5.2 Hz, 1H), 8.12 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 7.89 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.33 (d, <i>J</i> = 6.8 Hz, 2H), 6.82 (d, <i>J</i> = 6.8 Hz, 2H), 4.89–4.82 (m, 1H), 4.74 (dd, <i>J</i> = 10.0 and 8.4 Hz, 1H), 4.55 (dd, <i>J</i> = 9.6 and 6.4 Hz, 1H), 4.24–4.16 (m, 1H), 3.70 (s, 3H), 3.53–3.46 (m, 1H), 3.38–3.26 (m, 2H), 3.25–3.14 (m, 1H), 3.04–2.91 (m, 1H). LC-MS: RT = 3.67 min, [M + H]<sup>+</sup> = 343.1. Purity >95% by HPLC method A, RT = 3.13 min. Purity >95% by HPLC method B, RT = 3.76 min.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-<i>N</i>-(4-Methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>(</b><i><b>S</b></i>)-<b>47</b>)</h4><div class="NLM_p last">The compound was prepared as described for compound <b>47</b> from (<i><b>S</b></i>)-<b>11</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.62 (br, 1H), 9.58–9.46 (br, 1H), 8.74 (s, 1H), 8.67 (d, <i>J</i> = 2.4 Hz, 1H), 8.46 (d, <i>J</i> = 5.2 Hz, 1H), 8.06 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 7.84 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.32 (d, <i>J</i> = 6.8 Hz, 2H), 6.82 (d, <i>J</i> = 6.8 Hz, 2H), 4.86–4.80 (m, 1H), 4.69 (dd, <i>J</i> = 10.0 and 8.4 Hz, 1H), 4.51 (dd, <i>J</i> = 9.6 and 6.4 Hz, 1H), 4.22–4.14 (m, 1H), 3.70 (s, 3H), 3.53–3.44 (m, 1H), 3.36–3.27 (m, 2H), 3.26–3.16 (m, 1H), 3.04–2.92 (m, 1H). LC-MS: RT = 4.27 min, [M + H]<sup>+</sup> = 343.1. Purity >95% by HPLC method A, RT = 3.57 min. Purity >95% by HPLC method B, RT = 3.75 min.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-Methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>48</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 3-methoxyphenylisocyanate (24 mg, 0.16 mmol) and <b>11</b> (45 mg, 0.15 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 78 mg (91%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.47 min, [M + H]<sup>+</sup> = 442.9. The material was deprotected as described for <b>37</b>, yielding 57 mg (99%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74–9.65 (br, 1H), 9.61–9.49 (br, 1H), 8.90 (s, 1H), 8.65 (d, <i>J</i> = 2.8 Hz, 1H), 8.45 (d, <i>J</i> = 4.4 Hz, 1H), 8.06–8.00 (m, 1H), 7.82 (dd, <i>J</i> = 8.8 and 5.4 Hz, 1H), 7.17–7.11 (m, 2H), 7.06–7.00 (m, 1H), 6.54 (dt, <i>J</i> = 8.0 and 1.2 Hz, 1H), 4.90–4.83 (m, 1H), 4.68 (dd, <i>J</i> = 10.0 and 8.4 Hz, 1H), 4.55 (dd, <i>J</i> = 9.6 and 6.4 Hz, 1H), 4.23–4.16 (m, 1H), 3.70 (s, 3H), 3.54–3.46 (m, 1H), 3.38–3.28 (m, 2H), 3.27–3.17 (m, 1H), 3.06–2.93 (m, 1H). LC-MS: RT = 3.61 min, [M + H]<sup>+</sup> = 343.0. Purity >95% by HPLC method A, RT = 3.48 min. Purity >95% by HPLC method B, RT = 4.06 min.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2-Methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>49</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 2-methoxyphenylisocyanate (38 mg, 0.26 mmol) and <b>11</b> (72 mg, 0.25 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 125 mg (92%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.84 min, [M + H]<sup>+</sup> = 443.2. The material was deprotected as described for <b>37</b>, yielding 91 mg (97%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.66–9.55 (br, 1H), 9.54–9.40 (br, 1H), 8.60 (d, <i>J</i> = 2.4 Hz, 1H), 8.43 (d, <i>J</i> = 4.8 Hz, 1H), 8.03 (s, 1H), 7.97–7.91 (m, 1H), 7.77 (dd, <i>J</i> = 8.2 and 5.4 Hz, 1H), 7.58 (dd, <i>J</i> = 8.0 and 1.6 Hz, 1H), 7.07–7.00 (m, 2H), 6.92–6.86 (m, 1H), 4.80–4.72 (m, 1H), 4.65–4.53 (m, 2H), 4.17–4.10 (m, 1H), 3.79 (s, 3H), 3.52–3.44 (m, 1H), 3.38–3.20 (m, 3H), 3.07–2.94 (m, 1H). LC-MS: RT = 3.73 min, [M + H]<sup>+</sup> = 343.2. Purity >95% by HPLC method A, RT = 3.39 min. Purity >95% by HPLC method B, RT = 4.09 min.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(2,4-Dimethoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>50</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 2,4-dimethoxyphenylisocyanate (46 mg, 0.26 mmol) and <b>11</b> (72 mg, 0.25 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 122 mg (84%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.53 min, [M + H]<sup>+</sup> = 473.2. The material was deprotected as described for <b>37</b>, yielding 89 mg (96%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67–9.58 (br, 1H), 9.53–9.41 (br, 1H), 8.64 (d, <i>J</i> = 2.8 Hz, 1H), 8.44 (d, <i>J</i> = 5.2 Hz, 1H), 8.02–7.93 (m, 2H), 7.80 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 6.58 (d, <i>J</i> = 2.4 Hz, 1H), 6.46 (dd, <i>J</i> = 8.8 and 2.8 Hz, 1H), 4.78–4.70 (m, 1H), 4.66 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.50 (dd, <i>J</i> = 9.8 and 6.6 Hz, 1H), 4.17–4.07 (m, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 3.52–3.44 (m, 1H), 3.38–3.26 (m, 2H), 3.26–3.16 (m, 1H), 3.04–2.92 (m, 1H). LC-MS: RT = 3.45 min, [M + H]<sup>+</sup> = 373.1. Purity >95% by HPLC method A, RT = 3.48 min. Purity >95% by HPLC method B, RT = 4.11 min.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(3-Chloro-4-methoxyphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>51</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 3-chloro-4-methoxyphenylisocyanate (76 mg, 0.42 mmol) and <b>11</b> (122 mg, 0.42 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 166 mg (68%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.87 min, [M + H]<sup>+</sup> = 477.8. The material was deprotected as described for <b>37</b>, yielding 119 mg (94%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.65–9.56 (br, 1H), 9.50–9.38 (br, 1H), 8.92 (s, 1H), 8.62 (d, <i>J</i> = 2.8 Hz, 1H), 8.43 (d, <i>J</i> = 5.2 Hz, 1H), 8.02–7.95 (m, 1H), 7.78 (dd, <i>J</i> = 8.6 and 5.2 Hz, 1H), 7.57 (d, <i>J</i> = 2.4 Hz, 1H), 7.33 (dd, <i>J</i> = 9.0 and 2.4 Hz, 1H), 7.04 (d, <i>J</i> = 9.0 Hz, 1H), 4.86–4.79 (m, 1H), 4.64 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.50 (dd, <i>J</i> = 10.2 and 6.6 Hz, 1H), 4.22–4.15 (m, 1H), 3.79 (s, 3H), 3.54–3.46 (m, 1H), 3.36–3.26 (m, 2H), 3.26–3.16 (m, 1H), 3.05–2.92 (m, 1H). LC-MS: RT = 4.02 min, [M + H]<sup>+</sup> = 377.6. Purity >95% by HPLC method A, RT = 3.85 min. Purity >95% by HPLC method B, RT = 4.66 min.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-((Pyridin-3-yloxy)methyl)-<i>N</i>-(4-(trifluoromethoxy)phenyl)piperazine-1-carboxamide Dihydrochloride (<b>52</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-(trifluoromethoxy)phenylisocyanate (65 mg, 0.32 mmol) and <b>11</b> (86 mg, 0.29 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 161 mg (89%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.89 min, [M + H]<sup>+</sup> = 497.2. The material was deprotected as described for <b>37</b>, yielding 112 mg (90%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.62 (br, 1H), 9.58–9.45 (br, 1H), 9.17 (s, 1H), 8.64 (d, <i>J</i> = 2.4 Hz, 1H), 8.44 (d, <i>J</i> = 5.2 Hz, 1H), 8.04–7.98 (m, 1H), 7.80 (dd, <i>J</i> = 8.6 and 5.2 Hz, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 2H), 7.25 (d, <i>J</i> = 8.8 Hz, 2H), 4.92–4.84 (m, 1H), 4.67 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.55 (dd, <i>J</i> = 10.0 and 6.8 Hz, 1H), 4.26–4.18 (m, 1H), 3.54–3.47 (m, 1H), 3.40–3.28 (m, 2H), 3.28–3.18 (m, 1H), 3.06–2.94 (m, 1H). LC-MS: RT = 4.91 min, [M + H]<sup>+</sup> = 397.1. Purity >95% by HPLC method A, RT = 4.86 min. Purity >95% by HPLC method B, RT = 5.81 min.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(4-Bromophenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>53</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-bromophenylisocyanate (68 mg, 0.34 mmol) and <b>11</b> (101 mg, 0.34 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). The desired fractions were combined, brought to pH 12 with 1 N NaOH, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure, yielding the <i>N</i>-Boc intermediate. LC-MS: RT = 9.69 min, [M + H]<sup>+</sup> = 491.1. The material was deprotected as described for <b>37</b> and was purified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). This gave 155 mg (97%) of the title compound as a white solid upon conversion to the dihydrochloride salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77–9.68 (br, 1H), 9.64–9.51 (br, 1H), 9.14 (s, 1H), 8.67 (d, <i>J</i> = 2.4 Hz, 1H), 8.47 (d, <i>J</i> = 5.2 Hz, 1H), 8.07 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 7.86 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.48–7.39 (m, 4H), 4.92–4.85 (m, 1H), 4.69 (dd, <i>J</i> = 10.0 and 8.0 Hz, 1H), 4.57 (dd, <i>J</i> = 9.6 and 6.8 Hz, 1H), 4.26–4.18 (m, 1H), 3.54–3.47 (m, 1H), 3.39–3.28 (m, 2H), 3.28–3.16 (m, 1H), 3.06–2.93 (m, 1H). LC-MS: RT = 4.48 min, [M + H]<sup>+</sup> = 391.0. Purity >95% by HPLC method A, RT = 4.35 min. Purity >95% by HPLC method B, RT = 5.28 min.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(4-Bromo-3-methylphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>54</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-bromo-3-methylphenylisocyanate (88 mg, 0.42 mmol) and <b>11</b> (122 mg, 0.42 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 165 mg (64%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.81 min, [M + H]<sup>+</sup> = 505.8. The material was deprotected as described for <b>37</b>, yielding 111 mg (87%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.64–9.55 (br, 1H), 9.50–9.38 (br, 1H), 8.98 (s, 1H), 8.61 (d, <i>J</i> = 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 4.8 Hz, 1H), 7.99–7.93 (m, 1H), 7.77 (dd, <i>J</i> = 8.6 and 4.8 Hz, 1H), 7.45–7.40 (m, 2H), 7.25 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.89–4.82 (m, 1H), 4.64 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.53 (dd, <i>J</i> = 10.0 and 6.8 Hz, 1H), 4.23–4.15 (m, 1H), 3.54–3.47 (m, 1H), 3.38–3.28 (m, 2H), 3.28–3.17 (m, 1H), 3.06–2.94 (m, 1H), 2.28 (s, 3H). LC-MS: RT = 4.68 min, [M + H]<sup>+</sup> = 405.6. Purity >95% by HPLC method A, RT = 4.73 min. Purity >95% by HPLC method B, RT = 6.11 min.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(4-Bromo-2-fluorophenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>55</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-bromo-2-fluorophenylisocyanate (90 mg, 0.42 mmol) and <b>11</b> (122 mg, 0.42 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 194 mg (75%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.50 min, [M + H]<sup>+</sup> = 509.8. The material was deprotected as described for <b>37</b>, yielding 141 mg (94%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70–9.62 (br, 1H), 9.57–9.44 (br, 1H), 8.82 (s, 1H), 8.63 (d, <i>J</i> = 2.4 Hz, 1H), 8.45 (d, <i>J</i> = 5.2 Hz, 1H), 8.04–7.98 (m, 1H), 7.81 (dd, <i>J</i> = 8.6 and 5.2 Hz, 1H), 7.53 (dd, <i>J</i> = 10.2 and 2.4 Hz, 1H), 7.42 (t, <i>J</i> = 8.8 Hz, 1H), 7.34 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 4.84–4.76 (m, 1H), 4.66 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.55 (dd, <i>J</i> = 9.8 and 7.0 Hz, 1H), 4.18–4.10 (m, 1H), 3.54–3.45 (m, 1H), 3.40–3.28 (m, 2H), 3.28–3.18 (m, 1H), 3.06–2.94 (m, 1H). LC-MS: RT = 4.45 min, [M + H]<sup>+</sup> = 409.6. Purity >95% by HPLC method A, RT = 4.14 min. Purity >95% by HPLC method B, RT = 5.02 min.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(Biphenyl-4-yl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>56</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-isocyanatobiphenyl (78 mg, 0.40 mmol) and <b>11</b> (117 mg, 0.40 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 210 mg (quantitative yield) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.92 min, [M + H]<sup>+</sup> = 489.2. The material was deprotected as described for <b>37</b>, yielding 126 mg (68%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.65–9.56 (br, 1H), 9.52–9.38 (br, 1H), 9.02 (s, 1H), 8.62 (d, <i>J</i> = 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 5.2 Hz, 1H), 8.00–7.95 (m, 1H), 7.77 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.63 (d, <i>J</i> = 6.8 Hz, 2H), 7.60–7.53 (m, 4H), 7.43 (t, <i>J</i> = 7.6 Hz, 2H), 7.31 (t, <i>J</i> = 7.6 Hz, 1H), 4.93–4.85 (m, 1H), 4.66 (appt t, <i>J</i> = 9.0 Hz, 1H), 4.55 (dd, <i>J</i> = 10.4 and 6.8 Hz, 1H), 4.26–4.19 (m, 1H), 3.56–3.48 (m, 1H), 3.40–3.30 (m, 2H), 3.30–3.20 (m, 1H), 3.08–2.96 (m, 1H). LC-MS: RT = 5.10 min, [M + H]<sup>+</sup> = 389.2. Purity >95% by HPLC method A, RT = 5.12 min. Purity >95% by HPLC method B, RT = 6.57 min.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(4-Benzoylphenyl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>57</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 4-isocyanatobenzophenone (89 mg, 0.40 mmol) and <b>11</b> (117 mg, 0.40 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 150 mg (60%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 8.43 min, [M + H]<sup>+</sup> = 517.2. The material was deprotected as described for <b>37</b>, yielding 80 mg (68%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67–9.58 (br, 1H), 9.54–9.43 (br, 1H), 9.42 (s, 1H), 8.60 (d, <i>J</i> = 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 5.2 Hz, 1H), 7.99–7.94 (m, 1H), 7.77 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.72–7.62 (m, 7H), 7.58–7.53 (m, 2H), 4.96–4.89 (m, 1H), 4.68–4.56 (m, 2H), 4.27–4.20 (m, 1H), 3.57–3.48 (m, 1H), 3.40–3.31 (m, 2H), 3.31–3.21 (m, 1H), 3.08–2.96 (m, 1H). LC-MS: RT = 4.70 min, [M + H]<sup>+</sup> = 417.1. Purity >95% by HPLC method A, RT = 4.69 min. Purity >95% by HPLC method B, RT = 6.04 min.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(2,3-Dihydrobenzofuran-5-yl)-2-((pyridin-3-yloxy)methyl)piperazine-1-carboxamide Dihydrochloride (<b>58</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>37</b> from 2,3-dihydro-1-benzofuran-5-yl isocyanate (55 mg, 0.34 mmol) and <b>11</b> (100 mg, 0.34 mmol). The material was purified by HPLC (10–90% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 157 mg (81%) of the <i>N</i>-Boc intermediate TFA salt as a white solid. LC-MS: RT = 7.28 min, [M + H]<sup>+</sup> = 455.2. The material was deprotected as described for <b>37</b> and was purified by HPLC (5–50% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). This gave 54 mg (45%) of the title compound as an off-white solid upon conversion to the dihydrochloride salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72–9.63 (br, 1H), 9.60–9.48 (br, 1H), 8.69 (s, 1H), 8.66 (d, <i>J</i> = 3.2 Hz, 1H), 8.46 (d, <i>J</i> = 5.2 Hz, 1H), 8.09–8.03 (m, 1H), 7.83 (dd, <i>J</i> = 8.8 and 5.2 Hz, 1H), 7.28 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (dd, <i>J</i> = 8.8 and 2.0 Hz, 1H), 6.23 (d, <i>J</i> = 8.8 Hz, 1H), 4.86–4.79 (m, 1H), 4.69 (appt t, <i>J</i> = 9.4 Hz, 1H), 4.56–4.44 (m, 3H), 4.21–4.13 (m, 1H), 3.54–3.46 (m, 1H), 3.37–3.26 (m, 2H), 3.25–3.10 (m, 3H), 3.05–2.92 (m, 1H). LC-MS: RT = 3.87 min, [M + H]<sup>+</sup> = 355.1. Purity >95% by HPLC method A, RT = 3.48 min. Purity >95% by HPLC method B, RT = 3.82 min.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>tert</i>-Butyl 4-(1<i>H</i>-Imidazole-1-carbonyl)-3-((pyridin-3-yloxy)methyl)piperazine-1-carboxylate (<b>31</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Carbonyldiimidazole (0.506 g, 3.12 mmol) was added to a solution of <b>11</b> (0.458 g, 1.56 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL). After stirring overnight, an additional portion of <i>N</i>,<i>N</i>-carbonyldiimidazole (1.27 g, 7.80 mmol) was added. After 4 h, the reaction mixture was diluted with EtOAc (30 mL) and washed with water (3 × 25 mL) and brine (25 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. This gave 0.542 g (90% crude yield) of the title compound as a white foam. The material was used without further purification. LC-MS: RT = 5.87 min, [M + H]<sup>+</sup> = 388.1.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Phenyl 2-((Pyridin-3-yloxy)methyl)piperazine-1-carboxylate Dihydrochloride (<b>39</b>)</h4><div class="NLM_p last">Phenol (53 mg, 0.56 mmol), triethylamine (0.078 mL, 0.56 mmol), and <b>31</b> (109 mg, 0.28 mmol) were heated to 70 °C in acetonitrile (4 mL). After stirring overnight, Cs<sub>2</sub>CO<sub>3</sub> (182 mg, 0.56 mmol) and phenol (53 mg, 0.56 mmol) were added and heating was continued for 1 h. Upon cooling to rt, the reaction mixture was filtered, concentrated under reduced pressure, and purified by HPLC (10–70% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). This gave 108 mg (73%) of the <i>N</i>-Boc intermediate TFA salt as a thick oil. LC-MS: RT = 8.54 min, [M + H]<sup>+</sup> = 414.2. Then 4 M HCl in 1,4-dioxane (6 mL, 24 mmol) was added to a solution of the intermediate in MeOH (1 mL). After stirring for 1 h, the reaction mixture was concentrated under reduced pressure, yielding 72 mg (91%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77–9.68 (br, 1H), 9.54–9.41 (br, 1H), 8.64 (br s, 1H), 8.43 (d, <i>J</i> = 4.4 Hz, 1H), 8.04–7.94 (m, 1H), 7.83–7.73 (m, 1H), 7.41 (t, <i>J</i> = 7.8 Hz, 2H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 7.18–7.07 (m, 2H), 4.96–4.58 (m, 4H), 4.30–4.06 (m, 1H), 3.54–3.46 (m, 1H), 3.38–3.29 (m, 2H), 3.18–3.04 (m, 1H). LC-MS: RT = 3.89 min, [M + H]<sup>+</sup> = 314.1. Purity >95% by HPLC method A, RT = 3.61 min. Purity >95% by HPLC method B, RT = 4.22 min.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-Chlorophenyl 2-((Pyridin-3-yloxy)methyl)piperazine-1-carboxylate Dihydrochloride (<b>40</b>)</h4><div class="NLM_p last">The compound was prepared as described for <b>39</b> from 4-chlorophenol (2 × 72 mg, 2 × 0.56 mmol) and <b>31</b> (109 mg, 0.28 mmol). The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient). The desired fractions were combined, brought to pH 12 with 1 N NaOH, and extracted with EtOAc (3 × 15 mL). The combined organics were washed with 1 N NaOH (2 × 30 mL) and brine (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. This gave 68 mg (54%) of the <i>N</i>-Boc intermediate as a thick oil. LC-MS: RT = 9.24 min, [M + H]<sup>+</sup> = 448.1. The material was deprotected as described for <b>39</b>, yielding 63 mg (99%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.93–9.83 (br, 1H), 9.68–9.54 (br, 1H), 8.69 (br s, 1H), 8.47 (d, <i>J</i> = 4.8 Hz, 1H), 8.10–8.03 (m, 1H), 7.90–7.80 (m, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 7.24–7.14 (m, 2H), 4.94–4.62 (m, 4H), 4.30–4.06 (m, 1H), 3.53–3.45 (m, 1H), 3.36–3.28 (m, 2H), 3.18–3.02 (m, 1H). LC-MS: RT = 4.66 min, [M + H]<sup>+</sup> = 348.1. Purity >95% by HPLC method A, RT = 4.40 min. Purity >95% by HPLC method B, RT = 5.35 min.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-Methoxyphenyl 2-((Pyridin-3-yloxy)methyl)piperazine-1-carboxylate Dihydrochloride (<b>41</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Carbonyldiimidazole (90 mg, 0.56 mmol) was added to a solution of <b>11</b> (163 mg, 0.56 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After stirring overnight, the reaction mixture was concentrated under reduced pressure and dissolved in acetonitrile (10 mL). 4-Methoxyphenol (207 mg, 1.67 mmol) and triethylamine (1 mL) were added, and the reaction mixture was heated to 70 °C. After 6 h, the reaction mixture was diluted with EtOAc (50 mL) and was washed with 1 N NaOH (3 × 30 mL) and brine (30 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The material was purified by HPLC (10–95% MeCN/0.1% TFA in H<sub>2</sub>O/0.1% TFA gradient), yielding 155 mg (50%) of the <i>N</i>-Boc intermediate TFA salt as a colorless oil. LC-MS: RT = 8.46 min, [M + H]<sup>+</sup> = 444.2. The material was deprotected as described for <b>39</b>, yielding 106 mg (91%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82–9.73 (br, 1H), 9.58–9.46 (br, 1H), 8.66 (br s, 1H), 8.45 (d, <i>J</i> = 5.2 Hz, 1H), 8.06–7.98 (m, 1H), 7.86–7.78 (m, 1H), 7.10–7.00 (m, 2H), 6.92 (d, <i>J</i> = 8.8 Hz, 2H), 4.94–4.60 (m, 4H), 4.30–4.06 (m, 1H), 3.53–3.45 (m, 1H), 3.36–3.28 (m, 2H), 3.16–3.02 (m, 1H). LC-MS: RT = 4.07 min, [M + H]<sup>+</sup> = 344.1. Purity >95% by HPLC method A, RT = 3.76 min. Purity >95% by HPLC method B, RT = 4.69 min.</div></div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Rat PC12 Fluorescently Labeled α-Bungarotoxin Binding Assay</h3><div class="NLM_p last">PC12 cells (ATCC, Manassas, Va.) were resuspended in binding buffer (PBS containing 1.0% FBS and 0.02% sodium azide) and added to a 96-well v-bottom plate at 0.08–1.5 × 10<sup>5</sup> cells per well. Each compound tested was diluted in binding buffer and added to the cells. Each sample contained 0.1% DMSO. Biotinylated α-bungarotoxin (Invitrogen Corporation, Carlsbad, California) was diluted in binding buffer and added to cells to yield a final concentration of 10 nM. An excess of unlabeled α-bungarotoxin was added to the nonspecific binding control at a final concentration of 1.5 μM. The samples were incubated at room temperature for 1 h. After incubation, the cells were washed one time with binding buffer to remove the unbound α-bungarotoxin. Phycoerythrin-labeled streptavidin (Becton-Dickinson Biosciences, San Jose, CA) was diluted in binding buffer and added to the cells for a final concentration of 1.0 μg/mL. The samples were incubated in the dark at room temperature for 15 min. The cells were washed once with binding buffer to remove the excess phycoerythrin-labeled streptavidin. The samples were then resuspended in binding buffer, and α-bungarotoxin binding was quantified by FACS analysis. Compounds were initially tested at 10 and 1 μM. Compounds showing 50% or greater inhibition of α-bungarotoxin binding at 10 μM were then tested in an eight-point IC<sub>50</sub> assay. Briefly, compounds were 3-fold serially diluted and added to cells at the following concentrations: compounds showing greater than or equal to 50% inhibition at 10 μM and less than 75% inhibition at 1 μM were serially diluted from a concentration of 50 μM, compounds showing greater than 50% inhibition at 10 μM and between 70 and 95% inhibition at 1 μM were serially diluted from 10 μM, and last, compounds showing inhibition greater than 50% inhibition at 10 μM and greater than 95% inhibition at 1 μM were serially diluted from 1 μM. IC<sub>50</sub> curves were then generated from the percent inhibition values at each of the eight concentrations.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Balb/c Mouse Ovalbumin Sensitization and Challenge Model of Allergic Lung Inflammation</h3><div class="NLM_p last">Male, BALB/c mice, 6–8 weeks of age, were sensitized intraperitoneally with 10 μg of ovalbumin on days 1 and 14. On days 29, 30, and 31, the animals were challenged intranasally with 100 μg of ovalbumin. Test compounds were dissolved in saline and administered orally, starting 30 min prior to the three intranasal ovalbumin challenges. Groups of six mice were treated with either compound or vehicle control at the doses and intervals described in the figure legends. Sham groups of mice were sensitized with saline and challenged with allergen. The sham groups were included in the study to assess the effect of the sensitization-challenges procedure on the animals. Eight hours after the final ovalbumin challenge, mice were sacrificed and bronchoalveolar lavage (BAL) was performed. Microscope slides were prepared for each BAL sample and differential cell counts were performed.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-8"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm5004599">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Binding assay data on panel of 55 receptors, ion channels, and transporters for compounds (<b><i>R</i></b>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b>. Activity inhibition data on panel of 11 enzymes for compounds (<i><b>R</b></i>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b>.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5004599/suppl_file/jm5004599_si_001.pdf">jm5004599_si_001.pdf (437.82 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5004599" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Elbaum</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6c080809000e0d19012c0b010d0500420f0301"><span class="__cf_email__" data-cfemail="a9cdcdccc5cbc8dcc4e9cec4c8c0c587cac6c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger B. Clark</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Lamppu</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lyn Libertine</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy McDonough</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anjali Kumar</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Greg LaRosa</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger Rush</span> - <span class="hlFld-Affiliation affiliation">Critical Therapeutics, Inc., 60 Westview Street, Lexington, Massachusetts 02421, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2704e7254-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Margreit J. Vervoordeldonk and Roger Papke for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> Abbreviations Used</h2><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchalveolar lavage</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>t</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">Cyp</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorter</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FEV1</td><td class="NLM_def"><p class="first last">forced expiratory volume in 1 s</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phosphomolybdic acid</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="note"><p class="first last">For leading references on nAChRs, see:</p></div><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17009926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=699-729&author=J.+A.+Daniauthor=D.+Bertrand&title=Nicotinic+Acetylcholine+Receptors+and+Nicotinic+Cholinergic+Mechanisms+of+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span></div><div class="casAuthors">Dani, John A.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-729</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacol. characteristics.  Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability.  Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention.  Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70HAk5CzKZbVg90H21EOLACvtfcHk0liyUg7dUzseiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D&md5=72cacc238ec2a67f7ebae0b74582682f</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105214%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptors%2520and%2520Nicotinic%2520Cholinergic%2520Mechanisms%2520of%2520the%2520Central%2520Nervous%2520System%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D699%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors: from Structure to Pathology</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.pneurobio.2004.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15649582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2004&pages=363-396&author=C.+Gottiauthor=F.+Clementi&title=Neuronal+Nicotinic+Receptors%3A+from+Structure+to+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors: from structure to pathology</span></div><div class="casAuthors">Gotti, C.; Clementi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-396</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are differently expressed in many regions of the central nervous system (CNS) and peripheral nervous system.  These different receptor subtypes, which have characteristic pharmacol. and biophys. properties, have a pentameric structure consisting of the homomeric or heteromeric combination of 12 different subunits (α2-α10, β2-β4).  By responding to the endogenous neurotransmitter acetylcholine, NAChRs contribute to a wide range of brain activities and influence a no. of physiol. functions.  Furthermore, it is becoming evident that the perturbation of cholinergic nicotinic neurotransmission can lead to various diseases involving nAChR dysfunction during development, adulthood and aging.  In recent years, it has been discovered that NAChRs are present in a no. of non-neuronal cells where they play a significant functional role and are the pathogenetic targets in several diseases.  NAChRs are also the target of natural ligands and toxins including nicotine (Nic), the most widespread drug of abuse.  This review will attempt to survey the major achievements reached in the study of the structure and function of NAChRs by examg. their regional and cellular localization and the mol. basis of their functional diversity mainly in pharmacol. and biochem. terms.  The recent availability of mice with the genetic ablation of single or double nicotinic subunits or point mutations have shed light on the role of nAChRs in major physiol. functions, and we will here discuss recent data relating to their behavioral phenotypes.  Finally, the role of NAChRs in disease will be considered in some details.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Q3RLpSUGVrVg90H21EOLACvtfcHk0liyUg7dUzseiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVertA%253D%253D&md5=887cf2153d3a412b292de7eba676ef70</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2004.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2004.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%253A%2520from%2520Structure%2520to%2520Pathology%26jtitle%3DProg.%2520Neurobiol.%26date%3D2004%26volume%3D74%26spage%3D363%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakics, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visanji, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">The Role of Neuronal Nicotinic Acetylcholine Receptors in acute and Chronic Neurodegeneration</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568007023339166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12769612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=399-411&author=M.+J.+O%E2%80%99Neillauthor=T.+K.+Murrayauthor=V.+Lakicsauthor=N.+P.+Visanjiauthor=S.+Duty&title=The+Role+of+Neuronal+Nicotinic+Acetylcholine+Receptors+in+acute+and+Chronic+Neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration</span></div><div class="casAuthors">O'Neill, M. J.; Murray, T. K.; Lakics, V.; Visanji, N. P.; Duty, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last five years there has been a rapid explosion of publications reporting that neuronal nicotinic acetylcholine receptors (nAChRs) play a role in neurodegenerative disorders.  Furthermore, there is a well-established loss of nAChRs in post-mortem brains from patients with Alzheimer's disease, Parkinson's disease and a range of other disorders.  In the present review the authors discuss the evidence that nicotine and subtype selective nAChR ligands can provide neuroprotection in in vitro cell culture systems and in in vivo studies in animal models of such disorders.  While in vitro data pertaining to a protective effect of nicotine against nigral neurotoxins like MPTP is less robust, most studies agree that nicotine is protective against glutamate and β-amyloid toxicity in various culture systems.  This effect appears to be mediated by α7 subtype nAChRs since the protection is blocked by α-bungarotoxin and is mimicked by α7 selective agonists.  In vivo studies indicate that α7 receptors play a crit. role in protection from cholinergic lesions and enhancing cognitive function.  The exact subtype involved in the neuroprotectant effects seen in animal models of Parkinson's disease is not clear, but in general broad spectrum nAChR agonists appear to provide protection, while α4β2 receptors appear to mediate symptomatic improvements.  Evidence favoring a protectant effect of nicotine against acute degenerative conditions is less strong, though some protection has been obsd. with nicotine pre-treatment in global ischemia models.  A variety of cellular mechanisms ranging from the prodn. of growth factors through to inactivation of toxins and antioxidant actions of nicotine have been proposed to underlie the nAChR-mediated neuroprotection in vitro and in vivo.  In summary, although the lack of subtype selective ligands has hampered progress, it is clear that in the future neuronal nAChR agonists could provide functional improvements and slow or halt the progress of several crippling degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWuObmpWTELVg90H21EOLACvtfcHk0lhHw8MiqlVmQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsro%253D&md5=f7ab213c62cd9304c9a073a5d223d84f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.2174%2F1568007023339166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339166%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DVisanji%26aufirst%3DN.%2BP.%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DThe%2520Role%2520of%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%2520in%2520acute%2520and%2520Chronic%2520Neurodegeneration%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dani, J. A.</span><span> </span><span class="NLM_article-title">Overview of Nicotinic Receptors and Their Roles in the Central Nervous System</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3223%2800%2901011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11230867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=166-174&author=J.+A.+Dani&title=Overview+of+Nicotinic+Receptors+and+Their+Roles+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of nicotinic receptors and their roles in the central nervous system</span></div><div class="casAuthors">Dani, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-174</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 105 refs.  Alzheimer's disease is a complex disorder affecting multiple neurotransmitters.  In particular, the degenerative progression is assocd. with loss within the cholinergic systems.  It should be anticipated that both muscarinic and nicotinic mechanisms are affected as cholinergic neurons are lost.  This review focuses on the basic roles of neuronal nicotinic receptors, some subtypes of which decrease during Alzheimer's disease.  Nicotinic acetylcholine receptors belong to a superfamily of ligand-gated ion channels that play key roles in synaptic transmission throughout the central nervous system.  Neuronal nicotinic receptors, however, are not a single entity, but rather there are many different subtypes constructed from a variety of nicotinic subunit combinations.  This structural diversity and the presynaptic, axonal, and postsynaptic locations of nicotinic receptors contribute to the varied roles these receptors play in the central nervous system.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, and postsynaptic nicotinic receptors mediate a small minority of fast excitatory transmission.  In addn., some nicotinic receptor subtypes have roles in synaptic plasticity and development.  Nicotinic receptors are distributed to influence many neurotransmitter systems at more than one location, and the broad, but sparse, cholinergic innervation throughout the brain ensures that nicotinic acetylcholine receptors are important modulators of neuronal excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVstmEaLl67Vg90H21EOLACvtfcHk0lhHw8MiqlVmQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtLY%253D&md5=5ea652d009184424ab870437e5863907</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901011-8%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26atitle%3DOverview%2520of%2520Nicotinic%2520Receptors%2520and%2520Their%2520Roles%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D166%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariou, V.</span><span> </span><span class="NLM_article-title">Nicotinic Receptors in the Brain; Links Between Molecular Biology and Behavior</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=451-465&author=M.+R.+Picciottoauthor=B.+J.+Caldaroneauthor=S.+L.+Kingauthor=V.+Zachariou&title=Nicotinic+Receptors+in+the+Brain%3B+Links+Between+Molecular+Biology+and+Behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DKing%26aufirst%3DS.%2BL.%26aulast%3DZachariou%26aufirst%3DV.%26atitle%3DNicotinic%2520Receptors%2520in%2520the%2520Brain%253B%2520Links%2520Between%2520Molecular%2520Biology%2520and%2520Behavior%26jtitle%3DNeuropsychopharmacology%26date%3D2000%26volume%3D22%26spage%3D451%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1f"><span><span class="NLM_label">(f) </span> <span class="citation_source-book">Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities</span>; <span class="NLM_contrib-group">Arneric, S. P.; Brioni, J. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Liss</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=S.+P.+Arneric&author=J.+D.+Brioni&title=Neuronal+Nicotinic+Receptors%3A+Pharmacology+and+Therapeutic+Opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNeuronal%2520Nicotinic%2520Receptors%253A%2520Pharmacology%2520and%2520Therapeutic%2520Opportunities%26aulast%3DArneric%26aufirst%3DS.%2BP.%26pub%3DWiley-Liss%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parri, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span> </span><span class="NLM_article-title">Research Update: Alpha7 Nicotinic Acetylcholine Receptor Mechanisms in Alzheimer’s Disease</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=931-942&author=H.+R.+Parriauthor=C.+M.+Hernandezauthor=K.+T.+Dineley&title=Research+Update%3A+Alpha7+Nicotinic+Acetylcholine+Receptor+Mechanisms+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParri%26aufirst%3DH.%2BR.%26aulast%3DHernandez%26aufirst%3DC.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26atitle%3DResearch%2520Update%253A%2520Alpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D931%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woodruff-Pak, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T. J.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia</span> <span class="citation_source-journal">Behav. Cognit. Neurosci. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1177%2F1534582302001001002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17715584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2svps12qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=5-20&author=D.+S.+Woodruff-Pakauthor=T.+J.+Gould&title=Neuronal+Nicotinic+Acetylcholine+Receptors%3A+Involvement+in+Alzheimer%E2%80%99s+Disease+and+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Woodruff-Pak Diana S; Gould Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Behavioral and cognitive neuroscience reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-20</span>
        ISSN:<span class="NLM_cas:issn">1534-5823</span>.
    </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) play a role in a variety of diseases of the central nervous system including Alzheimer's disease (AD) and schizophrenia.  There is great interest in evaluating disease-related nA ChR changes, and pharmacological treatment of nAChR deficits is a promising therapy.  In AD, 7 nAChRs remain relatively stable, contrasting to 4 2 nAChRs that are lost in substantial numbers. -amyloid, a major neuropathology in AD, blocks 4 2 and 7 nAChRs.  Agonists selective to 7nAChRs are neuroprotective against--amyloid.  Paradoxically, 7nAChRs may function as receptors for -amyloid.  These results indicate 7 nAChR antagonists may be appropriate therapy in AD.  In schizophrenia, 7 nAChRs are significantly reduced in hippocampus and neocortex.  The exceptionally high rate of smoking in schizophrenics is likely a form of self-medication.  Therapy with 7 nAChR agonists relieves some schizophrenic symptoms.  Despite disparities in etiology and symptomatology, AD and schizophrenia share a target for therapeutic intervention--7 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzCfYUXsypXZVVjGoY74BafW6udTcc2eanE4XuP7wXn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svps12qtA%253D%253D&md5=a85db74fd91f39e41b17a825662e84ae</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1177%2F1534582302001001002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1534582302001001002%26sid%3Dliteratum%253Aachs%26aulast%3DWoodruff-Pak%26aufirst%3DD.%2BS.%26aulast%3DGould%26aufirst%3DT.%2BJ.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520Involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Schizophrenia%26jtitle%3DBehav.%2520Cognit.%2520Neurosci.%2520Rev.%26date%3D2002%26volume%3D1%26spage%3D5%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. T.</span><span> </span><span class="NLM_article-title">The Nicotinic Acetylcholine Receptor, Smoking, and Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12446934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XotV2nsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=317-325&author=M.+N.+Sabbaghauthor=R.+J.+Lukasauthor=D.+L.+Sparksauthor=R.+T.+Reid&title=The+Nicotinic+Acetylcholine+Receptor%2C+Smoking%2C+and+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Lukas, Ronald J.; Sparks, D. Larry; Reid, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinergic dysfunction is one of the cornerstones of Alzheimer's disease (AD) pathol.  Reviewed here is evidence evaluating relationships between smoking, nicotine exposure, nicotinic cholinergic signaling, and AD.  Epidemiol. studies initially indicating a lower incidence of AD in smokers now suggest conflicting results.  Clinicopathol. findings also are mixed as to how smoking behavior affects manifestation of AD markers.  Studies that show nicotine-induced increases in nicotinic acetylcholine receptors (nAChR) and protection against age-related nAChR decline contrast, perhaps in a functionally relevant way, to losses of nAChR in AD.  Although epidemiol., clinicopathol., and functional studies in humans do not present a cohesive picture, much in vitro data suggests neuroprotective properties of nicotine when used in models of neurodegenerative disorders.  Studies of nicotine and nicotinic agonist effects on cognitive function in the non-demented and in AD are not compelling.  More work is needed to ascertain whether acute or repetitive activation of nAChR with acute or intermittent exposure to nicotine or the persistent inactivation of nAChR with chronic nicotine exposure is a therapeutic objective and/or explains any pro-cognitive effects of those drugs.  Other studies show complex interactions between nAChR, nicotinic agonists, and agents implicated in AD etiol.  Thus, while controversies still exist, ongoing research is illuminating how nicotinic receptor changes and functions may be relevant to clin., pathol. and neurochem. changes that occur in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcug2bL8lVrrVg90H21EOLACvtfcHk0lhoSLdjo0JiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotV2nsrk%253D&md5=6d48f98ca53931b6b2afef4199e584e8</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DSparks%26aufirst%3DD.%2BL.%26aulast%3DReid%26aufirst%3DR.%2BT.%26atitle%3DThe%2520Nicotinic%2520Acetylcholine%2520Receptor%252C%2520Smoking%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2002%26volume%3D4%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Cognitive Effects of Nicotine</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3223%2800%2901094-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11230877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=258-267&author=A.+H.+Rezvaniauthor=E.+D.+Levin&title=Cognitive+Effects+of+Nicotine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive effects of nicotine</span></div><div class="casAuthors">Rezvani, A. H.; Levin, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Nicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks.  Clin. studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments assocd. with Alzheimer's disease, schizophrenia, and attention-deficit/hyperactivity disorder.  Exptl. animal studies have demonstrated the persistence of nicotine-induced working memory improvement with chronic exposure, in addn. to the efficacy of a variety of nicotinic agonists.  Mechanistic studies have found that α7 and α4β2 nicotinic receptors in the hippocampus are crit. for nicotinic involvement in cognitive function.  Clin. and exptl. animal studies provide mutually supporting information for the development of novel nicotinic therapies for cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjXiYhwf7QbVg90H21EOLACvtfcHk0lhoSLdjo0JiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbY%253D&md5=2142a7de336eec31e59faa210cccc7c8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901094-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901094-5%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DCognitive%2520Effects%2520of%2520Nicotine%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D258%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehouse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino-Barrows, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span> </span><span class="NLM_article-title">Muscarinic and Nicotinic Cholinergic Binding Sites in Alzheimer’s Disease Cerebral Cortex</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2F0006-8993%2887%2991556-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=3690354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaL1cXjsFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=1987&pages=62-68&author=K.+J.+Kellarauthor=P.+J.+Whitehouseauthor=A.+M.+Martino-Barrowsauthor=K.+Marcusauthor=D.+L.+Price&title=Muscarinic+and+Nicotinic+Cholinergic+Binding+Sites+in+Alzheimer%E2%80%99s+Disease+Cerebral+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex</span></div><div class="casAuthors">Kellar, Kenneth J.; Whitehouse, Peter J.; Martino-Barrows, Andrea M.; Marcus, Kendall; Price, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-8</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The total population of muscarinic receptors and a subpopulation of muscarinic receptors with high affinity for agonists were measured with [3H]quinuclidinyl benzilate and [3H]acetylcholine, resp., in homogenates of cerebral cortex from control and Alzheimer's disease brains.  No differences between control and Alzheimer's diseased cortex were found in either the total population of receptors or the subpopulation with high affinity for agonists in either the frontal or temporal poles.  Nicotinic cholinergic receptors labeled by [3H]acetylcholine were measured in homogenates and by autoradiog. in the same brain areas.  In contrast to muscarinic sites, binding to nicotinic sites was markedly decreased in Alzheimer's disease cortex.  Autoradiog. of [3H]acetylcholine binding to nicotinic sites indicated that in control cortex these sites are more concd. in laminae IV-VI than in the superficial laminae, and that in Alzheimer's disease there is loss of these sites in all cortical laminae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7zR32awpUbVg90H21EOLACvtfcHk0lhoSLdjo0JiSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXjsFymtQ%253D%253D&md5=6c6fcf75194559190c47599b3fbe2f69</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2991556-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252991556-3%26sid%3Dliteratum%253Aachs%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DWhitehouse%26aufirst%3DP.%2BJ.%26aulast%3DMartino-Barrows%26aufirst%3DA.%2BM.%26aulast%3DMarcus%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26atitle%3DMuscarinic%2520and%2520Nicotinic%2520Cholinergic%2520Binding%2520Sites%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Cerebral%2520Cortex%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D436%26spage%3D62%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wallace, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Alpha7 Neuronal Nicotinic Receptors as a Drug Target in Schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1517%2F14728222.2013.736498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=23231385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=139-155&author=T.+L.+Wallaceauthor=D.+Bertrand&title=Alpha7+Neuronal+Nicotinic+Receptors+as+a+Drug+Target+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia</span></div><div class="casAuthors">Wallace, Tanya L.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-155</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Schizophrenia is a profoundly debilitating disease that represents not only an individual, but a societal problem.  Once characterized solely by the hyperactivity of the dopaminergic system, therapies directed to dampen dopaminergic neurotransmission were developed.  However, these drugs do not address the significant impairments in cognition and the neg. symptoms of the disease, and it is now apparent that disequil. of many neurotransmitter systems is involved.  Despite enormous efforts, minimal progress has been made toward the development of safer, more effective therapies to date.Areas covered: The high preponderance of smoking in schizophrenics suggests that nicotine may provide symptomatic improvement, which has led to investigation for selective mols. targeted to individual nicotinic receptor (nAChR) subtypes.  Of special interest is activation of the homomeric α7nAChR, which is widely distributed in the brain and has been implicated in the pathophysiol. of schizophrenia through numerous approaches.Expert opinion: Preclin. and clin. data suggest that neuronal α7nAChRs play an important role in cognitive functions.  Moreover, some, but not all, early clin. trials conducted with α7nAChR agonists show cognitive benefits in schizophrenics.  These encouraging results suggest that development of compds. targeting α7nAChRs will represent a valuable tool to mitigate symptoms assocd. with schizophrenia, and open new strategies for better pharmacol. treatment of these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonmAqWvgG0_rVg90H21EOLACvtfcHk0ljpHwY5PMoUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVyjug%253D%253D&md5=e625c6965844e11c47a46e5335a10f3d</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.736498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.736498%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DAlpha7%2520Neuronal%2520Nicotinic%2520Receptors%2520as%2520a%2520Drug%2520Target%2520in%2520Schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26spage%3D139%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Alpha7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F138161211795049561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=21355839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=121-129&author=M.+Ishikawaauthor=K.+Hashimoto&title=Alpha7+Nicotinic+Acetylcholine+Receptor+as+a+Potential+Therapeutic+Target+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia</span></div><div class="casAuthors">Ishikawa, Masatomo; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence suggests that the α7 subtype of nicotinic acetylcholine receptors (nAChRs) plays a role in the patho-physiol. of schizophrenia.  Deficits in auditory P50 evoked potential suppression in patients with schizophrenia are assocd. with decreased d. of α7 nAChRs in the brain.  Some agonists (e.g., DMXB-A and tropisetron) at α7 nAChRs can improve P50 deficits in patients with schizophrenia.  Together, these findings indicate that α7 nAChRs are a potential therapeutic target for schizophrenia.  Currently, a no. of agonists and allosteric modulators at α7 nAChRs are under development as potential therapeutic drugs.  In this article, we review recent topics on α7 nAChR agonists and α7 nAChR allosteric modulators as therapeutic drugs for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiPKBnCbTnLVg90H21EOLACvtfcHk0ljpHwY5PMoUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVSmsbk%253D&md5=4e16cc1e1aea2589a01ad722f760a8f1</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F138161211795049561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049561%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DAlpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520as%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=171-184&author=K.+Hashimotoauthor=K.+Koikeauthor=E.+Shimizuauthor=M.+Iyo&title=%CE%B17+Nicotinic+Receptor+Agonists+as+Potential+Therapeutic+Drugs+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic receptor agonists as potential therapeutic drugs for schizophrenia</span></div><div class="casAuthors">Hashimoto, Kenji; Koike, Kaori; Shimizu, Eiji; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Deficient inhibitory processing of the P50 auditory evoked potential is a measurable marker obsd. in schizophrenia.  Several lines of evidence suggest that α7 nicotinic receptors (α7 nAChRs) play a crit. role in P50 auditory sensory gating in the human brain.  Similar to schizophrenic patients, DBA/2 mice spontaneously exhibit a deficit in inhibitory processing of the P20-N40 auditory evoked potential, which is a rodent analog of the human P50 auditory evoked potential.  Agonists at α7 nAChRs improve deficient inhibitory processing of the P20-N40 auditory gating potential in DBA/2 mice.  In this article, we review the role of α7 nAChRs in the pathophysiol. of schizophrenia, and α7 nAChR agonists and indirect agonists (5-hydroxytryptamine-3 (5-HT3) receptor antagonists, pos. allosteric modulators (galantamine, 5-hydroxyindole, PNU-120596), FK960, FR236924) at α7 nAChRs as potential therapeutic drugs for the treatment of schizophrenia.  In addn., we also discuss the role of kynurenic acid as an endogenous antagonist of α7 nAChRs in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYcI0WdtDnLVg90H21EOLACvtfcHk0ljpHwY5PMoUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D&md5=69bc7ca07eb3b46da3bef6c9c8db956f</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3D%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonists%2520as%2520Potential%2520Therapeutic%2520Drugs%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ripoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronnec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span> </span><span class="NLM_article-title">Nicotinic Receptors and Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1185%2F030079904125004060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15265251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVyktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=1057-1074&author=N.+Ripollauthor=M.+Bronnecauthor=M.+Bourin&title=Nicotinic+Receptors+and+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors and schizophrenia</span></div><div class="casAuthors">Ripoll, Nadege; Bronnec, Marie; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1057-1074</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence of smoking is very high in nonschizophrenic subjects presenting various psychiatric disorders (35 to 54%).  However, the incidence of smoking is extremely high in schizophrenic patients: 80% to 90%, vs. 25% to 30% of the general population.  Various studies have demonstrated that the use of tobacco transiently restores the schizophrenic patient's cognitive and sensory deficits.  Smoking cessation also appears to exacerbate the symptoms of the disease.  Post-mortem binding studies have revealed a disturbance of nicotinic receptor expression, affecting the α7 and α4β2 subunits, in various cerebral areas.  Genetic linkage studies have also shown that the α7 subunit is involved in schizophrenia.  This review assesses the involvement of the nicotinic system in schizophrenia and suggests ways in which this system may participate in the pathophysiol. of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvoLWwOQISrVg90H21EOLACvtfcHk0ljpHwY5PMoUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVyktLk%253D&md5=23e174f0c6b1ccd4acbf0bb8ade6d530</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1185%2F030079904125004060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079904125004060%26sid%3Dliteratum%253Aachs%26aulast%3DRipoll%26aufirst%3DN.%26aulast%3DBronnec%26aufirst%3DM.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DNicotinic%2520Receptors%2520and%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2004%26volume%3D20%26spage%3D1057%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olincy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pender, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allensworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbe, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kem, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Proof-of-Concept Trial of an Alpha7 Nicotinic Agonist in Schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1001%2Farchpsyc.63.6.630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16754836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=630-638&author=A.+Olincyauthor=J.+G.+Harrisauthor=L.+L.+Johnsonauthor=V.+Penderauthor=S.+Kongsauthor=D.+Allensworthauthor=J.+Ellisauthor=G.+O.+Zerbeauthor=S.+Leonardauthor=K.+E.+Stevensauthor=J.+O.+Stevensauthor=L.+Martinauthor=L.+E.+Adlerauthor=F.+Sotiauthor=W.+R.+Kemauthor=R.+Freedman&title=Proof-of-Concept+Trial+of+an+Alpha7+Nicotinic+Agonist+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia</span></div><div class="casAuthors">Olincy, Ann; Harris, Josette G.; Johnson, Lynn L.; Pender, Vicki; Kongs, Susan; Allensworth, Diana; Ellis, Jamey; Zerbe, Gary O.; Leonard, Sherry; Stevens, Karen E.; Stevens, James O.; Martin, Laura; Adler, Lawrence E.; Soti, Ferenc; Kem, William R.; Freedman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">630-638</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor gene, CHRNA7, is assocd. with genetic transmission of schizophrenia and related cognitive and neurophysiol. sensory gating deficits.  Cognitive dysfunction is responsible for significant psychosocial disability in schizophrenia.  Nicotine, a low-potency agonist at the α7 receptor, has some pos. effects on neurophysiol. and neurocognitive deficits assocd. with schizophrenia, which suggests that more effective receptor activation might meaningfully enhance cognition in schizophrenia.  To det. if 3-[(2,4-dimethoxy) benzylidene]anabasine (DMXB-A), a natural alkaloid deriv. and a partial α7 nicotinic cholinergic agonist, significantly improves neurocognition, and to assess, by effects on P50 auditory evoked potential inhibition, whether its neurobiol. actions are consistent with activation of α7 nicotinic receptors.  Randomized, double-blind crossover trial of 2 drug doses and 1 placebo.  General clin. research center.  12 Persons with schizophrenia who did not smoke and were concurrently treated with antipsychotic drugs.  1 Person was withdrawn because of a transient decrease in white blood cell count.  Administration of DMXB-A.  Total scale score of the Repeatable Battery for the Assessment of Neuropsychol. Status and P50 inhibitory gating.  Significant neurocognitive improvement was found on the Repeatable Battery for the Assessment of Neuropsychol. Status total scale score, particularly for the lower DMXB-A dose compared with placebo.  Effects were greater than those of nicotine in a similar study.  Significant improvement in P50 inhibition also occurred.  Patients generally tolerated the drug well.  An α7 nicotinic agonist appears to have pos. effects on neurocognition in persons with schizophrenia.  Longer trials are needed to det. the clin. utility of this novel treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNiy8qbdR6tbVg90H21EOLACvtfcHk0lijHFSAKWFfOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKgurc%253D&md5=f4589fdf1f448fc17063a182faf7eabf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.63.6.630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.63.6.630%26sid%3Dliteratum%253Aachs%26aulast%3DOlincy%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DL.%2BL.%26aulast%3DPender%26aufirst%3DV.%26aulast%3DKongs%26aufirst%3DS.%26aulast%3DAllensworth%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DZerbe%26aufirst%3DG.%2BO.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DK.%2BE.%26aulast%3DStevens%26aufirst%3DJ.%2BO.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DAdler%26aufirst%3DL.%2BE.%26aulast%3DSoti%26aufirst%3DF.%26aulast%3DKem%26aufirst%3DW.%2BR.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DProof-of-Concept%2520Trial%2520of%2520an%2520Alpha7%2520Nicotinic%2520Agonist%2520in%2520Schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2006%26volume%3D63%26spage%3D630%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kitagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesnes, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clody, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. L.</span><span> </span><span class="NLM_article-title">Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=542-551&author=H.+Kitagawaauthor=T.+Takenouchiauthor=R.+Azumaauthor=K.+A.+Wesnesauthor=W.+G.+Kramerauthor=D.+E.+Clodyauthor=A.+L.+Burnett&title=Safety%2C+Pharmacokinetics%2C+and+Effects+on+Cognitive+Function+of+Multiple+Doses+of+GTS-21+in+Healthy%2C+Male+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DTakenouchi%26aufirst%3DT.%26aulast%3DAzuma%26aufirst%3DR.%26aulast%3DWesnes%26aufirst%3DK.%2BA.%26aulast%3DKramer%26aufirst%3DW.%2BG.%26aulast%3DClody%26aufirst%3DD.%2BE.%26aulast%3DBurnett%26aufirst%3DA.%2BL.%26atitle%3DSafety%252C%2520Pharmacokinetics%252C%2520and%2520Effects%2520on%2520Cognitive%2520Function%2520of%2520Multiple%2520Doses%2520of%2520GTS-21%2520in%2520Healthy%252C%2520Male%2520Volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D542%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span>See Forum (formerly EnVivo) Pharmaceuticals Website: <a href="http://www.forumpharma.com/innovation-pipeline/a7-receptor-agonists.html" class="extLink">http://www.forumpharma.com/innovation-pipeline/a7-receptor-agonists.html</a>, accessed May 4, 2014.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Forum+%28formerly+EnVivo%29+Pharmaceuticals+Website%3A+http%3A%2F%2Fwww.forumpharma.com%2Finnovation-pipeline%2Fa7-receptor-agonists.html%2C+accessed+May+4%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gahring, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S. W.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptor Expression and Function on Nonneuronal Cells</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">E885</span><span class="NLM_x">–</span> <span class="NLM_lpage">E894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=E885-E894&author=L.+C.+Gahringauthor=S.+W.+Rogers&title=Neuronal+Nicotinic+Acetylcholine+Receptor+Expression+and+Function+on+Nonneuronal+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGahring%26aufirst%3DL.%2BC.%26aulast%3DRogers%26aufirst%3DS.%2BW.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Expression%2520and%2520Function%2520on%2520Nonneuronal%2520Cells%26jtitle%3DAAPS%2520J.%26date%3D2006%26volume%3D7%26spage%3DE885%26epage%3DE894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayaraghavan, S.</span><span> </span><span class="NLM_article-title">Nicotinic Receptor Signaling in Nonexcitable Cells</span> <span class="citation_source-journal">J. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fneu.10114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12436417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Klsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=524-534&author=G.+Sharmaauthor=S.+Vijayaraghavan&title=Nicotinic+Receptor+Signaling+in+Nonexcitable+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor signaling in nonexcitable cells</span></div><div class="casAuthors">Sharma, Geeta; Vijayaraghavan, Sukumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-534</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The finding that neuronal nicotinic acetylcholine receptors (nAChRs) are present in non-neuronal cells both within and outside the nervous system raises some interesting issues.  The mechanisms underlying receptor signaling and its downstream consequences in these cells remain to be elucidated.  Factors controlling the release of acetylcholine and the extent of its diffusion are likely to be different for these cells than for traditional neuronal synapses.  Recent advances on the physiol. functions of some of these cell types have provided a better insight into possible functional roles for nAChRs in nonexcitable cells.  The presence of nAChRs on these cells also implies a broader scope for the actions of nicotine that needs to be considered from a clin. viewpoint.  Revealing the potential physiol. roles for nAChRs on nonexcitable cells is likely to provide a more complete understanding of cholinergic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bxjyA9UnMLVg90H21EOLACvtfcHk0lgr7WOwo8MiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Klsb8%253D&md5=231fad2b31c4bb777de3cadc8227db76</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1002%2Fneu.10114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.10114%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DVijayaraghavan%26aufirst%3DS.%26atitle%3DNicotinic%2520Receptor%2520Signaling%2520in%2520Nonexcitable%2520Cells%26jtitle%3DJ.%2520Neurobiol.%26date%3D2002%26volume%3D53%26spage%3D524%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors in Non-Neuronal Cells: New Modulators of Tobacco Toxicity?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0014-2999%2800%2900036-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10771024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFKjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2000&pages=279-294&author=B.+M.+Conti-Fineauthor=D.+Navaneethamauthor=S.+Leiauthor=A.+D.+J.+Maus&title=Neuronal+Nicotinic+Receptors+in+Non-Neuronal+Cells%3A+New+Modulators+of+Tobacco+Toxicity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?</span></div><div class="casAuthors">Conti-Fine, B. M.; Navaneetham, D.; Lei, S.; Maus, A. D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  The nicotinic acetylcholine receptors are prototypic ionotropic receptors that mediate fast synaptic transmission.  However, also non-excitable cells, and particularly the tegumental cells that line external and internal body surfaces, express acetylcholine receptors of neuronal type sensitive to nicotine.  Bronchial epithelial cells, endothelial cells of blood vessels, and skin keratinocytes express neuronal nicotinic receptors composed of α3, α5, β2, and β4 subunits, similar to those expressed in sympathetic ganglia, and neuronal nicotinic receptors composed of α7 subunits.  Neuronal nicotinic receptors in tegumental cells are involved in modulating cell shape and motility, and therefore in maintaining the integrity of the surfaces lined by those cells.  Neuronal nicotinic receptors in non-neuronal tissues may modulate other functions, including cell proliferation and differentiation.  Acetylcholine is synthesized, secreted, and degraded by a variety of cells, including the tegumental cells that express neuronal nicotinic receptors.  Thus, acetylcholine may function as a local hormone that is able to modulate cell functions that require fast adaptation to new conditions.  The presence of neuronal nicotinic receptors sensitive to nicotine in tissues known to be involved in tobacco toxicity, like bronchi and blood vessels, raises the possibility that they mediate some of the toxic effects of smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhBtISpa-YLVg90H21EOLACvtfcHk0lgr7WOwo8MiTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFKjs7c%253D&md5=66302d10e39477c6c18c284efffa651f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900036-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900036-4%26sid%3Dliteratum%253Aachs%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520in%2520Non-Neuronal%2520Cells%253A%2520New%2520Modulators%2520of%2520Tobacco%2520Toxicity%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D393%26spage%3D279%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wevers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maelicke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, H.</span><span> </span><span class="NLM_article-title">Expression of Alpha Subunit Genes of Nicotinic Acetylcholine Receptors in Human Lymphocytes</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1996&pages=171-174&author=C.+Hiemkeauthor=M.+Stolpauthor=S.+Reussauthor=A.+Weversauthor=S.+Reinhardtauthor=A.+Maelickeauthor=S.+Schlegelauthor=H.+Schroeder&title=Expression+of+Alpha+Subunit+Genes+of+Nicotinic+Acetylcholine+Receptors+in+Human+Lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStolp%26aufirst%3DM.%26aulast%3DReuss%26aufirst%3DS.%26aulast%3DWevers%26aufirst%3DA.%26aulast%3DReinhardt%26aufirst%3DS.%26aulast%3DMaelicke%26aufirst%3DA.%26aulast%3DSchlegel%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DH.%26atitle%3DExpression%2520of%2520Alpha%2520Subunit%2520Genes%2520of%2520Nicotinic%2520Acetylcholine%2520Receptors%2520in%2520Human%2520Lymphocytes%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D214%26spage%3D171%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sato, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazuko, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, K.</span><span> </span><span class="NLM_article-title">Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1999&pages=17-20&author=K.+Z.+Satoauthor=T.+Fujiiauthor=Y.+Watanabeauthor=S.+Yamadaauthor=T.+Andoauthor=F.+Kazukoauthor=K.+Kawashima&title=Diversity+of+mRNA+Expression+for+Muscarinic+Acetylcholine+Receptor+Subtypes+and+Neuronal+Nicotinic+Acetylcholine+Receptor+Subunits+in+Human+Mononuclear+Leukocytes+and+Leukemic+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%2BZ.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DKazuko%26aufirst%3DF.%26aulast%3DKawashima%26aufirst%3DK.%26atitle%3DDiversity%2520of%2520mRNA%2520Expression%2520for%2520Muscarinic%2520Acetylcholine%2520Receptor%2520Subtypes%2520and%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Subunits%2520in%2520Human%2520Mononuclear%2520Leukocytes%2520and%2520Leukemic%2520Cell%2520Lines%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D266%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amella, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptor α7 Subunit is an Essential Regulator of Inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=384-388&author=H.+Wangauthor=M.+Yuauthor=M.+Ochaniauthor=C.+A.+Amellaauthor=M.+Tanovicauthor=S.+Susarlaauthor=J.+H.+Liauthor=H.+Wangauthor=H.+Yangauthor=L.+Ulloaauthor=Y.+Al-Abedauthor=C.+J.+Czuraauthor=K.+J.+Tracey&title=Nicotinic+Acetylcholine+Receptor+%CE%B17+Subunit+is+an+Essential+Regulator+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DAmella%26aufirst%3DC.%2BA.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DSusarla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptor%2520%25CE%25B17%2520Subunit%2520is%2520an%2520Essential%2520Regulator%2520of%2520Inflammation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D384%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Macklin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human Vascular Endothelial Cells Express Functional Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9765366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVWjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=1998&pages=435-439&author=K.+D.+Macklinauthor=A.+D.+J.+Mausauthor=E.+F.+R.+Pereiraauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+Vascular+Endothelial+Cells+Express+Functional+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Human vascular endothelial cells express functional nicotinic acetylcholine receptors</span></div><div class="casAuthors">Macklin, Kevin D.; Maus, Arno D. J.; Pereira, Edna F. R.; Albuquerque, Edson X.; Conti-Fine, Bianca M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">435-439</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">ACh receptors sensitive to nicotine (nAChR) are present in human skin keratinocytes and in bronchial epithelial cells.  They are stimulated by ACh secreted by the same cells that express them, and they modulate cell motility and shape.  A variety of non-neuronal tissues, including endothelial cells, synthesize ACh, which raises the possibility that they are sensitive to nicotine.  We demonstrate here that endothelial cells that line blood vessels express functional nAChRs.  Their structure and ion-gating properties are similar to those of the nAChRs expressed by ganglionic neurons and by skin keratinocytes and bronchial epithelial cells.  In situ hybridization expts. using primary cultures of endothelial cells from human aorta demonstrated the presence in these cells of the subunits believed to contribute to ganglionic ACh receptors (AChRs) of the α3 subtype: α3, α5, β2 and β4.  Binding of radiolabeled epibatidine-a high-affinity specific ligand of certain neuronal AChRs, including the α3 subtypes-revealed the presence of approx. 900 specific binding sites per cell.  We assessed the presence of functional AChRs by patch-clamp expts.  Cultured human endothelial cells express ion channels that are opened by (+)-anatoxin-a and are blocked by dihydro-β-erythroidine.  These are specific agonist and antagonist, resp., of neuronal AChRs of the α3 subtype.  The ion-gating properties of the endothelial AChRs were similar to those of neuronal ganglionic AChRs.  The presence of AChRs sensitive to nicotine in endothelial cells may be related to the toxic effects of nicotine on the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jjBi9STJLrVg90H21EOLACvtfcHk0lgOi6Z1gYOBCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVWjsrc%253D&md5=61f62a74b42c873c6042fc2c3ba1c12c</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacklin%26aufirst%3DK.%2BD.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520Vascular%2520Endothelial%2520Cells%2520Express%2520Functional%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D287%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karachunski, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macklin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human and Rodent Bronchial Epithelial Cells Express Functional Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=779-788&author=A.+D.+J.+Mausauthor=E.+F.+R.+Pereiraauthor=P.+I.+Karachunskiauthor=R.+M.+Hortonauthor=D.+Navaneethamauthor=K.+Macklinauthor=W.+S.+Cortesauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+and+Rodent+Bronchial+Epithelial+Cells+Express+Functional+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DKarachunski%26aufirst%3DP.%2BI.%26aulast%3DHorton%26aufirst%3DR.%2BM.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DMacklin%26aufirst%3DK.%26aulast%3DCortes%26aufirst%3DW.%2BS.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520and%2520Rodent%2520Bronchial%2520Epithelial%2520Cells%2520Express%2520Functional%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D779%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostlie, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1201-1209&author=Y.+Wangauthor=E.+F.+R.+Pereiraauthor=A.+D.+J.+Mausauthor=N.+S.+Ostlieauthor=D.+Navaneethamauthor=S.+Leiauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+Bronchial+Epithelial+and+Endothelial+Cells+Express+%CE%B17+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DOstlie%26aufirst%3DN.%2BS.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DS.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520Bronchial%2520Epithelial%2520and%2520Endothelial%2520Cells%2520Express%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Plummer, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuller, H. M.</span><span> </span><span class="NLM_article-title">Expression of the Alpha7 Nicotinic Acetylcholine Receptor in Human Lung Cells</span> <span class="citation_source-journal">Respir. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1186%2F1465-9921-6-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15807899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2M7pvVeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=29&author=H.+K.+Plummerauthor=M.+Dharauthor=H.+M.+Schuller&title=Expression+of+the+Alpha7+Nicotinic+Acetylcholine+Receptor+in+Human+Lung+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells</span></div><div class="casAuthors">Plummer Howard K 3rd; Dhar Madhu; Schuller Hildegard M</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We and others have shown that one of the mechanisms of growth regulation of small cell lung cancer cell lines and cultured pulmonary neuroendocrine cells is by the binding of agonists to the alpha7 neuronal nicotinic acetylcholine receptor.  In addition, we have shown that the nicotine-derived carcinogenic nitrosamine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is a high affinity agonist for the alpha7 nicotinic acetylcholine receptor.  In the present study, our goal was to determine the extent of alpha7 mRNA and protein expression in the human lung.  METHODS:  Experiments were done using reverse transcription polymerase chain reaction (RT-PCR), a nuclease protection assay and western blotting using membrane proteins.  RESULTS:  We detected mRNA for the neuronal nicotinic acetylcholine receptor alpha7 receptor in seven small cell lung cancer (SCLC) cell lines, in two pulmonary adenocarcinoma cell lines, in cultured normal human small airway epithelial cells (SAEC), one carcinoid cell line, three squamous cell lines and tissue samples from nine patients with various types of lung cancer.  A nuclease protection assay showed prominent levels of alpha7 in the NCI-H82 SCLC cell line while alpha7 was not detected in SAEC, suggesting that alpha7 mRNA levels may be higher in SCLC compared to normal cells.  Using a specific antibody to the alpha7 nicotinic receptor, protein expression of alpha7 was determined.  All SCLC cell lines except NCI-H187 expressed protein for the alpha7 receptor.  In the non-SCLC cells and normal cells that express the alpha7 nAChR mRNA, only in SAEC, A549 and NCI-H226 was expression of the alpha7 nicotinic receptor protein shown.  When NCI-H69 SCLC cell line was exposed to 100 pm NNK, protein expression of the alpha7 receptor was increased at 60 and 150 min.  CONCLUSION:  Expression of mRNA for the neuronal nicotinic acetylcholine receptor alpha7 seems to be ubiquitously expressed in all human lung cancer cell lines tested (except for NCI-H441) as well as normal lung cells.  The alpha7 nicotinic receptor protein is expressed in fewer cell lines, and the tobacco carcinogen NNK increases alpha7 nicotinic receptor protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPugvXjXbpPsSzjBFCN0BJfW6udTcc2eZw87J0kANJh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7pvVeqsw%253D%253D&md5=37a6eee22b5bf0aa62020828773b4b97</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-6-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-6-29%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DH.%2BK.%26aulast%3DDhar%26aufirst%3DM.%26aulast%3DSchuller%26aufirst%3DH.%2BM.%26atitle%3DExpression%2520of%2520the%2520Alpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520in%2520Human%2520Lung%2520Cells%26jtitle%3DRespir.%2520Res.%26date%3D2005%26volume%3D6%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amella, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptor α7 Subunit is an Essential Regulator of Inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=384-388&author=H.+Wangauthor=M.+Yuauthor=M.+Ochaniauthor=C.+A.+Amellaauthor=M.+Tanovicauthor=S.+Susarlaauthor=J.+H.+Liauthor=H.+Wangauthor=H.+Yangauthor=L.+Ulloaauthor=Y.+Al-Abedauthor=C.+J.+Czuraauthor=K.+J.+Tracey&title=Nicotinic+Acetylcholine+Receptor+%CE%B17+Subunit+is+an+Essential+Regulator+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DAmella%26aufirst%3DC.%2BA.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DSusarla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptor%2520%25CE%25B17%2520Subunit%2520is%2520an%2520Essential%2520Regulator%2520of%2520Inflammation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D384%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pavlov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14571320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlCksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=125-134&author=V.+A.+Pavlovauthor=H.+Wangauthor=C.+J.+Czuraauthor=S.+G.+Friedmanauthor=K.+J.+Tracey&title=The+Cholinergic+Anti-inflammatory+Pathway%3A+A+Missing+Link+in+Neuroimmunomodulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation</span></div><div class="casAuthors">Pavlov, Valentin A.; Wang, Hong; Czura, Christopher J.; Friedman, Steven G.; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5-8</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">North Shore-Long Island Jewish Research Institute</span>)
        </div><div class="casAbstract">A review.  This review outlines the mechanisms underlying the interaction between the nervous and immune systems of the host in response to an immune challenge.  The main focus is the cholinergic anti-inflammatory pathway, which we recently described as a novel function of the efferent vagus nerve.  This pathway plays a crit. role in controlling the inflammatory response through interaction with peripheral α7 subunit-contg. nicotinic acetylcholine receptors expressed on macrophages.  We describe the modulation of systemic and local inflammation by the cholinergic anti-inflammatory pathway and its function as an interface between the brain and the immune system.  The clin. implications of this novel mechanism also are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMRtAr1my92bVg90H21EOLACvtfcHk0lhcstXse2HFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlCksr4%253D&md5=18c41ff029ff7891365eb48a4ae0f75f</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPavlov%26aufirst%3DV.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFriedman%26aufirst%3DS.%2BG.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Anti-inflammatory%2520Pathway%253A%2520A%2520Missing%2520Link%2520in%2520Neuroimmunomodulation%26jtitle%3DMol.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D125%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">de Jonge, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span> </span><span class="NLM_article-title">The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fsj.bjp.0707264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17502850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1yls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=915-929&author=W.+J.+de+Jongeauthor=L.+Ulloa&title=The+alpha7+nicotinic+acetylcholine+receptor+as+a+pharmacological+target+for+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation</span></div><div class="casAuthors">de Jonge, W. J.; Ulloa, L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-929</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The physiol. regulation of the immune system encompasses comprehensive anti-inflammatory mechanisms that can be harnessed for the treatment of infectious and inflammatory disorders.  Recent studies indicate that the vagal nerve, involved in control of heart rate, hormone secretion and gastrointestinal motility, is also an immunomodulator.  In exptl. models of inflammatory diseases, vagal nerve stimulation attenuates the prodn. of proinflammatory cytokines and inhibits the inflammatory process.  Acetylcholine, the principal neurotransmitter of the vagal nerve, controls immune cell functions via the alpha7 nicotinic acetylcholine receptor (alpha7nAChR).  From a pharmacol. perspective, nicotinic agonists are more efficient than acetylcholine at inhibiting the inflammatory signaling and the prodn. of proinflammatory cytokines.  This 'nicotinic anti-inflammatory pathway' may have clin. implications as treatment with nicotinic agonists can modulate the prodn. of proinflammatory cytokines from immune cells.  Nicotine has been tested in clin. trials as a treatment for inflammatory diseases such as ulcerative colitis, but the therapeutic potential of this mechanism is limited by the collateral toxicity of nicotine.  Here, we review the recent advances that support the design of more specific receptor-selective nicotinic agonists that have anti-inflammatory effects while eluding its collateral toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLuWY2-j_xbVg90H21EOLACvtfcHk0lhcstXse2HFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1yls70%253D&md5=fc0c155afc3dccd06c539314721b77cd</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707264%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJonge%26aufirst%3DW.%2BJ.%26aulast%3DUlloa%26aufirst%3DL.%26atitle%3DThe%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520as%2520a%2520pharmacological%2520target%2520for%2520inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D915%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tracey, K. J.</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fnri2566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19461672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1SktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tracey%2C+K.+J.Nature+Rev.+Immunol.+2009%2C+9%2C+418%E2%80%93428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Reflex control of immunity</span></div><div class="casAuthors">Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammation can cause damage and even death.  What controls this primitive and potentially lethal innate immune response to injury and infection.  Mol. and neurophysiol. studies during the past decade have revealed a pivotal answer: immunity is coordinated by neural circuits that operate reflexively.  The afferent arc of the reflex consists of nerves that sense injury and infection.  This activates efferent neural circuits, including the cholinergic anti-inflammatory pathway, that modulate immune responses and the progression of inflammatory diseases.  It might be possible to develop therapeutics that target neural networks for the treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRGUQHObttSLVg90H21EOLACvtfcHk0lhcstXse2HFUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1SktLk%253D&md5=61820f359748be5534a3a21dc640387e</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1038%2Fnri2566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2566%26sid%3Dliteratum%253Aachs%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D418%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hamano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwagaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishibori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span> </span><span class="NLM_article-title">Stimulation of α7 Nicotinic Acetylcholine Receptor Inhibits CD14 and the Toll-Like Receptor 4 Expression in Human Monocytes</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=358-364&author=R.+Hamanoauthor=H.+K.+Takahashiauthor=H.+Iwagakiauthor=T.+Yoshinoauthor=M.+Nishiboriauthor=N.+Tanaka&title=Stimulation+of+%CE%B17+Nicotinic+Acetylcholine+Receptor+Inhibits+CD14+and+the+Toll-Like+Receptor+4+Expression+in+Human+Monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamano%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%2BK.%26aulast%3DIwagaki%26aufirst%3DH.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DNishibori%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DN.%26atitle%3DStimulation%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Inhibits%2520CD14%2520and%2520the%2520Toll-Like%2520Receptor%25204%2520Expression%2520in%2520Human%2520Monocytes%26jtitle%3DShock%26date%3D2006%26volume%3D26%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">van Westerloo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giebelen, I. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florquin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daalhuisen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span> </span><span class="NLM_article-title">The Cholinergic Anti-inflammatory Pathway Regulates the Host Response During Septic Peritonitis</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">2138</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1086%2F430323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15898001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFShs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=2138-2148&author=D.+J.+van+Westerlooauthor=I.+A.+J.+Giebelenauthor=S.+Florquinauthor=J.+Daalhuisenauthor=M.+J.+Brunoauthor=A.+F.+de+Vosauthor=K.+J.+Traceyauthor=T.+van+der+Poll&title=The+Cholinergic+Anti-inflammatory+Pathway+Regulates+the+Host+Response+During+Septic+Peritonitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis</span></div><div class="casAuthors">van Westerloo, David J.; Giebelen, Ilona A. J.; Florquin, Sandrine; Daalhuisen, Joost; Bruno, Marco J.; de Vos, Alex F.; Tracey, Kevin J.; van der Poll, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2138-2148</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background. The nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of tumor necrosis factor-α by endotoxin-stimulated macrophages.  This anti-inflammatory effect is mediated by an interaction between acetylcholine, the principal neurotransmitter of the vagus nerve, and cholinergic nicotinic acetylcholine receptors on macrophages.  Methods. the authors detd. the role of this "cholinergic anti-inflammatory pathway" during septic peritonitis induced in mice by i.p. injection of live Escherichia coli.  Septic peritonitis was preceded by inhibition of the cholinergic anti-inflammatory pathway by unilateral cervical vagotomy, by stimulation of this pathway by pretreatment of mice with nicotine, or by a combination of both interventions.  Results. Initial cytokine release during septic peritonitis was enhanced after previous vagotomy and was decreased after nicotine pretreatment, independently of the integrity of the vagus nerve.  Further study established that vagotomy before septic peritonitis resulted in an enhanced influx of neutrophils and a marked increase in proinflammatory cytokine levels and liver damage.  Conversely, nicotine pretreatment strongly decreased cell influx, proinflammatory cytokine levels, and liver damage, whereas bacterial clearance and survival were impaired.  Discussion. These data provide the first evidence, to the authors' knowledge, of an important role of the vagus nerve in regulating the innate immune response to a severe bacterial infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUlPngRpk2IbVg90H21EOLACvtfcHk0liFq4qsjoW_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFShs78%253D&md5=44a9d81735c0f20f475444ab5057c28c</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1086%2F430323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430323%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWesterloo%26aufirst%3DD.%2BJ.%26aulast%3DGiebelen%26aufirst%3DI.%2BA.%2BJ.%26aulast%3DFlorquin%26aufirst%3DS.%26aulast%3DDaalhuisen%26aufirst%3DJ.%26aulast%3DBruno%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BF.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26atitle%3DThe%2520Cholinergic%2520Anti-inflammatory%2520Pathway%2520Regulates%2520the%2520Host%2520Response%2520During%2520Septic%2520Peritonitis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D191%26spage%3D2138%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">de Jonge, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Zanden, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijlsma, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Westerloo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthoud, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uematsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Wijngaard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckxstaens, G. E.</span><span> </span><span class="NLM_article-title">Stimulation of the Vagus Nerve Attenuates Macrophage Activation by Activating the Jak2-STAT3 Signaling Pathway</span> <span class="citation_source-journal">Nature Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fni1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16025117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlSisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=844-851&author=W.+J.+de+Jongeauthor=E.+P.+van+der+Zandenauthor=F.+O.+Theauthor=M.+F.+Bijlsmaauthor=D.+J.+van+Westerlooauthor=R.+J.+Benninkauthor=H.-R.+Berthoudauthor=S.+Uematsuauthor=S.+Akiraauthor=R.+M.+van+den+Wijngaardauthor=G.+E.+Boeckxstaens&title=Stimulation+of+the+Vagus+Nerve+Attenuates+Macrophage+Activation+by+Activating+the+Jak2-STAT3+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway</span></div><div class="casAuthors">de Jonge, Wouter J.; van der Zanden, Esmerij P.; The, Frans O.; Bijlsma, Maarten F.; van Westerloo, David J.; Bennink, Roelof J.; Berthoud, Hans-Rudolf; Uematsu, Satoshi; Akira, Shizuo; van den Wijngaard, Rene M.; Boeckxstaens, Guy E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">844-851</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acetylcholine released by efferent vagus nerves inhibits macrophage activation.  Here the authors show that the anti-inflammatory action of nicotinic receptor activation in peritoneal macrophages was assocd. with activation of the transcription factor STAT3.  STAT3 was phosphorylated by the tyrosine kinase Jak2 that was recruited to the α7 subunit of the nicotinic acetylcholine receptor.  The anti-inflammatory effect of nicotine required the ability of phosphorylated STAT3 to bind and transactivate its DNA response elements.  In a mouse model of intestinal manipulation, stimulation of the vagus nerve ameliorated surgery-induced inflammation and postoperative ileus by activating STAT3 in intestinal macrophages.  The authors conclude that the vagal anti-inflammatory pathway acts by α7 subunit-mediated Jak2-STAT3 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR6EEpsubzdLVg90H21EOLACvtfcHk0liFq4qsjoW_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlSisb8%253D&md5=59cf7f4cb261379f4e163e3ceab88c6e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fni1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1229%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJonge%26aufirst%3DW.%2BJ.%26aulast%3Dvan%2Bder%2BZanden%26aufirst%3DE.%2BP.%26aulast%3DThe%26aufirst%3DF.%2BO.%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3Dvan%2BWesterloo%26aufirst%3DD.%2BJ.%26aulast%3DBennink%26aufirst%3DR.%2BJ.%26aulast%3DBerthoud%26aufirst%3DH.-R.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3Dvan%2Bden%2BWijngaard%26aufirst%3DR.%2BM.%26aulast%3DBoeckxstaens%26aufirst%3DG.%2BE.%26atitle%3DStimulation%2520of%2520the%2520Vagus%2520Nerve%2520Attenuates%2520Macrophage%2520Activation%2520by%2520Activating%2520the%2520Jak2-STAT3%2520Signaling%2520Pathway%26jtitle%3DNature%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D844%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Birtwistle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, K.</span><span> </span><span class="NLM_article-title">Does Nicotine Have Beneficial Effects in the Treatment of Certain Diseases?</span> <span class="citation_source-journal">Br. J. Nurs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9006184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADyaK2s7lvVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=1195-1202&author=J.+Birtwistleauthor=K.+Hall&title=Does+Nicotine+Have+Beneficial+Effects+in+the+Treatment+of+Certain+Diseases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Does nicotine have beneficial effects in the treatment of certain diseases?</span></div><div class="casAuthors">Birtwistle J; Hall K</div><div class="citationInfo"><span class="NLM_cas:title">British journal of nursing (Mark Allen Publishing)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1195-202</span>
        ISSN:<span class="NLM_cas:issn">0966-0461</span>.
    </div><div class="casAbstract">Although tobacco smoking has long been associated with diseases of the lungs and cardiovascular system, numerous studies have demonstrated a negative association between tobacco smoking and ulcerative colitis, and the neurodegenerative diseases, Alzheimer's disease (AD) and Parkinson's disease (PD).  The evidence suggests that nicotine--the main pharmacologically active ingredient of tobacco--appears to be responsible for this effect.  Pure nicotine has no known carcinogenic properties and can be administered in numerous ways including transdermal patches and tablets.  As a therapeutic agent, its association with tobacco can be likened to morphine and opium smoking.  There is ample clinical evidence to suggest that nicotine could be beneficial in the treatment of some patients with diseases.  Pharmacologically, nicotine acts on cholinergic (nicotinic-specific) receptors which are depleted in AD and PD.  Nicotinic receptors also interact closely with several neurotransmitters including dopamine, which is implicated in both PD and Gilles de la Tourettes's syndrome.  There is no doubt that tobacco smoking can be harmful and no-one should be encouraged to smoke.  However, although nicotine has many harmful side-effects, it may have therapeutic value or at the very least be a useful tool for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYgUrsouWemxcr74wzj5o5fW6udTcc2eaHGjVdouoBq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7lvVyhtA%253D%253D&md5=723f7a054eab2c62e6890bed4a976764</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirtwistle%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DK.%26atitle%3DDoes%2520Nicotine%2520Have%2520Beneficial%2520Effects%2520in%2520the%2520Treatment%2520of%2520Certain%2520Diseases%253F%26jtitle%3DBr.%2520J.%2520Nurs.%26date%3D1996%26volume%3D5%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rubin, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span> </span><span class="NLM_article-title">Smoking and Inflammatory Bowel Disease</span> <span class="citation_source-journal">Eur. J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1097%2F00042737-200012080-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10958212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FlsFCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=855-862&author=D.+T.+Rubinauthor=S.+B.+Hanauer&title=Smoking+and+Inflammatory+Bowel+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking and inflammatory bowel disease</span></div><div class="casAuthors">Rubin D T; Hanauer S B</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-62</span>
        ISSN:<span class="NLM_cas:issn">0954-691X</span>.
    </div><div class="casAbstract">It is well established that smoking cigarettes is associated with Crohn's disease (CD) and that non-smoking is associated with ulcerative colitis (UC).  Furthermore, there is convincing evidence that smoking cigarettes has a negative effect on the course of CD, and that smoking cigarettes may improve the disease severity or have a 'protective' effect in some patients with UC.  Despite these well-described associations, the mechanism by which cigarette smoking affects CD and UC is not known.  Researchers have studied the systemic effects, cellular and humoral immune effects, mucosal changes, and the intestinal permeability changes with inflammatory bowel disease (IBD) and smoking.  To date, none of these studies adequately explains the observed clinical patterns.  It has been assumed that nicotine is the active agent in these associations, but clinical trials of nicotine chewing gum and transdermal nicotine in UC have shown limited benefit, and have been complicated by significant side-effects.  Topical delivery systems for nicotine therapy are currently under development and await future clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRpsY2CvPbfRgd2Wuil24tfW6udTcc2eZgfoXioezWo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FlsFCltw%253D%253D&md5=833eb3fc739914b49feda1439cf63e15</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1097%2F00042737-200012080-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00042737-200012080-00004%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DD.%2BT.%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26atitle%3DSmoking%2520and%2520Inflammatory%2520Bowel%2520Disease%26jtitle%3DEur.%2520J.%2520Gastroenterol.%2520Hepatol.%26date%3D2000%26volume%3D12%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wolf, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashner, B. A.</span><span> </span><span class="NLM_article-title">Inflammatory Bowel Disease: Sorting Out the Treatment Options</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span><div class="note"><p class="first last">and 629–631.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.3949%2Fccjm.69.8.621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12184470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD38vislOnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2002&pages=621-626&author=J.+M.+Wolfauthor=B.+A.+Lashner&title=Inflammatory+Bowel+Disease%3A+Sorting+Out+the+Treatment+Options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease: sorting out the treatment options</span></div><div class="casAuthors">Wolf Jason M; Lashner Bret A</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">621-6, 629-31</span>
        ISSN:<span class="NLM_cas:issn">0891-1150</span>.
    </div><div class="casAbstract">An increasing array of treatments such as immunosuppressive drugs and tumor necrosis factor inhibitors can offer patients with ulcerative colitis and Crohn disease improved relief from symptoms with fewer adverse effects.  Several additional drugs have shown promise, including nicotine, antimicrobials, and heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQvGKtVttfRzslzEEsg76ufW6udTcc2eZgfoXioezWo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vislOnug%253D%253D&md5=e3c9d17fae9937053398085ef92fe919</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.3949%2Fccjm.69.8.621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.69.8.621%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DJ.%2BM.%26aulast%3DLashner%26aufirst%3DB.%2BA.%26atitle%3DInflammatory%2520Bowel%2520Disease%253A%2520Sorting%2520Out%2520the%2520Treatment%2520Options%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2002%26volume%3D69%26spage%3D621%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guinet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouri-Shirazi, M.</span><span> </span><span class="NLM_article-title">Nicotinic Environment Affects the Differentiation and Functional Maturation of Monocytes Derived Dendritic Cells (DCs)</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=45-55&author=E.+Guinetauthor=K.+Yoshidaauthor=M.+Nouri-Shirazi&title=Nicotinic+Environment+Affects+the+Differentiation+and+Functional+Maturation+of+Monocytes+Derived+Dendritic+Cells+%28DCs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuinet%26aufirst%3DE.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DNouri-Shirazi%26aufirst%3DM.%26atitle%3DNicotinic%2520Environment%2520Affects%2520the%2520Differentiation%2520and%2520Functional%2520Maturation%2520of%2520Monocytes%2520Derived%2520Dendritic%2520Cells%2520%2528DCs%2529%26jtitle%3DImmunol.%2520Lett.%26date%3D2004%26volume%3D95%26spage%3D45%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patton, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pross, S.</span><span> </span><span class="NLM_article-title">Nicotine Modulation of Cytokine Induction by LPS-Stimulated Human Monocytes and Coronary Artery Endothelial Cells</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.intimp.2005.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16332510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2MnltFCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=26-35&author=G.+W.+Pattonauthor=D.+A.+Powellauthor=A.+Hakkiauthor=H.+Friedmanauthor=S.+Pross&title=Nicotine+Modulation+of+Cytokine+Induction+by+LPS-Stimulated+Human+Monocytes+and+Coronary+Artery+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells</span></div><div class="casAuthors">Patton G W; Powell D A; Hakki A; Friedman H; Pross S</div><div class="citationInfo"><span class="NLM_cas:title">International immunopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    </div><div class="casAbstract">Nicotine, the major addictive component of tobacco, is an immunomodulator that impacts on many cells, including immune cells involved in inflammatory processes.  Nicotine also induces oxidative damage to the vascular endothelium and accentuates lipid peroxidation, resulting in vascular cell dysfunction.  Furthermore, vascular endothelial cells produce growth factors, such as cytokines and chemokines capable of stimulating and recruiting immune cells to atheromatous lesions.  In addition, bacterial products including lipopolysaccharides (LPS), a major component of Gram negative bacterial cell walls, activate gene expression resulting in inflammatory cytokine production causing further damage to the vasculature.  In the present study, the combined effects of nicotine and bacterial LPS on the expression of IL-6, IL-8, GRO-alpha and MCP-1 in cell lines of human coronary artery endothelial cells (HCAEC) and pulmonary monocytes (THP-1) were examined by quantitative real-time PCR and ELISA.  Results showed that nicotine suppressed the LPS induced production of IL-6 and IL-8 in both cell lines.  Since cytokines which alter homeostasis of both vascular endothelial and immune cells are critical for the atherogenic process, further studies are warranted to examine in detail the role of nicotine in terms of effects on inflammatory reactions, including those induced by bacterial infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaTQKW9iBlq8-crCu0nI_sfW6udTcc2eZgfoXioezWo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnltFCnsw%253D%253D&md5=29fcb24d379703ee391539d3af5385e4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2005.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2005.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DPatton%26aufirst%3DG.%2BW.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DHakki%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DPross%26aufirst%3DS.%26atitle%3DNicotine%2520Modulation%2520of%2520Cytokine%2520Induction%2520by%2520LPS-Stimulated%2520Human%2520Monocytes%2520and%2520Coronary%2520Artery%2520Endothelial%2520Cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2006%26volume%3D6%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mannino, D. M.</span><span> </span><span class="NLM_article-title">Chronic Obstructive Pulmonary Disease: Definition and Epidemiology</span> <span class="citation_source-journal">Respir. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1185</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14651759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD3srntFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=1185-1191&author=D.+M.+Mannino&title=Chronic+Obstructive+Pulmonary+Disease%3A+Definition+and+Epidemiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic obstructive pulmonary disease: definition and epidemiology</span></div><div class="casAuthors">Mannino David M</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory care</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1185-91; discussion 1191-3</span>
        ISSN:<span class="NLM_cas:issn">0020-1324</span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) continues to cause a heavy health and economic burden in the United States and around the world.  Some of the risk factors for COPD are well known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions remain, such as why < 20% of smokers develop substantial airway obstruction.  There are several different definitions of COPD and the definitions depend on accurate diagnosis.  Small differences in the definition can have large effects on the estimates of COPD in the population.  In addition, newer measures, such as functional status or exercise capability, have emerged as important in determining the prognosis of COPD patients.  Furthermore, evidence continues to emerge that COPD represents several different disease processes, with potentially different interventions required.  In most of the world COPD prevalence and mortality are still increasing and will probably continue to rise in response to increases in smoking, particularly by women and adolescents.  Resources aimed at smoking cessation and prevention, COPD education, early detection, and better treatment will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrpDbsElJIFWTCLT8lX9SfW6udTcc2eZgfoXioezWo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srntFOrsw%253D%253D&md5=84767538c0f22eb6c2da165cace04148</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMannino%26aufirst%3DD.%2BM.%26atitle%3DChronic%2520Obstructive%2520Pulmonary%2520Disease%253A%2520Definition%2520and%2520Epidemiology%26jtitle%3DRespir.%2520Care%26date%3D2003%26volume%3D48%26spage%3D1185%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sopori, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, M. J.</span><span> </span><span class="NLM_article-title">Nicotine-Induced Modulation of T-Cell Function: Implications for Inflammation and Infection</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=1998&pages=279-289&author=M.+L.+Soporiauthor=W.+Kozakauthor=S.+M.+Savageauthor=Y.+Gengauthor=M.+J.+Kluger&title=Nicotine-Induced+Modulation+of+T-Cell+Function%3A+Implications+for+Inflammation+and+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSopori%26aufirst%3DM.%2BL.%26aulast%3DKozak%26aufirst%3DW.%26aulast%3DSavage%26aufirst%3DS.%2BM.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DKluger%26aufirst%3DM.%2BJ.%26atitle%3DNicotine-Induced%2520Modulation%2520of%2520T-Cell%2520Function%253A%2520Implications%2520for%2520Inflammation%2520and%2520Infection%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D437%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sopori, M.</span><span> </span><span class="NLM_article-title">Effects of Cigarette Smoke on the Immune System</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fnri803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12033743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2rs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=372-377&author=M.+Sopori&title=Effects+of+Cigarette+Smoke+on+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cigarette smoke on the immune system</span></div><div class="casAuthors">Sopori, Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Although the health risks of tobacco smoking are well documented, there is increasing evidence that smokers have a lower incidence of some inflammatory and neurodegenerative diseases.  Many of the adverse and beneficial effects of smoking might result from the ability of cigarette smoke to suppress the immune system.  Nicotine, which is one of the main constituents of cigarette smoke, suppresses the immune system but might have therapeutic potential as a neuroprotective and anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_FwtswO3hbVg90H21EOLACvtfcHk0ljujjK12qDcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2rs7o%253D&md5=19a3e65f577022460d7e8530c749012a</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1038%2Fnri803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri803%26sid%3Dliteratum%253Aachs%26aulast%3DSopori%26aufirst%3DM.%26atitle%3DEffects%2520of%2520Cigarette%2520Smoke%2520on%2520the%2520Immune%2520System%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D2%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Floto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. G.</span><span> </span><span class="NLM_article-title">The Vagus Nerve, Macrophages, and Nicotine</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=1069-1070&author=R.+A.+Flotoauthor=K.+G.+Smith&title=The+Vagus+Nerve%2C+Macrophages%2C+and+Nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloto%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BG.%26atitle%3DThe%2520Vagus%2520Nerve%252C%2520Macrophages%252C%2520and%2520Nicotine%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26spage%3D1069%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampognaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zongrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a Conformationally Restricted Analog of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000249r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4045-4050&author=G.+Mullenauthor=J.+Napierauthor=M.+Balestraauthor=T.+DeCoryauthor=G.+Haleauthor=J.+Macorauthor=R.+Mackauthor=J.+Lochauthor=E.+Wuauthor=A.+Koverauthor=P.+Verhoestauthor=A.+Sampognaroauthor=E.+Phillipsauthor=Y.+Zhuauthor=R.+Murrayauthor=R.+Griffithauthor=J.+Blosserauthor=D.+Gurleyauthor=A.+Machulskisauthor=J.+Zongroneauthor=A.+Rosenauthor=J.+Gordon&title=%28%E2%88%92%29-Spiro%5B1-azabicyclo%5B2.2.2%5Doctane-3%2C5%E2%80%B2-oxazolidin-2%E2%80%B2-one%5D%2C+a+Conformationally+Restricted+Analog+of+Acetylcholine%2C+Is+a+Highly+Selective+Full+Agonist+at+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm000249r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000249r%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DNapier%26aufirst%3DJ.%26aulast%3DBalestra%26aufirst%3DM.%26aulast%3DDeCory%26aufirst%3DT.%26aulast%3DHale%26aufirst%3DG.%26aulast%3DMacor%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSampognaro%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DR.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DMachulskis%26aufirst%3DA.%26aulast%3DZongrone%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529-Spiro%255B1-azabicyclo%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin-2%25E2%2580%25B2-one%255D%252C%2520a%2520Conformationally%2520Restricted%2520Analog%2520of%2520Acetylcholine%252C%2520Is%2520a%2520Highly%2520Selective%2520Full%2520Agonist%2520at%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4045%26epage%3D4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Van Maanen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoordeldonk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span> </span><span class="NLM_article-title">Stimulation of Nicotinic Acetylcholine Receptors Attenuates Collagen-Induced Arthritis in Mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fart.24177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19116908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=114-122&author=M.+A.+Van+Maanenauthor=M.+C.+Liebreauthor=T.+van+der+Pollauthor=G.+J.+La+Rosaauthor=D.+Elbaumauthor=M.+J.+Vervoordeldonkauthor=P.+P.+Tak&title=Stimulation+of+Nicotinic+Acetylcholine+Receptors+Attenuates+Collagen-Induced+Arthritis+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span></div><div class="casAuthors">van Maanen, Marjolein A.; Lebre, Maria C.; van der Poll, Tom; La Rosa, Gregory J.; Elbaum, Daniel; Vervoordeldonk, Margriet J.; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The parasympathetic nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of cytokines, including tumor necrosis factor α (TNFα), by activated macrophages.  The vagus nerve may exert antiinflammatory actions via a specific effect of its principal neurotransmitter, acetylcholine, on the α7 subunit of nicotinic acetylcholine receptors (α7nAChR) on macrophages.  The present study was undertaken to obtain insight into the role of the cholinergic antiinflammatory pathway in arthritis.  To inhibit the cholinergic antiinflammatory pathway, mice were subjected to unilateral cervical vagotomy or sham surgery, after which arthritis was induced with type II collagen.  In a sep. study, nicotine was added to the drinking water of mice with collagen-induced arthritis (CIA).  In addn., we investigated the effects of i.p. (IP)-injected nicotine and the specific α7nAChR agonist AR-R17779.  Clin. arthritis was exacerbated by vagotomy and ameliorated by oral nicotine administration.  Moreover, oral nicotine inhibited bone degrdn. and reduced TNFα expression in synovial tissue.  Both IP-injected nicotine and AR-R17779 ameliorated clin. arthritis and reduced synovial inflammation.  This was accompanied by a redn. of TNFα levels in both plasma and synovial tissue.  The effect of AR-R17779 was more potent compared with that of nicotine and was assocd. with delayed onset of the disease as well as with protection against joint destruction.  These data provide the first evidence of a role of the cholinergic antiinflammatory pathway in the murine CIA model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3s5iC-YbxFLVg90H21EOLACvtfcHk0li-hQUQzqSpcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D&md5=409abcd4db452578bab75b9a62cf2b04</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fart.24177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24177%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMaanen%26aufirst%3DM.%2BA.%26aulast%3DLiebre%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DLa%2BRosa%26aufirst%3DG.%2BJ.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DVervoordeldonk%26aufirst%3DM.%2BJ.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DStimulation%2520of%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Attenuates%2520Collagen-Induced%2520Arthritis%2520in%2520Mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompe, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordinou de Gouberville, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Hoeven, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoedemaekers, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickkers, P.</span><span> </span><span class="NLM_article-title">Effects if the α7 Nicotinic Acetylcholine Receptor Agonist GTS-21 on the Innate Immune Response in Humans</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=5-11&author=M.+Koxauthor=J.+C.+Pompeauthor=M.+C.+Gordinou+de+Goubervilleauthor=J.+G.+van+der+Hoevenauthor=C.+W.+Hoedemaekersauthor=P.+Pickkers&title=Effects+if+the+%CE%B17+Nicotinic+Acetylcholine+Receptor+Agonist+GTS-21+on+the+Innate+Immune+Response+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKox%26aufirst%3DM.%26aulast%3DPompe%26aufirst%3DJ.%2BC.%26aulast%3DGordinou%2Bde%2BGouberville%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BHoeven%26aufirst%3DJ.%2BG.%26aulast%3DHoedemaekers%26aufirst%3DC.%2BW.%26aulast%3DPickkers%26aufirst%3DP.%26atitle%3DEffects%2520if%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonist%2520GTS-21%2520on%2520the%2520Innate%2520Immune%2520Response%2520in%2520Humans%26jtitle%3DShock%26date%3D2011%26volume%3D36%26spage%3D5%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span>Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of TC-6987; <span class="NLM_publisher-name">Targacept</span>: <span class="NLM_publisher-loc">Winston-Salem, NC</span>, <span class="NLM_month">March</span><span class="NLM_day">27</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.targacept.com/newsroom/index.cfm?nid=Targacept%20Announces%20Top%2DLine%20Results%20from%20Two%20Exploratory%20Phase%202%20Studies%20of%20TC%2D6987&amp;newsyear=2012" class="extLink">http://www.targacept.com/newsroom/index.cfm?nid=Targacept%20Announces%20Top%2DLine%20Results%20from%20Two%20Exploratory%20Phase%202%20Studies%20of%20TC%2D6987&newsyear=2012</a>, accessed October 6, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Targacept+Announces+Top-Line+Results+from+Two+Exploratory+Phase+2+Studies+of+TC-6987%3B+Targacept%3A+Winston-Salem%2C+NC%2C+March27%2C+2012%3B+http%3A%2F%2Fwww.targacept.com%2Fnewsroom%2Findex.cfm%3Fnid%3DTargacept%2520Announces%2520Top%252DLine%2520Results%2520from%2520Two%2520Exploratory%2520Phase%25202%2520Studies%2520of%2520TC%252D6987%26newsyear%3D2012%2C+accessed+October+6%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTargacept%2520Announces%2520Top-Line%2520Results%2520from%2520Two%2520Exploratory%2520Phase%25202%2520Studies%2520of%2520TC-6987%26pub%3DTargacept%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speake, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yohannes, D.</span><span> </span><span class="NLM_article-title">Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7943</span><span class="NLM_x">–</span> <span class="NLM_lpage">7961</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007672" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7943-7961&author=A.+Mazurovauthor=J.+D.+Speakeauthor=D.+Yohannes&title=Discovery+and+Development+of+%CE%B17+Nicotinic+Acetylcholine+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm2007672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007672%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DSpeake%26aufirst%3DJ.%2BD.%26aulast%3DYohannes%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7943%26epage%3D7961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. H.</span><span> </span><span class="NLM_article-title">Selective α7 Nicotinic Acetylcholine Receptor Ligands</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F092986706777442011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16787204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1567-1584&author=A.+Mazurovauthor=T.+Hauserauthor=C.+H.+Miller&title=Selective+%CE%B17+Nicotinic+Acetylcholine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective α7 nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Mazurov, Anatoly; Hauser, Terry; Miller, Craig H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1567-1584</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand gated ion channels of broad distribution and structural heterogeneity.  Their functional diversity demonstrated involvement in a variety of neuronal processes (e.g., sensory gating and cognitive function) and generated great interest in them as targets for therapeutic intervention in a no. of neuropathol. conditions and diseases.  In order to control distinct nicotinic functions pharmacol., it is important to design ligands that selectively interact with distinct receptor subtypes in such a way as to maximize the therapeutic effect and minimize the adverse effects.  The α7 nAChR, a CNS subtype, has been the most intensively studied nAChR in recent years.  Selective α7 nAChR agonists have been developed as potential candidates for the treatment of schizophrenia, cognitive disorders (including Alzheimer's disease), and inflammation.  Despite early concerns that the rapid desensitization property of the α7 nAChR would limit their therapeutic potential, several have already been advanced to clin. trials (e.g., PH-399733, Pfizer; MEM 3454, Memory Pharmaceuticals/Roche).  Further development of allosteric modulators and pharmaceutically relevant antagonists might expand the therapeutic potential of compds. that target α7 nAChRs.  In this review we briefly describe the structure and function of the α7 nAChR and its in vitro and in vivo pharmacol., discuss the clin. relevance of these efforts, and review the current progress in α7 ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDkem3VpTTzrVg90H21EOLACvtfcHk0li-hQUQzqSpcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D&md5=a7ce411b57d1e7b704bdce077563eea3</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.2174%2F092986706777442011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777442011%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1567%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljefors, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic Inspirations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4705</span><span class="NLM_x">–</span> <span class="NLM_lpage">4745</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040219e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4705-4745&author=A.+A.+Jensenauthor=B.+Frolundauthor=T.+Liljeforsauthor=P.+Krogsgaard-Larsen&title=Neuronal+Nicotinic+Acetylcholine+Receptors%3A+Structural+Revelations%2C+Target+Identifications%2C+and+Therapeutic+Inspirations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic Inspirations</span></div><div class="casAuthors">Jensen, Anders A.; Frolund, Bente; Liljefors, Tommy; Krogsgaard-Larsen, Povl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4705-4745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Structures, drug targeting and therapeutic applications of Neuronal Nicotinic Acetylcholine Receptors are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQuGlS_ZxYXbVg90H21EOLACvtfcHk0lhCuMhXK5bDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlSgt78%253D&md5=267f469aca2e0f319da123669da5197b</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm040219e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040219e%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFrolund%26aufirst%3DB.%26aulast%3DLiljefors%26aufirst%3DT.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520Structural%2520Revelations%252C%2520Target%2520Identifications%252C%2520and%2520Therapeutic%2520Inspirations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4705%26epage%3D4745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=171-184&author=K.+Hashimotoauthor=K.+Koikeauthor=E.+Shimizuauthor=M.+Iyo&title=%CE%B17+Nicotinic+Receptor+Agonists+as+Potential+Therapeutic+Drugs+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic receptor agonists as potential therapeutic drugs for schizophrenia</span></div><div class="casAuthors">Hashimoto, Kenji; Koike, Kaori; Shimizu, Eiji; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Deficient inhibitory processing of the P50 auditory evoked potential is a measurable marker obsd. in schizophrenia.  Several lines of evidence suggest that α7 nicotinic receptors (α7 nAChRs) play a crit. role in P50 auditory sensory gating in the human brain.  Similar to schizophrenic patients, DBA/2 mice spontaneously exhibit a deficit in inhibitory processing of the P20-N40 auditory evoked potential, which is a rodent analog of the human P50 auditory evoked potential.  Agonists at α7 nAChRs improve deficient inhibitory processing of the P20-N40 auditory gating potential in DBA/2 mice.  In this article, we review the role of α7 nAChRs in the pathophysiol. of schizophrenia, and α7 nAChR agonists and indirect agonists (5-hydroxytryptamine-3 (5-HT3) receptor antagonists, pos. allosteric modulators (galantamine, 5-hydroxyindole, PNU-120596), FK960, FR236924) at α7 nAChRs as potential therapeutic drugs for the treatment of schizophrenia.  In addn., we also discuss the role of kynurenic acid as an endogenous antagonist of α7 nAChRs in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYcI0WdtDnLVg90H21EOLACvtfcHk0lhCuMhXK5bDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D&md5=69bc7ca07eb3b46da3bef6c9c8db956f</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3D%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonists%2520as%2520Potential%2520Therapeutic%2520Drugs%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span> </span><span class="NLM_article-title">Design of Ligands for the Nicotinic Acetylcholine Receptors: The Quest for Selectivity</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568026043451438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14754449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=299-334&author=W.+H.+Bunnelleauthor=M.+J.+Dartauthor=M.+R.+Schrimpf&title=Design+of+Ligands+for+the+Nicotinic+Acetylcholine+Receptors%3A+The+Quest+for+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21eR"><div class="casContent"><span class="casTitleNuber">21e</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ligands for the nicotinic acetylcholine receptors: The quest for selectivity</span></div><div class="casAuthors">Bunnelle, William H.; Dart, Michael J.; Schrimpf, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-334</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decade, nicotinic acetylcholine receptors (nAChRs) have emerged as important targets for drug discovery.  The therapeutic potential of nicotinic agonists depends substantially on the ability to selectively activate certain receptor subtypes that mediate beneficial effects.  The design of such compds. has proceeded in spite of a general shortage of data pertaining to subtype selectivity.  Medicinal chem. efforts have been guided principally by binding affinities to the α4β2 and/or α7 subtypes, even though these are not predictive of agonist activity at either subtype.  Nevertheless, a diverse family of nAChR ligands has been developed, and several analogs with promising therapeutic potential have now advanced to human clin. trials.  This paper provides an overview of the structure-affinity relationships that continue to drive development of new nAChR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5dOTgvAdLbVg90H21EOLACvtfcHk0lhCuMhXK5bDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D&md5=158b682f8eb51091cd9b03b74b65927d</span></div><a href="/servlet/linkout?suffix=cit21e&amp;dbid=16384&amp;doi=10.2174%2F1568026043451438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451438%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDesign%2520of%2520Ligands%2520for%2520the%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520The%2520Quest%2520for%2520Selectivity%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Cholinergic Nicotinic Receptors: Competitive Ligands, Allosteric Modulators, and Their Potential Applications</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fmed.10037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12710018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=393-426&author=M.+N.+Romanelliauthor=F.+Gualtieri&title=Cholinergic+Nicotinic+Receptors%3A+Competitive+Ligands%2C+Allosteric+Modulators%2C+and+Their+Potential+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21fR"><div class="casContent"><span class="casTitleNuber">21f</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications</span></div><div class="casAuthors">Romanelli, M. Novella; Gualtieri, Fulvio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-426</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Discovery of the important role played by nicotinic acetylcholine receptors (nAChRs) in several CNS disorders has called attention to these membrane proteins and to ligands able to modulate their functions.  The existence of different subtypes at multiple levels has complicated the understanding of this receptor's physiol. role, but at the same time has increased the efforts to discover selective compds. to improve the pharmacol. characterization of this kind of receptor and to make the possible therapeutical use of its modulators safer.  This review focuses on the structure of new ligands for nAChRs, agonists, antagonists and allosteric modulators, and on their possible applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDvFmKJJTrLVg90H21EOLACvtfcHk0lhCuMhXK5bDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFGkt7w%253D&md5=166db6bdd8d5b7c809e2fcc98797b739</span></div><a href="/servlet/linkout?suffix=cit21f&amp;dbid=16384&amp;doi=10.1002%2Fmed.10037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10037%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCholinergic%2520Nicotinic%2520Receptors%253A%2520Competitive%2520Ligands%252C%2520Allosteric%2520Modulators%252C%2520and%2520Their%2520Potential%2520Applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D393%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Astles, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568007023339256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12769608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=337-348&author=P.+C.+Astlesauthor=S.+R.+Bakerauthor=J.+R.+Bootauthor=L.+M.+Broadauthor=C.+P.+Dellauthor=M.+Keenan&title=Recent+Progress+in+the+Development+of+Subtype+Selective+Nicotinic+Acetylcholine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21gR"><div class="casContent"><span class="casTitleNuber">21g</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Astles, P. C.; Baker, S. R.; Boot, J. R.; Broad, L. M.; Dell, C. P.; Keenan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion channels, which are found at the neuromuscular junction and in the central and peripheral nervous systems.  The channels can be assembled from fourteen known subunits.  The exact combination and function of all the channels are still not detd. but in the CNS certain combinations have been identified which appear to modulate the release of specific neurotransmitters.  Non-specific nAChR agonists like nicotine and epibatidine, have been shown to have interesting pharmacol. but their clin. value is limited by their undesirable side effects.  Selective ligands for different receptor subtypes have been reported and these compds. are probably the best tools for detg. the function of the subtypes.  The expectation is that some receptor subtype selective nAChR ligands will be clin. useful for the treatment of a broad range of CNS disorders.  The development of stable cell lines functionally expressing specific combinations of subunits has greatly improved our understanding of ligand specificity.  There have also been advances in the modeling of the ligand binding site, thanks to the discovery of a homologous snail ACh binding protein the x-ray structure of which was detd. in 2001.  These techniques should lead to rapid advances in the development of truly subtype selective ligands.  In this review we describe recent progress in the area and describe the first 1000 fold selective low mol. wt. ligands from the Astra-Zeneca group.  We also comment on the first subtype specific channel modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7blv1UIcybVg90H21EOLACvtfcHk0liEXCkO5sb8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D&md5=dc305ccf03024133de5219453a82cb88</span></div><a href="/servlet/linkout?suffix=cit21g&amp;dbid=16384&amp;doi=10.2174%2F1568007023339256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339256%26sid%3Dliteratum%253Aachs%26aulast%3DAstles%26aufirst%3DP.%2BC.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DKeenan%26aufirst%3DM.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Subtype%2520Selective%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span> </span><span class="NLM_article-title">Exploring the Nature of Molecular Recognition in Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F0929867003374660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10828287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltVGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=749-800&author=J.+D.+Schmitt&title=Exploring+the+Nature+of+Molecular+Recognition+in+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21hR"><div class="casContent"><span class="casTitleNuber">21h</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the nature of molecular recognition in nicotinic acetylcholine receptors</span></div><div class="casAuthors">Schmitt, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">749-800</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 224 refs.  Nicotinic acetylcholine receptors (nAChRs) are the subject of ever increasing interest because of their presumed involvement in the etiol. of numerous clin. disorders.  Unfortunately, the absence of at.-level structural data, as well as the pharmacol. complexity of these receptors leaves many fundamental questions unanswered.  An understanding of how ligands interact with the receptor and, in-turn, how these interactions lead to pharmacol. effect is vital in the advancement of nAChR-based therapeutics.  We will first explore physico-chem. themes that are evidenced to be of particular importance in nAChR mol. recognition; these are- π-cation interaction, conformational entropy and stereochem.  The second objective of this review is an interpretive encapsulation of the extensive and disparate body of structure-activity data that now exists for nAChRs.  Finally, this review will advocate a re-investigation of distance geometry based methods as well as the need for addnl. approaches in nicotinic receptor pharmacophore generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodugV1iwAXWLVg90H21EOLACvtfcHk0liEXCkO5sb8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltVGitLg%253D&md5=cb5cec41c69141cc29012aa2376468ad</span></div><a href="/servlet/linkout?suffix=cit21h&amp;dbid=16384&amp;doi=10.2174%2F0929867003374660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867003374660%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26atitle%3DExploring%2520the%2520Nature%2520of%2520Molecular%2520Recognition%2520in%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D749%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Meyer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.-l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fiebre, C. M.</span><span> </span><span class="NLM_article-title">3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) Selectively Activates Rat α7 Receptors and Improves Memory-Related Behaviors in a Mecamylamine-Sensitive Manner</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">768</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-8993%2897%2900536-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9369300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK2sXlsleltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=768&publication_year=1997&pages=49-56&author=E.+M.+Meyerauthor=E.+T.+Tayauthor=R.+L.+Papkeauthor=C.+Meyersauthor=G.-l.+Huangauthor=C.+M.+de+Fiebre&title=3-%5B2%2C4-Dimethoxybenzylidene%5Danabaseine+%28DMXB%29+Selectively+Activates+Rat+%CE%B17+Receptors+and+Improves+Memory-Related+Behaviors+in+a+Mecamylamine-Sensitive+Manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner</span></div><div class="casAuthors">Meyer, Edwin M.; Tay, Ee Tein; Papke, Roger L.; Meyers, Craig; Huang, Guang-ling; de Fiebre, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">768</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The α7 nicotinic receptor agonist 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB; GTS-21) was investigated for its ability to: (1) activate a variety of nicotinic receptor subtypes in Xenopus oocytes; (2) improve passive avoidance and spatial Morris water task performances in mecamylamine-sensitive manners in bilaterally nucleus basalis lesioned rats; and (3) elevate high-affinity [3H]acetylcholine (ACh) and high-affinity α-[125I]bungarotoxin binding in rat neocortex following 2 wk of daily injections.  DMXB (100 μM) activated α7 homo-oligomeric receptors, without significant activity at α2-, α3- and α4-contg. subtypes.  Mecamylamine blocked rat α7 receptors weakly if co-administered with agonist, but much more potently when pre-applied.  Bilateral ibotenic acid lesions of the nucleus basalis interfered with passive avoidance and spatial memory-related behaviors.  DMXB (0.5 mg/kg, i.p.) improved passive avoidance behavior in lesioned animals in a mecamylamine-sensitive manner.  DMXB (0.5 mg/kg 15 min before each session) also improved performance in the training and probe components of the Morris water task.  DMXB-induced improvement in the probe component but not the training phase was mecamylamine-sensitive.  [3H]ACh binding was elevated after 14 days of daily i.p. injections with 0.2 mg/kg nicotine but not after 1 mg/kg DMXB.  Neither drug elevated high-affinity α-[125I]bungarorotoxin binding over this interval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM55sLnGyIOrVg90H21EOLACvtfcHk0liEXCkO5sb8JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsleltLc%253D&md5=bb3c4d49046f80910eca0d0c52fe9418</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2897%2900536-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252897%252900536-2%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%2BM.%26aulast%3DTay%26aufirst%3DE.%2BT.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DG.-l.%26aulast%3Dde%2BFiebre%26aufirst%3DC.%2BM.%26atitle%3D3-%255B2%252C4-Dimethoxybenzylidene%255Danabaseine%2520%2528DMXB%2529%2520Selectively%2520Activates%2520Rat%2520%25CE%25B17%2520Receptors%2520and%2520Improves%2520Memory-Related%2520Behaviors%2520in%2520a%2520Mecamylamine-Sensitive%2520Manner%26jtitle%3DBrain%2520Res.%26date%3D1997%26volume%3D768%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abreo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlik, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9506884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK28Xntlyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=817-25&author=M.+A.+Abreoauthor=N.-H.+Linauthor=D.+S.+Garveyauthor=D.+E.+Gunnauthor=A.-M.+Hettingerauthor=J.+T.+Wasicakauthor=P.+A.+Pavlikauthor=Y.+C.+Martinauthor=D.+L.+Donnelly-Robertsauthor=D.+J.+Andersonauthor=J.+P.+Sullivanauthor=M.+Williamsauthor=S.+P.+Arnericauthor=M.+W.+Holladay&title=Novel+3-Pyridyl+Ethers+with+Subnanomolar+Affinity+for+Central+Neuronal+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Abreo, Melwyn A.; Lin, Nan-Horng; Garvey, David S.; Gunn, David E.; Hettinger, Anne-Marie; Wasicak, James T.; Pavlik, Patricia A.; Martin, Yvonne C.; Donnelly-Roberts, Diana L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-25</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence indicating the therapeutic potential of cholinergic channel modulators for the treatment of central nervous system (CNS) disorders as well as the diversity of brain neuronal nicotinic acetylcholine receptors (nAChRs) have suggested an opportunity to develop subtype-selective nAChR ligands for the treatment of specific CNS disorders with reduced side effect liabilities.  The synthesis of a novel series of 3-pyridyl ether compds. was reported which possess subnanomolar affinity for brain nAChRs and differentially activate subtypes of neuronal nAChRs.  The synthesis and structure-activity relationships for the leading members of the series are described, including A-85380, which possesses ca. 50 pM affinity for rat brain [3H]-(-)-cytisine binding sites and 163% efficacy compared to nicotine to stimulate ion flux at human α4β2 nAChR subtype, and A-84543, which exhibits 84-fold selectivity to stimulate ion flux at human α4β2 nAChR subtype compared to human ganglionic type nAChRs.  Computational studies indicate that a reasonable superposition of a low energy conformer of A-85380 with (S)-nicotine and (-)-epibatidine can be achieved.  An example compd. are (S)-3-[(1-methyl-2-pyrrolidinyl)methoxy]pyridine and (S)-3-(1-methyl-2-azetidinylmethoxy)pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQJNpsnACwLbVg90H21EOLACvtfcHk0lhGf0Yg2oaRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlyltw%253D%253D&md5=5deeea6b10b0c4efe2fdd92b617a5430</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm9506884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9506884%26sid%3Dliteratum%253Aachs%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DHettinger%26aufirst%3DA.-M.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DPavlik%26aufirst%3DP.%2BA.%26aulast%3DMartin%26aufirst%3DY.%2BC.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DNovel%25203-Pyridyl%2520Ethers%2520with%2520Subnanomolar%2520Affinity%2520for%2520Central%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D817%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guendisch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilotta, M. C.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Phenylcarbamate Derivatives as Ligands for Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4953-4962&author=D.+Guendischauthor=M.+Andraeauthor=L.+Munozauthor=M.+C.+Tilotta&title=Synthesis+and+Evaluation+of+Phenylcarbamate+Derivatives+as+Ligands+for+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuendisch%26aufirst%3DD.%26aulast%3DAndrae%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DTilotta%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Phenylcarbamate%2520Derivatives%2520as%2520Ligands%2520for%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4953%26epage%3D4962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">+)-3-[2-(Benzo[<i>b</i>]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as Potent Agonists for the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3781-3784&author=R.+Tatsumiauthor=K.+Seioauthor=M.+Fujioauthor=J.+Katayamaauthor=T.+Horikawaauthor=K.+Hashimotoauthor=H.+Tanaka&title=%2B%29-3-%5B2-%28Benzo%5Bb%5Dthiophen-2-yl%29-2-oxoethyl%5D-1-azabicyclo%5B2.2.2%5Doctane+as+Potent+Agonists+for+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%252B%2529-3-%255B2-%2528Benzo%255Bb%255Dthiophen-2-yl%2529-2-oxoethyl%255D-1-azabicyclo%255B2.2.2%255Doctane%2520as%2520Potent%2520Agonists%2520for%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3781%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bodnar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span> </span><span class="NLM_article-title">Discovery and Structure–Activity Relationship of Quinuclidine Benzamides as Agonists of α7 Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049363q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=905-908&author=A.+L.+Bodnarauthor=L.+A.+Cortes-Burgosauthor=K.+K.+Cookauthor=D.+M.+Dinhauthor=V.+E.+Groppiauthor=M.+Hajosauthor=N.+R.+Higdonauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=J.+K.+Myersauthor=B.+N.+Rogersauthor=T.+M.+Wallauthor=M.+L.+Wolfeauthor=E.+Wong&title=Discovery+and+Structure%E2%80%93Activity+Relationship+of+Quinuclidine+Benzamides+as+Agonists+of+%CE%B17+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm049363q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049363q%26sid%3Dliteratum%253Aachs%26aulast%3DBodnar%26aufirst%3DA.%2BL.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Quinuclidine%2520Benzamides%2520as%2520Agonists%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span> </span><span class="NLM_article-title">2-(Arylmethyl)-3-Substituted Quinuclidines as Selective α7 Nicotinic Receptor Ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2073-2077&author=A.+Mazurovauthor=J.+Klucikauthor=L.+Miaoauthor=T.+Y.+Phillipsauthor=A.+Seamansauthor=J.+D.+Schmittauthor=T.+A.+Hauserauthor=R.+T.+Johnsonauthor=C.+Miller&title=2-%28Arylmethyl%29-3-Substituted+Quinuclidines+as+Selective+%CE%B17+Nicotinic+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DT.%2BY.%26aulast%3DSeamans%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BT.%26aulast%3DMiller%26aufirst%3DC.%26atitle%3D2-%2528Arylmethyl%2529-3-Substituted%2520Quinuclidines%2520as%2520Selective%2520%25CE%25B17%2520Nicotinic%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2073%26epage%3D2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+L.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=L.+A.+Cortes-Burgosauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-Azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+Agonist+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor%2C+for+the+Potential+Treatment+of+Cognitive+Deficits+in+Schizophrenia%3A+Synthesis+and+Structure%E2%80%93Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-Azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520Agonist%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%252C%2520for%2520the%2520Potential%2520Treatment%2520of%2520Cognitive%2520Deficits%2520in%2520Schizophrenia%253A%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetman, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinholt, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structure–Activity Relationship, and in Vivo Activity of Azabicyclic Aryl Amides as α7 Nicotinic Acetylcholine Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8219-8248&author=D.+P.+Walkerauthor=D.+G.+Wishkaauthor=D.+W.+Piotrowskiauthor=S.+Jiaauthor=S.+C.+Reitzauthor=K.+M.+Yatesauthor=J.+K.+Myersauthor=T.+N.+Vetmanauthor=B.+J.+Margolisauthor=E.+J.+Jacobsenauthor=B.+A.+Ackerauthor=V.+E.+Groppiauthor=M.+L.+Wolfeauthor=B.+A.+Thornburghauthor=P.+M.+Tinholtauthor=L.+A.+Cortes-Burgosauthor=R.+R.+Waltersauthor=M.+R.+Hesterauthor=E.+P.+Seestauthor=L.+A.+Dolakauthor=F.+Hanauthor=B.+A.+Olsonauthor=L.+Fitzgeraldauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=M.+Hajosauthor=W.+E.+Hoffmannauthor=K.+S.+Liauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=E.+H.+F.+Wongauthor=B.+N.+Rogers&title=Design%2C+Synthesis%2C+Structure%E2%80%93Activity+Relationship%2C+and+in+Vivo+Activity+of+Azabicyclic+Aryl+Amides+as+%CE%B17+Nicotinic+Acetylcholine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DVetman%26aufirst%3DT.%2BN.%26aulast%3DMargolis%26aufirst%3DB.%2BJ.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DAcker%26aufirst%3DB.%2BA.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DTinholt%26aufirst%3DP.%2BM.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHester%26aufirst%3DM.%2BR.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DB.%2BA.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLi%26aufirst%3DK.%2BS.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Azabicyclic%2520Aryl%2520Amides%2520as%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8219%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Clark, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span> </span><span class="NLM_article-title">An Orthogonal Protection Strategy for the Synthesis of 2-Substituted Piperazines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3065</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=3057-3065&author=R.+B.+Clarkauthor=D.+Elbaum&title=An+Orthogonal+Protection+Strategy+for+the+Synthesis+of+2-Substituted+Piperazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BB.%26aulast%3DElbaum%26aufirst%3DD.%26atitle%3DAn%2520Orthogonal%2520Protection%2520Strategy%2520for%2520the%2520Synthesis%2520of%25202-Substituted%2520Piperazines%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D3057%26epage%3D3065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hooper, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsunomiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Scope and Mechanism of Palladium-Catalyzed Amination of Five-Membered Heterocyclic Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2861</span><span class="NLM_x">–</span> <span class="NLM_lpage">2873</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0266339" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvF2ltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=2861-2873&author=M.+W.+Hooperauthor=M.+Utsunomiyaauthor=J.+F.+Hartwig&title=Scope+and+Mechanism+of+Palladium-Catalyzed+Amination+of+Five-Membered+Heterocyclic+Halides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scope and Mechanism of Palladium-Catalyzed Amination of Five-Membered Heterocyclic Halides</span></div><div class="casAuthors">Hooper, Mark W.; Utsunomiya, Masaru; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2861-2873</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Detailed studies have been conducted to det. the activity of palladium catalysts for the amination of five-membered heterocyclic halides and to det. the factors that control the scope of this reaction.  Palladium-catalyzed aminations of the electron-rich furanyl, thiophenyl, and indolyl halides and of the related 2-halogenated thiazoles, benzimidazole, and benzoxazole have been shown to occur with a subset of amines.  Various combinations of palladium precursors and PtBu3 were tested as catalysts for reaction of 3-bromothiophene with N-methylaniline, and the fastest reactions occurred with the Pd(I) dimer, [PdBr(PtBu3)]2.  The fastest aminations of thiazoles, benzimidazoles, and benzoxazoles occurred with the combination of palladium trifluoroacetate and PtBu3 as catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aQmjLVtO6LVg90H21EOLACvtfcHk0lgOsuPuA0Sb9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvF2ltLs%253D&md5=3fb8603411fc1099b4fd2e3c2f9e86f9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo0266339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0266339%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DM.%2BW.%26aulast%3DUtsunomiya%26aufirst%3DM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DScope%2520and%2520Mechanism%2520of%2520Palladium-Catalyzed%2520Amination%2520of%2520Five-Membered%2520Heterocyclic%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D2861%26epage%3D2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Available from ChemPacific Corporation, Baltimore, MD.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">van Maanen, M. A.; Papke, R. L.; Koopman, F. A.; Koepke, J.; Bevaart, L.; Clark, R.; Lamppu, D.; Elbaum, D.; LaRosa, G. J.; Tak, P. P.; Vervoordeldonk, M. J.</span><span> </span><span class="NLM_article-title">Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induce arthritis in mice</span>. <div class="note"><p class="first last">Submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=van+Maanen%2C+M.+A.%3B+Papke%2C+R.+L.%3B+Koopman%2C+F.+A.%3B+Koepke%2C+J.%3B+Bevaart%2C+L.%3B+Clark%2C+R.%3B+Lamppu%2C+D.%3B+Elbaum%2C+D.%3B+LaRosa%2C+G.+J.%3B+Tak%2C+P.+P.%3B+Vervoordeldonk%2C+M.+J.+Two+novel+%CE%B17+nicotinic+acetylcholine+receptor+ligands%3A+in+vitro+properties+and+their+efficacy+in+collagen-induce+arthritis+in+mice.+Submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMaanen%26aufirst%3DM.%2BA.%26atitle%3DTwo%2520novel%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%253A%2520in%2520vitro%2520properties%2520and%2520their%2520efficacy%2520in%2520collagen-induce%2520arthritis%2520in%2520mice" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct Profiles of α7 nAChR Postive Allosteric Modulation Revealed by Structurally Divers Chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=715-724&author=J.+H.+Gr%C3%B8nlienauthor=M.+H%C3%A5kerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+Profiles+of+%CE%B17+nAChR+Postive+Allosteric+Modulation+Revealed+by+Structurally+Divers+Chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520Profiles%2520of%2520%25CE%25B17%2520nAChR%2520Postive%2520Allosteric%2520Modulation%2520Revealed%2520by%2520Structurally%2520Divers%2520Chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">A Structural Basis for Drug-Induced Long QT Syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12329</span><span class="NLM_x">–</span> <span class="NLM_lpage">12333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1073%2Fpnas.210244497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11005845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12329-12333&author=J.+S.+Mitchesonauthor=J.+Chenauthor=M.+Linauthor=C.+Culbersonauthor=M.+C.+Sanguinetti&title=A+Structural+Basis+for+Drug-Induced+Long+QT+Syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A structural basis for drug-induced long QT syndrome</span></div><div class="casAuthors">Mitcheson, John S.; Chen, Jun; Lin, Monica; Culberson, Chris; Sanguinetti, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12329-12333</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the HERG K+ channel gene cause inherited long QT syndrome (LQT), a disorder of cardiac repolarization that predisposes affected individuals to lethal arrhythmias.  Acquired LQT is far more common and is most often caused by block of cardiac HERG K+ channels by commonly used medications.  It is unclear why so many structurally diverse compds. block HERG channels, but this undesirable side effect now is recognized as a major hurdle in the development of new and safe drugs.  Here we use alanine-scanning mutagenesis to det. the structural basis for high-affinity drug block of HERG channels by MK-499, a methanesulfonanilide antiarrhythmic drug.  The binding site, corroborated with homol. modeling, is comprised of amino acids located on the S6 transmembrane domain (G648, Y652, and F656) and pore helix (T623 and V625) of the HERG channel subunit that face the cavity of the channel.  Other compds. that are structurally unrelated to MK-499, but cause LQT, also were studied.  The antihistamine terfenadine and a gastrointestinal prokinetic drug, cisapride, interact with Y652 and F656, but not with V625.  The arom. residues of the S6 domain that interact with these drugs (Y652 and F656) are unique to eag/erg K+ channels.  Other voltage-gated K+ (Kv) channels have lle and Val (lle) in the equiv. positions.  These findings suggest a possible structural explanation for how so many commonly used medications block HERG but not other Kv channels and should facilitate the rational design of drugs devoid of HERG channel binding activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczBuinwjCZrVg90H21EOLACvtfcHk0lgEXNU1xr-eXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D&md5=595505ebd987ee7a4af280016c03ea35</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.210244497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.210244497%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DA%2520Structural%2520Basis%2520for%2520Drug-Induced%2520Long%2520QT%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D12329%26epage%3D12333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">Assays at Cerep were performed according to previously described procedures with the noted exceptions. α4β2:</p></div><div class="NLM_citation" id="cit31a"><span><span class="NLM_contrib-group">Pabereza, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]cytisine binding to nicotinic cholinergic receptors in brain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=9-12&author=L.+A.+Paberezaauthor=S.+Dhawanauthor=K.+J.+Kellar&title=%5B3H%5Dcytisine+binding+to+nicotinic+cholinergic+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPabereza%26aufirst%3DL.%2BA.%26aulast%3DDhawan%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3D%255B3H%255Dcytisine%2520binding%2520to%2520nicotinic%2520cholinergic%2520receptors%2520in%2520brain%26jtitle%3DMol.%2520Pharmacol.%26date%3D1991%26volume%3D39%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">α1β1γδ:</p></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1471-4159.1986.tb08516.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=3701338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaL28XkvFaks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=1936-1941&author=R.+J.+Lukas&title=Characterization+of+curaremimetic+neurotoxin+binding+sites+on+membrane+fractions+derived+from+the+human+medulloblastoma+clonal+line%2C+TE671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671</span></div><div class="casAuthors">Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1936-41</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Studies were conducted on curaremimetic neurotoxin binding to the nicotinic acetylcholine  [51-84-3] receptor present on membrane fractions derived from the human medulloblastoma clonal line, TE671.  High-affinity binding sites (KD = 2 nM for 1-h incubation at 20°) and low-affinity binding sites (KD = 40 nM) for 125I-labeled α-bungarotoxin  [11032-79-4] are present in equal quantities (60 fmol/mg membrane protein).  The kinetically detd. dissocn. const. for high-affinity binding of toxin is 0.56 nM (k1 = 6.3 · 10-3 min-1 nM-1; k-1 = 3.5 · 10-3 min-1) at 20°.  Nicotine  [54-11-5], d-tubocurarine  [57-95-4], and acetylcholine are among the most effective inhibitors of high-affinity toxin binding.  The quantity of toxin binding sites and their affinity for cholinergic agonists is sensitive to redn., alkylation, and(or) oxidn. of membrane sulfhydryl residues.  High-affinity toxin binding sites that have been subjected to reaction with the sulfhydryl reagent dithiothreitol are irreversibly blocked by the nicotinic receptor affinity reagent bromoacetylcholine  [17139-54-7].  High-affinity toxin binding is inhibited in the presence of either of 2 polyclonal antisera or a monoclonal antibody raised against nicotinic acetylcholine receptors from fish elec. tissue.  Taken together, these results indicate that curaremimetic neurotoxin binding sites on membrane fractions of the TE671 cell line share some properties with nicotinic acetylcholine receptors of peripheral origin and with toxin binding sites on other neuronal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4MXeyhaVG7Vg90H21EOLACvtfcHk0lgEXNU1xr-eXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XkvFaks74%253D&md5=cd35020c5445171bc033fefdafeacfa2</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1986.tb08516.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1986.tb08516.x%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520curaremimetic%2520neurotoxin%2520binding%2520sites%2520on%2520membrane%2520fractions%2520derived%2520from%2520the%2520human%2520medulloblastoma%2520clonal%2520line%252C%2520TE671%26jtitle%3DJ.%2520Neurochem.%26date%3D1986%26volume%3D46%26spage%3D1936%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">5-HT<sub>3</sub>:</p></div><div class="NLM_citation" id="cit31c"><span><span class="NLM_contrib-group">Hope, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-As) subunit stably expressed in HEK 293 cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1476-5381.1996.tb15529.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=8818349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Ghsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1237-1245&author=A.+G.+Hopeauthor=J.+A.+Petersauthor=A.+M.+Brownauthor=J.+J.+Lambertauthor=T.+P.+Blackburn&title=Characterization+of+a+human+5-hydroxytryptamine3+receptor+type+A+%28h5-HT3R-As%29+subunit+stably+expressed+in+HEK+293+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31cR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-As) subunit stably expressed in HEK 293 cells</span></div><div class="casAuthors">Hope, Anthony G.; Peters, John A.; Brown, Angus M.; Lambert, Jeremy J.; Blackburn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1237-1245</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">A cloned cDNA encoding a human 5-hydroxytryptamine3 receptor type A subunit (h5-HT3R-As) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high d. of the recombinant receptor was selected.  Membrane homogenates prepd. from transfected but not untransfected, cells exhibited a homogeneous and saturable population (Bmax = 4.49 pmol mg-1 protein) of sites that bound the radiolabeled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pKD = 8.87).  Kinetic studies (at 37°) revealed rapid assocn. (k+1 = 4.76 × 108 M-1 min-1) and dissocn. (k-1 = 0.21 min-1) of the radioligand.  Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > m-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS.  In electrophysiol. recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 mV.  Such responses were antagonized in a reversible manner by granisetron (1 nM).  The construction of a stable cell line expressing a high d. of recombinant human 5-HT3 receptors which display appropriate pharmacol. and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphoHkEVXGW9bVg90H21EOLACvtfcHk0lg0up4MRjKOfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Ghsbc%253D&md5=103e1995ab3c9fad24b272e017028c98</span></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15529.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15529.x%26sid%3Dliteratum%253Aachs%26aulast%3DHope%26aufirst%3DA.%2BG.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DLambert%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DCharacterization%2520of%2520a%2520human%25205-hydroxytryptamine3%2520receptor%2520type%2520A%2520%2528h5-HT3R-As%2529%2520subunit%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D118%26spage%3D1237%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">This assay was performed using [<sup>3</sup>H]BRL-43694 at 0.5 nM as the ligand. hERG:</p></div><div class="NLM_citation" id="cit31d"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=G.+Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31dR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0lg0up4MRjKOfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit31d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DG.%2BQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Cytochrome P450 all isoforms:</p></div><div class="NLM_citation" id="cit31e"><span><span class="NLM_contrib-group">Dierks, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. E.</span><span> </span><span class="NLM_article-title">A method for the simulataneus evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><div class="note"><p class="first last">The cytochrome P450 assays were performed as described with single substrates rather than a substrate cocktail. The substrates used are: 1A2, ethoxyresorufin; 2C9, diclofenac; 2C19, <i>S</i>-mephenytoin; 2D6, bufuralol; 3A4, midazolam.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=23-29&author=E.+A.+Dierksauthor=K.+R.+Stamsauthor=H.-K.+Limauthor=G.+Corneliusauthor=H.+Zhangauthor=S.+E.+Ball&title=A+method+for+the+simulataneus+evaluation+of+the+activities+of+seven+major+human+drug-metabolizing+cytochrome+P450s+using+an+in+vitro+cocktail+of+probe+substrates+and+fast+gradient+liquid+chromatography+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DStams%26aufirst%3DK.%2BR.%26aulast%3DLim%26aufirst%3DH.-K.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26atitle%3DA%2520method%2520for%2520the%2520simulataneus%2520evaluation%2520of%2520the%2520activities%2520of%2520seven%2520major%2520human%2520drug-metabolizing%2520cytochrome%2520P450s%2520using%2520an%2520in%2520vitro%2520cocktail%2520of%2520probe%2520substrates%2520and%2520fast%2520gradient%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hide, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrä, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohsaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, Y.</span><span> </span><span class="NLM_article-title">Microglial α7 Nicotinic Acetylcholine Receptors Drive a Phospholipase C/IP3 Pathway and Modulate the Cell Activation toward a Neuroprotective Role</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fjnr.20850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16652343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1461-1470&author=T.+Suzukiauthor=I.+Hideauthor=A.+Matsubaraauthor=C.+Hamaauthor=K.+Haradaauthor=K.+Miyanoauthor=M.+Andr%C3%A4author=H.+Matsubayashiauthor=N.+Sakaiauthor=S.+Kohsakaauthor=K.+Inoueauthor=Y.+Nakata&title=Microglial+%CE%B17+Nicotinic+Acetylcholine+Receptors+Drive+a+Phospholipase+C%2FIP3+Pathway+and+Modulate+the+Cell+Activation+toward+a+Neuroprotective+Role"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role</span></div><div class="casAuthors">Suzuki, Tomohisa; Hide, Izumi; Matsubara, Akiyo; Hama, Chihiro; Harada, Kana; Miyano, Kanako; Andra, Matthias; Matsubayashi, Hiroaki; Sakai, Norio; Kohsaka, Shinichi; Inoue, Kazuhide; Nakata, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1461-1470</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Microglia perform both neuroprotective and neurotoxic functions in the brain, with this depending on their state of activation and their release of mediators.  Upon P2X7 receptor stimulation, for example, microglia release small amts. of TNF, which protect neurons, whereas LPS causes massive TNF release leading to neuroinflammation.  Here we report that, in rat primary cultured microglia, nicotine enhances P2X7 receptor-mediated TNF release, while suppressing LPS-induced TNF release but without affecting TNF mRNA expression via activation of α7 nicotinic acetylcholine receptors (α7 nAChRs).  In microglia, nicotine elicited a transient increase in intracellular Ca2+ levels, which was abolished by specific blockers of α7 nAChRs.  However, this response was independent of extracellular Ca2+ and blocked by U 73122, an inhibitor of phospholipase C (PLC), and xestospongin C, a blocker of the IP3 receptor.  Repeated expts. showed that currents were not detected in nicotine-stimulated microglia.  Moreover, nicotine modulation of LPS-induced TNF release was also blocked by xestospongin C.  Upon LPS stimulation, inhibition of TNF release by nicotine was assocd. with the suppression of JNK and p38 MAP kinase activation, which regulate the post-transcriptional steps of TNF synthesis.  In contrast, nicotine did not alter any MAP kinase activation, but enhanced Ca2+ response in P2X7 receptor-activated microglia.  In conclusion, microglial α7 nAChRs might drive a signaling process involving the activation of PLC and Ca2+ release from intracellular Ca2+ stores, rather than function as conventional ion channels.  This novel α7 nAChR signal may be involved in the nicotine modification of microglia activation towards a neuroprotective role by suppressing the inflammatory state and strengthening the protective function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2gUrBM0HirrVg90H21EOLACvtfcHk0lg0up4MRjKOfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlOqt74%253D&md5=ad2973479343f0d0e3e472c27bd7a13f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20850%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHide%26aufirst%3DI.%26aulast%3DMatsubara%26aufirst%3DA.%26aulast%3DHama%26aufirst%3DC.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DAndr%25C3%25A4%26aufirst%3DM.%26aulast%3DMatsubayashi%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DKohsaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DNakata%26aufirst%3DY.%26atitle%3DMicroglial%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Drive%2520a%2520Phospholipase%2520C%252FIP3%2520Pathway%2520and%2520Modulate%2520the%2520Cell%2520Activation%2520toward%2520a%2520Neuroprotective%2520Role%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1461%26epage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Chojnacka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horenstein, N. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a Conditionally-Silent Agonist of the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4145</span><span class="NLM_x">–</span> <span class="NLM_lpage">4149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.bmcl.2013.05.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=23746476" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4145-4149&author=K.+Chojnackaauthor=R.+L.+Papkeauthor=N.+A.+Horenstein&title=Synthesis+and+evaluation+of+a+Conditionally-Silent+Agonist+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DChojnacka%26aufirst%3DK.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DHorenstein%26aufirst%3DN.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520Conditionally-Silent%2520Agonist%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4145%26epage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Thomsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span> </span><span class="NLM_article-title">The alpha7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysacharide-induced TNF-alpha release from microglia</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.jneuroim.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=22884467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2nt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2012&pages=65-72&author=M.+S.+Thomsenauthor=J.+D.+Mikkelsen&title=The+alpha7+nicotinic+acetylcholine+receptor+ligands+methyllycaconitine%2C+NS6740+and+GTS-21+reduce+lipopolysacharide-induced+TNF-alpha+release+from+microglia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia</span></div><div class="casAuthors">Thomsen, Morten S.; Mikkelsen, Jens D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The anti-inflammatory properties of, particularly the α7, nicotinic acetylcholine receptors (nAChRs) in the peripheral immune system are well documented.  There are also reports of anti-inflammatory actions of nicotine in the CNS, but it is unclear, whether this is due to activation or inhibition of nAChRs.  Here the authors investigate the mechanisms behind α7 nAChR-mediated modulation of TNF-α release.  The authors show that α7 nAChR agonists or pos. allosteric modulators do not affect LPS-induced release of the pro-inflammatory cytokine TNF-α from cultured microglia.  This suggests that classical activation of, i.e., ion-flux through, the α7 nAChR does not reduce TNF-α release from activated microglia.  Contrarily, the α7 nAChR antagonist methyllycaconitine and the weak (< 10%) agonist NS6740 reduced LPS-induced TNF-α release, indicating that α7 nAChR antagonism conveys anti-inflammatory properties on microglia.  The effect of methyllycaconitine or NS6740 was not due to changes in MAPK signaling.  These results suggest that the anti-inflammatory effects of nicotine seen in vivo are not due to classical activation of the α7 nAChR, and further suggest that antagonism of α7 nAChRs may reduce neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Yn3hEYZ7OrVg90H21EOLACvtfcHk0lhEqJNpKBulRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2nt7zN&md5=954f106f0919ba3c2353b7533b29d2ba</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%2520methyllycaconitine%252C%2520NS6740%2520and%2520GTS-21%2520reduce%2520lipopolysacharide-induced%2520TNF-alpha%2520release%2520from%2520microglia%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D251%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Br. J. Phamacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1476-5381.2009.00426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19845675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSkurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1486-1494&author=C.+A.+Briggsauthor=J.+H.+Gr%C3%B8nlienauthor=P.+Curzonauthor=D.+B.+Timmermannauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=P.+Kerrauthor=D.+A.+Andersonauthor=J.+Malyszauthor=T.+Dyhringauthor=G.+M.+Olsenauthor=D.+Petersauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Role+of+channel+activation+in+cognitive+enhancement+mediated+by+%CE%B17+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Briggs, Clark A.; Gronlien, Jens Halvard; Curzon, Peter; Timmermann, Daniel B.; Ween, Hilde; Thorin-Hagene, Kirsten; Kerr, Paige; Anderson, David J.; Malysz, John; Dyhring, Tino; Olsen, Gunnar M.; Peters, Dan; Bunnelle, William H.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1486-1494</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Several agonists of the α7 nicotinic acetylcholine receptor (nAChR) have been developed for treatment of cognitive deficits.  However, agonist efficacy in vivo is difficult to reconcile with rapid α7 nAChR desensitization in vitro; and furthermore, the correlation between in vitro receptor efficacy and in vivo behavioral efficacy is not well delineated.  The possibility that agonists of this receptor actually function in vivo as inhibitors via desensitization has not been finally resolved.  Exptl. approach: Two structurally related α7 nAChR agonists were characterized and used to assess the degree of efficacy required in a behavioral paradigm.  Key results: NS6784 activated human and rat α7 nAChR with EC50s of 0.72 and 0.88 μM, and apparent efficacies of 77 and 97% resp.  NS6740, in contrast, displayed little efficacy at α7 nAChR (<2% in oocytes, ≤8% in GH4C1 cells), although its agonist-like properties were revealed by adding a pos. allosteric modulator of α7 nAChRs or using the slowly desensitizing α7V274T receptor.  In mouse inhibitory avoidance (IA) memory retention, NS6784 enhanced performance as did the 60% partial agonist A-582941.  In contrast, NS6740 did not enhance performance, but blocked effects of A-582941.  Conclusions and implications: Collectively, these findings suggest that a degree of α7 nAChR agonist efficacy is required for behavioral effects in the IA paradigm, and that such behavioral efficacy is not due to α7 nAChR desensitization.  Also, a partial agonist of very low efficacy for this receptor could be used as an inhibitor, in the absence of α7 nAChR antagonists with favorable CNS penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo32atdw4MkkLVg90H21EOLACvtfcHk0lhEqJNpKBulRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSkurvO&md5=9fe212784ed34e2ba5b96f88bc1011f5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00426.x%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DKerr%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BA.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DOlsen%26aufirst%3DG.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DRole%2520of%2520channel%2520activation%2520in%2520cognitive%2520enhancement%2520mediated%2520by%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBr.%2520J.%2520Phamacol.%26date%3D2009%26volume%3D158%26spage%3D1486%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Assayag, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, Y.</span><span> </span><span class="NLM_article-title">Bronchodilatory and Anti-Inflammatory Effects of ASM-024, a Nicotinic Receptor Ligand Developed for the Treatment of Asthma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e86091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e86091&author=E.+I.+Assayagauthor=M.-J.+Beaulieuauthor=Y.+Cormier&title=Bronchodilatory+and+Anti-Inflammatory+Effects+of+ASM-024%2C+a+Nicotinic+Receptor+Ligand+Developed+for+the+Treatment+of+Asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssayag%26aufirst%3DE.%2BI.%26aulast%3DBeaulieu%26aufirst%3DM.-J.%26aulast%3DCormier%26aufirst%3DY.%26atitle%3DBronchodilatory%2520and%2520Anti-Inflammatory%2520Effects%2520of%2520ASM-024%252C%2520a%2520Nicotinic%2520Receptor%2520Ligand%2520Developed%2520for%2520the%2520Treatment%2520of%2520Asthma%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De86091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><div class="note"><p class="first last">The ovalbumin challenge procedure was adapted from</p></div><span class="NLM_contrib-group">Hamelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvin, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography</span> <span class="citation_source-journal">Am. J. Resp. Crti. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1164%2Fajrccm.156.3.9606031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9309991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADyaK2svlsFOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1997&pages=766-775&author=E.+Hamelmannauthor=J.+Schwarzeauthor=K.+Takedaauthor=A.+Oshibaauthor=G.+L.+Larsenauthor=C.+G.+Irvinauthor=E.+W.+Gelfand&title=Noninvasive+Measurement+of+Airway+Responsiveness+in+Allergic+Mice+Using+Barometric+Plethysmography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography</span></div><div class="casAuthors">Hamelmann E; Schwarze J; Takeda K; Oshiba A; Larsen G L; Irvin C G; Gelfand E W</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3 Pt 1</span>),
    <span class="NLM_cas:pages">766-75</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">To study the mechanisms and kinetics underlying the development of increased airway responsiveness (AR) after allergic sensitization, animal models have been invaluable.  Using barometric whole-body plethysmography and increases in enhanced pause (Penh) as an index of airway obstruction, we measured responses to inhaled methacholine in conscious, unrestrained mice after sensitization and airway challenge with ovalbumin (OVA).  Sensitized and challenged animals had significantly increased AR to aerosolized methacholine compared with control animals.  AR measured as Penh was associated with increased IgE production and eosinophil lung infiltration.  In a separate approach we confirmed the involvement of the lower airways in the response to aerosolized methacholine using tracheotomized mice.  Increases in Penh values after methacholine challenge were also correlated with increased intrapleural pressure, measured via an esophageal tube.  Lastly, mice demonstrating AR using a noninvasive technique also demonstrated increased pulmonary resistance responses to aerosolized methacholine when measured using an invasive technique the following day in the same animals.  The increases in Penh values were inhibited by pretreatment of the mice with a beta 2-agonist.  These data indicate that measurement of AR to inhaled methacholine by barometric whole-body plethysmography is a valid indicator of airway hyperresponsiveness after allergic sensitization in mice.  The measurement of AR in unrestrained, conscious animals provides new opportunities to evaluate the mechanisms and kinetics underlying the development and maintenance of airway hyperresponsiveness and to assess various therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-tCkOZh2wflVwdslNBF-tfW6udTcc2ebjkgwjwqQCBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svlsFOksg%253D%253D&md5=75a577fc5fbe44e26cd8ec900f8e490a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.156.3.9606031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.156.3.9606031%26sid%3Dliteratum%253Aachs%26aulast%3DHamelmann%26aufirst%3DE.%26aulast%3DSchwarze%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DOshiba%26aufirst%3DA.%26aulast%3DLarsen%26aufirst%3DG.%2BL.%26aulast%3DIrvin%26aufirst%3DC.%2BG.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DNoninvasive%2520Measurement%2520of%2520Airway%2520Responsiveness%2520in%2520Allergic%2520Mice%2520Using%2520Barometric%2520Plethysmography%26jtitle%3DAm.%2520J.%2520Resp.%2520Crti.%2520Care%2520Med.%26date%3D1997%26volume%3D156%26spage%3D766%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Investigation of the Molecular Mechanism of the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator PNU-120596 Provides Evidence for Two Distinct Desensitized States</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=1013-1032&author=D.+K.+Williamsauthor=J.+Wangauthor=R.+L.+Papke&title=Investigation+of+the+Molecular+Mechanism+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor+Positive+Allosteric+Modulator+PNU-120596+Provides+Evidence+for+Two+Distinct+Desensitized+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DInvestigation%2520of%2520the%2520Molecular%2520Mechanism%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Positive%2520Allosteric%2520Modulator%2520PNU-120596%2520Provides%2520Evidence%2520for%2520Two%2520Distinct%2520Desensitized%2520States%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D1013%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Brieden, W.; Roduit, J.-P.</span><span> </span><span class="NLM_article-title">Process for Preparing 2-Piperazinecarboxylic Acid Derivatives</span>. United States Patent 5,856,485,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=W.+Brieden&author=J.-P.+Roduit&title=Process+for+Preparing+2-Piperazinecarboxylic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrieden%26aufirst%3DW.%26atitle%3DProcess%2520for%2520Preparing%25202-Piperazinecarboxylic%2520Acid%2520Derivatives%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><div class="note"><p class="first last">Compounds were prepared from 2-aminophenols as described in</p></div><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiokawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span> </span><span class="NLM_article-title">Orally Active Benzoxazole Derivative as 5-HT3 Receptor Partial Agonist for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7075</span><span class="NLM_x">–</span> <span class="NLM_lpage">7079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050209t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7075-7079&author=S.+Yoshidaauthor=S.+Shiokawaauthor=K.+Kawanoauthor=T.+Itoauthor=H.+Murakamiauthor=H.+Suzukiauthor=Y.+Sato&title=Orally+Active+Benzoxazole+Derivative+as+5-HT3+Receptor+Partial+Agonist+for+Treatment+of+Diarrhea-Predominant+Irritable+Bowel+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050209t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050209t%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DShiokawa%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DOrally%2520Active%2520Benzoxazole%2520Derivative%2520as%25205-HT3%2520Receptor%2520Partial%2520Agonist%2520for%2520Treatment%2520of%2520Diarrhea-Predominant%2520Irritable%2520Bowel%2520Syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7075%26epage%3D7079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><div class="note"><p class="first last">The 2-chlorobenzothiazoles were prepared from 2-haloanilines as described in</p></div><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span> </span><span class="NLM_article-title">A convenient synthesis of 2-mercapto- and 2-chlorobenzothiazoles</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=727-730&author=L.+Zhuauthor=M.+Zhangauthor=M.+Dai&title=A+convenient+synthesis+of+2-mercapto-+and+2-chlorobenzothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthesis%2520of%25202-mercapto-%2520and%25202-chlorobenzothiazoles%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2005%26volume%3D42%26spage%3D727%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e','cit1f'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c','cit21d','cit21e','cit21f','cit21g','cit21h'],'ref22':['cit22'],'ref23':['cit23a'],'ref24':['cit24a','cit24b','cit24c','cit24d','cit24e','cit24f'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b','cit31c','cit31d','cit31e'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Horenstein</span>, . </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of
              α
              7 Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (3)
                                     , 1118-1149. <a href="https://doi.org/10.1124/pharmrev.120.000097" title="DOI URL">https://doi.org/10.1124/pharmrev.120.000097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pharmrev.120.000097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpharmrev.120.000097%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DTherapeutic%252BTargeting%252Bof%252B%2525CE%2525B1%252B7%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DPapke%26aufirst%3DRoger%2BL.%26date%3D2021%26date%3D2021%26volume%3D73%26issue%3D3%26spage%3D1118%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Run-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Yan  Guo</span>, <span class="hlFld-ContribAuthor ">Hao  Deng</span>, <span class="hlFld-ContribAuthor ">Jinzi  Li</span>, <span class="hlFld-ContribAuthor ">Zhe-Shan  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Piperazine skeleton in the structural modification of natural products: a review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1165-1197. <a href="https://doi.org/10.1080/14756366.2021.1931861" title="DOI URL">https://doi.org/10.1080/14756366.2021.1931861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1931861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1931861%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DPiperazine%252Bskeleton%252Bin%252Bthe%252Bstructural%252Bmodification%252Bof%252Bnatural%252Bproducts%25253A%252Ba%252Breview%26aulast%3DZhang%26aufirst%3DRun-Hui%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1165%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Chiara  Pismataro</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Horenstein</span>, <span class="hlFld-ContribAuthor ">Clare  Stokes</span>, <span class="hlFld-ContribAuthor ">Marta  Quadri</span>, <span class="hlFld-ContribAuthor ">Marco  De Amici</span>, <span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Clelia  Dallanoce</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112669. <a href="https://doi.org/10.1016/j.ejmech.2020.112669" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112669%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Belectrophysiological%252Bevaluation%252Bof%252BNS6740%252Bderivatives%25253A%252BExploration%252Bof%252Bthe%252Bstructure-activity%252Brelationship%252Bfor%252Balpha7%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bsilent%252Bactivation%26aulast%3DPismataro%26aufirst%3DMaria%2BChiara%26date%3D2020%26volume%3D205%26spage%3D112669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepika  Purohit</span>, <span class="hlFld-ContribAuthor ">Vandana  Saini</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Ajit  Kumar</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Narasimhan</span>. </span><span class="cited-content_cbyCitation_article-title">Three-dimensional Quantitative Structure-activity Relationship (3DQSAR) and Molecular Docking Study of 2-((pyridin-3-yloxy)methyl) Piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (11)
                                     , 1031-1041. <a href="https://doi.org/10.2174/1389557519666190904151227" title="DOI URL">https://doi.org/10.2174/1389557519666190904151227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190904151227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190904151227%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DThree-dimensional%252BQuantitative%252BStructure-activity%252BRelationship%252B%2525283DQSAR%252529%252Band%252BMolecular%252BDocking%252BStudy%252Bof%252B2-%252528%252528pyridin-3-yloxy%252529methyl%252529%252BPiperazines%252Bas%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDisorders%26aulast%3DPurohit%26aufirst%3DDeepika%26date%3D2020%26volume%3D20%26issue%3D11%26spage%3D1031%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wisam  Toma</span>, <span class="hlFld-ContribAuthor ">Esad  Ulker</span>, <span class="hlFld-ContribAuthor ">Mashael  Alqasem</span>, <span class="hlFld-ContribAuthor ">Shakir D.  AlSharari</span>, <span class="hlFld-ContribAuthor ">J. Michael  McIntosh</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 153-166. <a href="https://doi.org/10.1007/7854_2020_135" title="DOI URL">https://doi.org/10.1007/7854_2020_135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7854_2020_135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7854_2020_135%26sid%3Dliteratum%253Aachs%26atitle%3DBehavioral%252Band%252BMolecular%252BBasis%252Bof%252BCholinergic%252BModulation%252Bof%252BPain%25253A%252BFocus%252Bon%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DToma%26aufirst%3DWisam%26date%3D2020%26date%3D2020%26spage%3D153%26epage%3D166%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBehavioral%252BPharmacology%252Bof%252Bthe%252BCholinergic%252BSystem%26aulast%3DShoaib%26aufirst%3DMohammed%26date%3D2020%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Stéphane  Gérard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wisam  Toma</span>, <span class="hlFld-ContribAuthor ">S. Lauren  Kyte</span>, <span class="hlFld-ContribAuthor ">Deniz  Bagdas</span>, <span class="hlFld-ContribAuthor ">Asti  Jackson</span>, <span class="hlFld-ContribAuthor ">Julie A.  Meade</span>, <span class="hlFld-ContribAuthor ">Faria  Rahman</span>, <span class="hlFld-ContribAuthor ">Zhi-Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Egidio  Del Fabbro</span>, <span class="hlFld-ContribAuthor ">Lucas  Cantwell</span>, <span class="hlFld-ContribAuthor ">Abhijit  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Ganesh A.  Thakur</span>, <span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">John W.  Bigbee</span>, <span class="hlFld-ContribAuthor ">David A.  Gewirtz</span>, <span class="hlFld-ContribAuthor ">M.Imad  Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2019,</strong> <em>320 </em>, 113010. <a href="https://doi.org/10.1016/j.expneurol.2019.113010" title="DOI URL">https://doi.org/10.1016/j.expneurol.2019.113010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2019.113010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2019.113010%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DThe%252B%2525CE%2525B17%252Bnicotinic%252Breceptor%252Bsilent%252Bagonist%252BR-47%252Bprevents%252Band%252Breverses%252Bpaclitaxel-induced%252Bperipheral%252Bneuropathy%252Bin%252Bmice%252Bwithout%252Btolerance%252Bor%252Baltering%252Bnicotine%252Breward%252Band%252Bwithdrawal%26aulast%3DToma%26aufirst%3DWisam%26date%3D2019%26volume%3D320%26spage%3D113010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rubén Oswaldo  Argüello‐Velasco</span>, <span class="hlFld-ContribAuthor ">Grecia Katherine  Sánchez‐Muñoz</span>, <span class="hlFld-ContribAuthor ">José Luis  Viveros‐Ceballos</span>, <span class="hlFld-ContribAuthor ">Mario  Ordóñez</span>, <span class="hlFld-ContribAuthor ">Pawel  Kafarski</span>. </span><span class="cited-content_cbyCitation_article-title">A Straightforward Synthesis of Six‐Membered‐Ring Heterocyclic α‐Aminophosphonic Acids from
              N
              ‐Acyliminium Ions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (7)
                                     , 2068-2073. <a href="https://doi.org/10.1002/jhet.3593" title="DOI URL">https://doi.org/10.1002/jhet.3593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3593%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252BStraightforward%252BSynthesis%252Bof%252BSix%2525E2%252580%252590Membered%2525E2%252580%252590Ring%252BHeterocyclic%252B%2525CE%2525B1%2525E2%252580%252590Aminophosphonic%252BAcids%252Bfrom%252BN%252B%2525E2%252580%252590Acyliminium%252BIons%26aulast%3DArg%25C3%25BCello%25E2%2580%2590Velasco%26aufirst%3DRub%25C3%25A9n%2BOswaldo%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D7%26spage%3D2068%26epage%3D2073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Quadri</span>, <span class="hlFld-ContribAuthor ">Almin  Silnović</span>, <span class="hlFld-ContribAuthor ">Carlo  Matera</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Horenstein</span>, <span class="hlFld-ContribAuthor ">Clare  Stokes</span>, <span class="hlFld-ContribAuthor ">Marco  De Amici</span>, <span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Clelia  Dallanoce</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>160 </em>, 207-228. <a href="https://doi.org/10.1016/j.ejmech.2018.10.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5-%252528quinuclidin-3-ylmethyl%252529-1%25252C2%25252C4-oxadiazoles%252Bto%252Binvestigate%252Bthe%252Bactivation%252Bof%252Bthe%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bsubtype%25253A%252BSynthesis%252Band%252Belectrophysiological%252Bevaluation%26aulast%3DQuadri%26aufirst%3DMarta%26date%3D2018%26volume%3D160%26spage%3D207%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger L  Papke</span>, <span class="hlFld-ContribAuthor ">Clare  Stokes</span>, <span class="hlFld-ContribAuthor ">M Imad  Damaj</span>, <span class="hlFld-ContribAuthor ">Ganesh A  Thakur</span>, <span class="hlFld-ContribAuthor ">Khan  Manther</span>, <span class="hlFld-ContribAuthor ">Millet  Treinin</span>, <span class="hlFld-ContribAuthor ">Deniz  Bagdas</span>, <span class="hlFld-ContribAuthor ">Abhijit R  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Nicole A  Horenstein</span>. </span><span class="cited-content_cbyCitation_article-title">Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2018,</strong> <em>175 </em>
                                    (11)
                                     , 1838-1854. <a href="https://doi.org/10.1111/bph.13851" title="DOI URL">https://doi.org/10.1111/bph.13851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13851%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPersistent%252Bactivation%252Bof%252B%2525CE%2525B17%252Bnicotinic%252BACh%252Breceptors%252Bassociated%252Bwith%252Bstable%252Binduction%252Bof%252Bdifferent%252Bdesensitized%252Bstates%26aulast%3DPapke%26aufirst%3DRoger%2BL%26date%3D2018%26date%3D2017%26volume%3D175%26issue%3D11%26spage%3D1838%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Shinde</span>, <span class="hlFld-ContribAuthor ">Pramod  Mahulikar</span>, <span class="hlFld-ContribAuthor ">Pravin C.  Mhaske</span>, <span class="hlFld-ContribAuthor ">Laxman  Nawale</span>, <span class="hlFld-ContribAuthor ">Dhiman  Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2018,</strong> <em>44 </em>
                                    (2)
                                     , 1247-1260. <a href="https://doi.org/10.1007/s11164-017-3164-4" title="DOI URL">https://doi.org/10.1007/s11164-017-3164-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-3164-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-3164-4%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B2-aryl-4-%252528%2525284-aryl-1H-1%25252C2%25252C3-triazol-1-yl%252529methyl%252529thiazole%252Bderivatives%26aulast%3DShinde%26aufirst%3DVikas%26date%3D2018%26date%3D2017%26volume%3D44%26issue%3D2%26spage%3D1247%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Quadri</span>, <span class="hlFld-ContribAuthor ">Carlo  Matera</span>, <span class="hlFld-ContribAuthor ">Almin  Silnović</span>, <span class="hlFld-ContribAuthor ">Maria Chiara  Pismataro</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Horenstein</span>, <span class="hlFld-ContribAuthor ">Clare  Stokes</span>, <span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Clelia  Dallanoce</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ
              2
              -Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (16)
                                     , 1335-1348. <a href="https://doi.org/10.1002/cmdc.201700162" title="DOI URL">https://doi.org/10.1002/cmdc.201700162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700162%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIdentification%252Bof%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BSilent%252BAgonists%252BBased%252Bon%252Bthe%252BSpirocyclic%252BQuinuclidine-%2525CE%252594%252B2%252B-Isoxazoline%252BScaffold%25253A%252BSynthesis%252Band%252BElectrophysiological%252BEvaluation%26aulast%3DQuadri%26aufirst%3DMarta%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D16%26spage%3D1335%26epage%3D1348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogita K.  Abhale</span>, <span class="hlFld-ContribAuthor ">Amit V.  Sasane</span>, <span class="hlFld-ContribAuthor ">Abhijit P.  Chavan</span>, <span class="hlFld-ContribAuthor ">Saddam Husen  Shekh</span>, <span class="hlFld-ContribAuthor ">Keshav K.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Sujit  Bhansali</span>, <span class="hlFld-ContribAuthor ">Laxman  Nawale</span>, <span class="hlFld-ContribAuthor ">Dhiman  Sarkar</span>, <span class="hlFld-ContribAuthor ">Pravin C.  Mhaske</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>132 </em>, 333-340. <a href="https://doi.org/10.1016/j.ejmech.2017.03.065" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.03.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.03.065%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantimycobacterial%252Bscreening%252Bof%252Bnew%252Bthiazolyl-oxazole%252Bderivatives%26aulast%3DAbhale%26aufirst%3DYogita%2BK.%26date%3D2017%26volume%3D132%26spage%3D333%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Adam  Kallel</span>, <span class="hlFld-ContribAuthor ">Colin  Vangel</span>, <span class="hlFld-ContribAuthor ">Daniel  Elbaum</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational analysis of 2-substituted piperazines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (13)
                                     , 3010-3013. <a href="https://doi.org/10.1016/j.bmcl.2016.05.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Banalysis%252Bof%252B2-substituted%252Bpiperazines%26aulast%3DKallel%26aufirst%3DE.%2BAdam%26date%3D2016%26volume%3D26%26issue%3D13%26spage%3D3010%26epage%3D3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Jingshu  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaozhuo  Ma</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Bingxue  Xie</span>, <span class="hlFld-ContribAuthor ">Yuchen  Hao</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Kewei  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 94-108. <a href="https://doi.org/10.1016/j.ejmech.2016.03.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bindolizine%252Bderivatives%252Bas%252Balpha-7%252BnAChR%252Bagonists%26aulast%3DXue%26aufirst%3DYu%26date%3D2016%26volume%3D115%26spage%3D94%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Criado</span>, <span class="hlFld-ContribAuthor ">Beatriz  Balsera</span>, <span class="hlFld-ContribAuthor ">José  Mulet</span>, <span class="hlFld-ContribAuthor ">Salvador  Sala</span>, <span class="hlFld-ContribAuthor ">Francisco  Sala</span>, <span class="hlFld-ContribAuthor ">Roberto  de la Torre-Martínez</span>, <span class="hlFld-ContribAuthor ">Asia  Fernández-Carvajal</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>, <span class="hlFld-ContribAuthor ">Silvia  Moreno-Fernández</span>, <span class="hlFld-ContribAuthor ">Marta  Miguel</span>, <span class="hlFld-ContribAuthor ">María Jesús  Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (7)
                                     , 731-749. <a href="https://doi.org/10.4155/fmc-2015-0001" title="DOI URL">https://doi.org/10.4155/fmc-2015-0001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2015-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2015-0001%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3-diphenylpropan-1-ones%252Bas%252Ballosteric%252Bmodulators%252Bof%252B%2525CE%2525B17%252BnACh%252Breceptors%252Bwith%252Banalgesic%252Band%252Bantioxidant%252Bproperties%26aulast%3DCriado%26aufirst%3DManuel%26date%3D2016%26volume%3D8%26issue%3D7%26spage%3D731%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  C. Bergmeier</span>, <span class="hlFld-ContribAuthor ">Fang  Fang</span>, <span class="hlFld-ContribAuthor ">Iwona  Maciagiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">A Synthesis of Hexahydro-H-oxazolo[3,4-a]pyrazin-3-ones from Fused Aziridines. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2016,</strong> <em>93 </em>
                                    (1)
                                     , 422. <a href="https://doi.org/10.3987/COM-15-S(T)24" title="DOI URL">https://doi.org/10.3987/COM-15-S(T)24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-15-S(T)24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-15-S%28T%2924%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DA%252BSynthesis%252Bof%252BHexahydro-H-oxazolo%25255B3%25252C4-a%25255Dpyrazin-3-ones%252Bfrom%252BFused%252BAziridines%26aulast%3DC.%2BBergmeier%26aufirst%3DStephen%26date%3D2016%26volume%3D93%26issue%3D1%26spage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Nurulain</span>, <span class="hlFld-ContribAuthor ">T.  Prytkova</span>, <span class="hlFld-ContribAuthor ">A.M.  Sultan</span>, <span class="hlFld-ContribAuthor ">O.  Ievglevskyi</span>, <span class="hlFld-ContribAuthor ">D.  Lorke</span>, <span class="hlFld-ContribAuthor ">K.-H.S.  Yang</span>, <span class="hlFld-ContribAuthor ">G.  Petroianu</span>, <span class="hlFld-ContribAuthor ">F.C.  Howarth</span>, <span class="hlFld-ContribAuthor ">N.  Kabbani</span>, <span class="hlFld-ContribAuthor ">M.  Oz</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory actions of bisabolol on α7-nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2015,</strong> <em>306 </em>, 91-99. <a href="https://doi.org/10.1016/j.neuroscience.2015.08.019" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2015.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2015.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2015.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DInhibitory%252Bactions%252Bof%252Bbisabolol%252Bon%252B%2525CE%2525B17-nicotinic%252Bacetylcholine%252Breceptors%26aulast%3DNurulain%26aufirst%3DS.%26date%3D2015%26volume%3D306%26spage%3D91%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandra Bhushan  Mishra</span>, <span class="hlFld-ContribAuthor ">Shikha  Kumari</span>, <span class="hlFld-ContribAuthor ">Manisha  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole: A promising heterocycle for the development of potent CNS active agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 1-34. <a href="https://doi.org/10.1016/j.ejmech.2014.12.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThiazole%25253A%252BA%252Bpromising%252Bheterocycle%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bpotent%252BCNS%252Bactive%252Bagents%26aulast%3DMishra%26aufirst%3DChandra%2BBhushan%26date%3D2015%26volume%3D92%26spage%3D1%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Mueller</span>, <span class="hlFld-ContribAuthor ">Hana  Starobova</span>, <span class="hlFld-ContribAuthor ">Marco C.  Inserra</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Deuis</span>, <span class="hlFld-ContribAuthor ">Sébastien  Dutertre</span>, <span class="hlFld-ContribAuthor ">Richard J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Paul F.  Alewood</span>, <span class="hlFld-ContribAuthor ">Norelle L.  Daly</span>, <span class="hlFld-ContribAuthor ">Irina  Vetter</span>. </span><span class="cited-content_cbyCitation_article-title">α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>94 </em>
                                    (2)
                                     , 155-163. <a href="https://doi.org/10.1016/j.bcp.2015.01.011" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3D%2525CE%2525B1-conotoxin%252BMrIC%252Bis%252Ba%252Bbiased%252Bagonist%252Bat%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DMueller%26aufirst%3DAlexander%26date%3D2015%26volume%3D94%26issue%3D2%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Kinga  Chojnacka</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Horenstein</span>. </span><span class="cited-content_cbyCitation_article-title">The Minimal Pharmacophore for Silent Agonism of the
              α
              7
              Nicotinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2014,</strong> <em>350 </em>
                                    (3)
                                     , 665-680. <a href="https://doi.org/10.1124/jpet.114.215236" title="DOI URL">https://doi.org/10.1124/jpet.114.215236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.215236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.215236%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DThe%252BMinimal%252BPharmacophore%252Bfor%252BSilent%252BAgonism%252Bof%252Bthe%252B%2525CE%2525B1%252B7%252BNicotinic%252BAcetylcholine%252BReceptor%26aulast%3DPapke%26aufirst%3DRoger%2BL.%26date%3D2014%26date%3D2014%26volume%3D350%26issue%3D3%26spage%3D665%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Recent examples of α7 nAChR agonists and design rational.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2 equiv Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH, 50 °C, 96% yield; (b) BH<sub>3</sub>–THF, THF, 50 °C; (c) 0.1 equiv NaH, THF, reflux, 80% yield for 2 steps; (d) 10 equiv 3-hydroxypyridine, 10 equiv KOtBu, DMF, 90 °C, 50–80% yield; (e) <b>12</b>, toluene, DMSO, 110 °C; (f) <b>13</b>, Pd(OAc)<sub>2</sub>, Ph<sub>3</sub>P, NaOtBu, toluene, 110 °C; (g) 4 M HCl in 1,4-dioxane, MeOH; (h) 1 equiv HCl.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArCOCl or ArOCH<sub>2</sub>COCl, CH<sub>2</sub>Cl<sub>2</sub>; (b) ArNCO, CH<sub>2</sub>Cl<sub>2</sub>; (c) 4 M HCl in 1,4-dioxane, MeOH; (d) <i>N</i>,<i>N</i>-carbonyldiimidazole, CH<sub>2</sub>Cl<sub>2</sub>; (e) ArOH, Et<sub>3</sub>N, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 70 °C.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of (<b><i>R</i></b>)-<b>18</b> (QD) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (**) <i>p</i> < 0.01 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of (<b><i>R</i></b>)-<b>47</b> (BID) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (**) <i>p</i> < 0.005 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/medium/jm-2014-004599_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>47</b>, (<b><i>R</i></b>)-<b>47</b>, and (<b><i>S</i></b>)-<b>47</b> (BID) in the Balb/c mouse ovalbumin sensitization and challenge model of allergic lung inflammation, with BAL fluid collection 8 h after the final challenge. (###) <i>p</i> < 0.001 vs sham control; (*) <i>p</i> < 0.05 vs vehicle control; (**) <i>p</i> < 0.005 vs vehicle control; (***) <i>p</i> < 0.001 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004599/production/images/large/jm-2014-004599_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004599&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="note"><p class="first last">For leading references on nAChRs, see:</p></div><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17009926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=699-729&author=J.+A.+Daniauthor=D.+Bertrand&title=Nicotinic+Acetylcholine+Receptors+and+Nicotinic+Cholinergic+Mechanisms+of+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span></div><div class="casAuthors">Dani, John A.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-729</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacol. characteristics.  Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability.  Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention.  Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70HAk5CzKZbVg90H21EOLACvtfcHk0lhcuRvM3eiWkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D&md5=72cacc238ec2a67f7ebae0b74582682f</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105214%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptors%2520and%2520Nicotinic%2520Cholinergic%2520Mechanisms%2520of%2520the%2520Central%2520Nervous%2520System%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D699%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors: from Structure to Pathology</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.pneurobio.2004.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15649582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2004&pages=363-396&author=C.+Gottiauthor=F.+Clementi&title=Neuronal+Nicotinic+Receptors%3A+from+Structure+to+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors: from structure to pathology</span></div><div class="casAuthors">Gotti, C.; Clementi, F.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-396</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are differently expressed in many regions of the central nervous system (CNS) and peripheral nervous system.  These different receptor subtypes, which have characteristic pharmacol. and biophys. properties, have a pentameric structure consisting of the homomeric or heteromeric combination of 12 different subunits (α2-α10, β2-β4).  By responding to the endogenous neurotransmitter acetylcholine, NAChRs contribute to a wide range of brain activities and influence a no. of physiol. functions.  Furthermore, it is becoming evident that the perturbation of cholinergic nicotinic neurotransmission can lead to various diseases involving nAChR dysfunction during development, adulthood and aging.  In recent years, it has been discovered that NAChRs are present in a no. of non-neuronal cells where they play a significant functional role and are the pathogenetic targets in several diseases.  NAChRs are also the target of natural ligands and toxins including nicotine (Nic), the most widespread drug of abuse.  This review will attempt to survey the major achievements reached in the study of the structure and function of NAChRs by examg. their regional and cellular localization and the mol. basis of their functional diversity mainly in pharmacol. and biochem. terms.  The recent availability of mice with the genetic ablation of single or double nicotinic subunits or point mutations have shed light on the role of nAChRs in major physiol. functions, and we will here discuss recent data relating to their behavioral phenotypes.  Finally, the role of NAChRs in disease will be considered in some details.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Q3RLpSUGVrVg90H21EOLACvtfcHk0lhvUH8dSMw5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVertA%253D%253D&md5=887cf2153d3a412b292de7eba676ef70</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2004.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2004.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%253A%2520from%2520Structure%2520to%2520Pathology%26jtitle%3DProg.%2520Neurobiol.%26date%3D2004%26volume%3D74%26spage%3D363%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakics, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visanji, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">The Role of Neuronal Nicotinic Acetylcholine Receptors in acute and Chronic Neurodegeneration</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568007023339166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12769612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=399-411&author=M.+J.+O%E2%80%99Neillauthor=T.+K.+Murrayauthor=V.+Lakicsauthor=N.+P.+Visanjiauthor=S.+Duty&title=The+Role+of+Neuronal+Nicotinic+Acetylcholine+Receptors+in+acute+and+Chronic+Neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration</span></div><div class="casAuthors">O'Neill, M. J.; Murray, T. K.; Lakics, V.; Visanji, N. P.; Duty, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last five years there has been a rapid explosion of publications reporting that neuronal nicotinic acetylcholine receptors (nAChRs) play a role in neurodegenerative disorders.  Furthermore, there is a well-established loss of nAChRs in post-mortem brains from patients with Alzheimer's disease, Parkinson's disease and a range of other disorders.  In the present review the authors discuss the evidence that nicotine and subtype selective nAChR ligands can provide neuroprotection in in vitro cell culture systems and in in vivo studies in animal models of such disorders.  While in vitro data pertaining to a protective effect of nicotine against nigral neurotoxins like MPTP is less robust, most studies agree that nicotine is protective against glutamate and β-amyloid toxicity in various culture systems.  This effect appears to be mediated by α7 subtype nAChRs since the protection is blocked by α-bungarotoxin and is mimicked by α7 selective agonists.  In vivo studies indicate that α7 receptors play a crit. role in protection from cholinergic lesions and enhancing cognitive function.  The exact subtype involved in the neuroprotectant effects seen in animal models of Parkinson's disease is not clear, but in general broad spectrum nAChR agonists appear to provide protection, while α4β2 receptors appear to mediate symptomatic improvements.  Evidence favoring a protectant effect of nicotine against acute degenerative conditions is less strong, though some protection has been obsd. with nicotine pre-treatment in global ischemia models.  A variety of cellular mechanisms ranging from the prodn. of growth factors through to inactivation of toxins and antioxidant actions of nicotine have been proposed to underlie the nAChR-mediated neuroprotection in vitro and in vivo.  In summary, although the lack of subtype selective ligands has hampered progress, it is clear that in the future neuronal nAChR agonists could provide functional improvements and slow or halt the progress of several crippling degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWuObmpWTELVg90H21EOLACvtfcHk0lhvUH8dSMw5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsro%253D&md5=f7ab213c62cd9304c9a073a5d223d84f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.2174%2F1568007023339166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339166%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DVisanji%26aufirst%3DN.%2BP.%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DThe%2520Role%2520of%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%2520in%2520acute%2520and%2520Chronic%2520Neurodegeneration%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dani, J. A.</span><span> </span><span class="NLM_article-title">Overview of Nicotinic Receptors and Their Roles in the Central Nervous System</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3223%2800%2901011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11230867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=166-174&author=J.+A.+Dani&title=Overview+of+Nicotinic+Receptors+and+Their+Roles+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of nicotinic receptors and their roles in the central nervous system</span></div><div class="casAuthors">Dani, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-174</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 105 refs.  Alzheimer's disease is a complex disorder affecting multiple neurotransmitters.  In particular, the degenerative progression is assocd. with loss within the cholinergic systems.  It should be anticipated that both muscarinic and nicotinic mechanisms are affected as cholinergic neurons are lost.  This review focuses on the basic roles of neuronal nicotinic receptors, some subtypes of which decrease during Alzheimer's disease.  Nicotinic acetylcholine receptors belong to a superfamily of ligand-gated ion channels that play key roles in synaptic transmission throughout the central nervous system.  Neuronal nicotinic receptors, however, are not a single entity, but rather there are many different subtypes constructed from a variety of nicotinic subunit combinations.  This structural diversity and the presynaptic, axonal, and postsynaptic locations of nicotinic receptors contribute to the varied roles these receptors play in the central nervous system.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, and postsynaptic nicotinic receptors mediate a small minority of fast excitatory transmission.  In addn., some nicotinic receptor subtypes have roles in synaptic plasticity and development.  Nicotinic receptors are distributed to influence many neurotransmitter systems at more than one location, and the broad, but sparse, cholinergic innervation throughout the brain ensures that nicotinic acetylcholine receptors are important modulators of neuronal excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVstmEaLl67Vg90H21EOLACvtfcHk0lhvUH8dSMw5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtLY%253D&md5=5ea652d009184424ab870437e5863907</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901011-8%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26atitle%3DOverview%2520of%2520Nicotinic%2520Receptors%2520and%2520Their%2520Roles%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D166%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariou, V.</span><span> </span><span class="NLM_article-title">Nicotinic Receptors in the Brain; Links Between Molecular Biology and Behavior</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=451-465&author=M.+R.+Picciottoauthor=B.+J.+Caldaroneauthor=S.+L.+Kingauthor=V.+Zachariou&title=Nicotinic+Receptors+in+the+Brain%3B+Links+Between+Molecular+Biology+and+Behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DCaldarone%26aufirst%3DB.%2BJ.%26aulast%3DKing%26aufirst%3DS.%2BL.%26aulast%3DZachariou%26aufirst%3DV.%26atitle%3DNicotinic%2520Receptors%2520in%2520the%2520Brain%253B%2520Links%2520Between%2520Molecular%2520Biology%2520and%2520Behavior%26jtitle%3DNeuropsychopharmacology%26date%3D2000%26volume%3D22%26spage%3D451%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1f"><span><span class="NLM_label">(f) </span> <span class="citation_source-book">Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities</span>; <span class="NLM_contrib-group">Arneric, S. P.; Brioni, J. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Liss</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=S.+P.+Arneric&author=J.+D.+Brioni&title=Neuronal+Nicotinic+Receptors%3A+Pharmacology+and+Therapeutic+Opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNeuronal%2520Nicotinic%2520Receptors%253A%2520Pharmacology%2520and%2520Therapeutic%2520Opportunities%26aulast%3DArneric%26aufirst%3DS.%2BP.%26pub%3DWiley-Liss%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parri, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span> </span><span class="NLM_article-title">Research Update: Alpha7 Nicotinic Acetylcholine Receptor Mechanisms in Alzheimer’s Disease</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=931-942&author=H.+R.+Parriauthor=C.+M.+Hernandezauthor=K.+T.+Dineley&title=Research+Update%3A+Alpha7+Nicotinic+Acetylcholine+Receptor+Mechanisms+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParri%26aufirst%3DH.%2BR.%26aulast%3DHernandez%26aufirst%3DC.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26atitle%3DResearch%2520Update%253A%2520Alpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D931%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woodruff-Pak, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T. J.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia</span> <span class="citation_source-journal">Behav. Cognit. Neurosci. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1177%2F1534582302001001002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17715584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2svps12qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=5-20&author=D.+S.+Woodruff-Pakauthor=T.+J.+Gould&title=Neuronal+Nicotinic+Acetylcholine+Receptors%3A+Involvement+in+Alzheimer%E2%80%99s+Disease+and+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Woodruff-Pak Diana S; Gould Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Behavioral and cognitive neuroscience reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-20</span>
        ISSN:<span class="NLM_cas:issn">1534-5823</span>.
    </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) play a role in a variety of diseases of the central nervous system including Alzheimer's disease (AD) and schizophrenia.  There is great interest in evaluating disease-related nA ChR changes, and pharmacological treatment of nAChR deficits is a promising therapy.  In AD, 7 nAChRs remain relatively stable, contrasting to 4 2 nAChRs that are lost in substantial numbers. -amyloid, a major neuropathology in AD, blocks 4 2 and 7 nAChRs.  Agonists selective to 7nAChRs are neuroprotective against--amyloid.  Paradoxically, 7nAChRs may function as receptors for -amyloid.  These results indicate 7 nAChR antagonists may be appropriate therapy in AD.  In schizophrenia, 7 nAChRs are significantly reduced in hippocampus and neocortex.  The exceptionally high rate of smoking in schizophrenics is likely a form of self-medication.  Therapy with 7 nAChR agonists relieves some schizophrenic symptoms.  Despite disparities in etiology and symptomatology, AD and schizophrenia share a target for therapeutic intervention--7 nAChRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzCfYUXsypXZVVjGoY74BafW6udTcc2eYmDCM0oqxydrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svps12qtA%253D%253D&md5=a85db74fd91f39e41b17a825662e84ae</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1177%2F1534582302001001002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1534582302001001002%26sid%3Dliteratum%253Aachs%26aulast%3DWoodruff-Pak%26aufirst%3DD.%2BS.%26aulast%3DGould%26aufirst%3DT.%2BJ.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520Involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Schizophrenia%26jtitle%3DBehav.%2520Cognit.%2520Neurosci.%2520Rev.%26date%3D2002%26volume%3D1%26spage%3D5%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. T.</span><span> </span><span class="NLM_article-title">The Nicotinic Acetylcholine Receptor, Smoking, and Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12446934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XotV2nsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=317-325&author=M.+N.+Sabbaghauthor=R.+J.+Lukasauthor=D.+L.+Sparksauthor=R.+T.+Reid&title=The+Nicotinic+Acetylcholine+Receptor%2C+Smoking%2C+and+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Lukas, Ronald J.; Sparks, D. Larry; Reid, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinergic dysfunction is one of the cornerstones of Alzheimer's disease (AD) pathol.  Reviewed here is evidence evaluating relationships between smoking, nicotine exposure, nicotinic cholinergic signaling, and AD.  Epidemiol. studies initially indicating a lower incidence of AD in smokers now suggest conflicting results.  Clinicopathol. findings also are mixed as to how smoking behavior affects manifestation of AD markers.  Studies that show nicotine-induced increases in nicotinic acetylcholine receptors (nAChR) and protection against age-related nAChR decline contrast, perhaps in a functionally relevant way, to losses of nAChR in AD.  Although epidemiol., clinicopathol., and functional studies in humans do not present a cohesive picture, much in vitro data suggests neuroprotective properties of nicotine when used in models of neurodegenerative disorders.  Studies of nicotine and nicotinic agonist effects on cognitive function in the non-demented and in AD are not compelling.  More work is needed to ascertain whether acute or repetitive activation of nAChR with acute or intermittent exposure to nicotine or the persistent inactivation of nAChR with chronic nicotine exposure is a therapeutic objective and/or explains any pro-cognitive effects of those drugs.  Other studies show complex interactions between nAChR, nicotinic agonists, and agents implicated in AD etiol.  Thus, while controversies still exist, ongoing research is illuminating how nicotinic receptor changes and functions may be relevant to clin., pathol. and neurochem. changes that occur in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcug2bL8lVrrVg90H21EOLACvtfcHk0lgmP7NrvmaDLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotV2nsrk%253D&md5=6d48f98ca53931b6b2afef4199e584e8</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DSparks%26aufirst%3DD.%2BL.%26aulast%3DReid%26aufirst%3DR.%2BT.%26atitle%3DThe%2520Nicotinic%2520Acetylcholine%2520Receptor%252C%2520Smoking%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2002%26volume%3D4%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Cognitive Effects of Nicotine</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3223%2800%2901094-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11230877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=258-267&author=A.+H.+Rezvaniauthor=E.+D.+Levin&title=Cognitive+Effects+of+Nicotine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive effects of nicotine</span></div><div class="casAuthors">Rezvani, A. H.; Levin, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Nicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks.  Clin. studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments assocd. with Alzheimer's disease, schizophrenia, and attention-deficit/hyperactivity disorder.  Exptl. animal studies have demonstrated the persistence of nicotine-induced working memory improvement with chronic exposure, in addn. to the efficacy of a variety of nicotinic agonists.  Mechanistic studies have found that α7 and α4β2 nicotinic receptors in the hippocampus are crit. for nicotinic involvement in cognitive function.  Clin. and exptl. animal studies provide mutually supporting information for the development of novel nicotinic therapies for cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjXiYhwf7QbVg90H21EOLACvtfcHk0lhkCOkk4HI1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbY%253D&md5=2142a7de336eec31e59faa210cccc7c8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901094-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901094-5%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DCognitive%2520Effects%2520of%2520Nicotine%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D258%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehouse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino-Barrows, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span> </span><span class="NLM_article-title">Muscarinic and Nicotinic Cholinergic Binding Sites in Alzheimer’s Disease Cerebral Cortex</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2F0006-8993%2887%2991556-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=3690354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaL1cXjsFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=1987&pages=62-68&author=K.+J.+Kellarauthor=P.+J.+Whitehouseauthor=A.+M.+Martino-Barrowsauthor=K.+Marcusauthor=D.+L.+Price&title=Muscarinic+and+Nicotinic+Cholinergic+Binding+Sites+in+Alzheimer%E2%80%99s+Disease+Cerebral+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex</span></div><div class="casAuthors">Kellar, Kenneth J.; Whitehouse, Peter J.; Martino-Barrows, Andrea M.; Marcus, Kendall; Price, Donald L.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-8</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The total population of muscarinic receptors and a subpopulation of muscarinic receptors with high affinity for agonists were measured with [3H]quinuclidinyl benzilate and [3H]acetylcholine, resp., in homogenates of cerebral cortex from control and Alzheimer's disease brains.  No differences between control and Alzheimer's diseased cortex were found in either the total population of receptors or the subpopulation with high affinity for agonists in either the frontal or temporal poles.  Nicotinic cholinergic receptors labeled by [3H]acetylcholine were measured in homogenates and by autoradiog. in the same brain areas.  In contrast to muscarinic sites, binding to nicotinic sites was markedly decreased in Alzheimer's disease cortex.  Autoradiog. of [3H]acetylcholine binding to nicotinic sites indicated that in control cortex these sites are more concd. in laminae IV-VI than in the superficial laminae, and that in Alzheimer's disease there is loss of these sites in all cortical laminae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7zR32awpUbVg90H21EOLACvtfcHk0lhkCOkk4HI1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXjsFymtQ%253D%253D&md5=6c6fcf75194559190c47599b3fbe2f69</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2991556-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252991556-3%26sid%3Dliteratum%253Aachs%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DWhitehouse%26aufirst%3DP.%2BJ.%26aulast%3DMartino-Barrows%26aufirst%3DA.%2BM.%26aulast%3DMarcus%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26atitle%3DMuscarinic%2520and%2520Nicotinic%2520Cholinergic%2520Binding%2520Sites%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Cerebral%2520Cortex%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D436%26spage%3D62%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wallace, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Alpha7 Neuronal Nicotinic Receptors as a Drug Target in Schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1517%2F14728222.2013.736498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=23231385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=139-155&author=T.+L.+Wallaceauthor=D.+Bertrand&title=Alpha7+Neuronal+Nicotinic+Receptors+as+a+Drug+Target+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia</span></div><div class="casAuthors">Wallace, Tanya L.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-155</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Schizophrenia is a profoundly debilitating disease that represents not only an individual, but a societal problem.  Once characterized solely by the hyperactivity of the dopaminergic system, therapies directed to dampen dopaminergic neurotransmission were developed.  However, these drugs do not address the significant impairments in cognition and the neg. symptoms of the disease, and it is now apparent that disequil. of many neurotransmitter systems is involved.  Despite enormous efforts, minimal progress has been made toward the development of safer, more effective therapies to date.Areas covered: The high preponderance of smoking in schizophrenics suggests that nicotine may provide symptomatic improvement, which has led to investigation for selective mols. targeted to individual nicotinic receptor (nAChR) subtypes.  Of special interest is activation of the homomeric α7nAChR, which is widely distributed in the brain and has been implicated in the pathophysiol. of schizophrenia through numerous approaches.Expert opinion: Preclin. and clin. data suggest that neuronal α7nAChRs play an important role in cognitive functions.  Moreover, some, but not all, early clin. trials conducted with α7nAChR agonists show cognitive benefits in schizophrenics.  These encouraging results suggest that development of compds. targeting α7nAChRs will represent a valuable tool to mitigate symptoms assocd. with schizophrenia, and open new strategies for better pharmacol. treatment of these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonmAqWvgG0_rVg90H21EOLACvtfcHk0lhkCOkk4HI1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVyjug%253D%253D&md5=e625c6965844e11c47a46e5335a10f3d</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.736498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.736498%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DAlpha7%2520Neuronal%2520Nicotinic%2520Receptors%2520as%2520a%2520Drug%2520Target%2520in%2520Schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26spage%3D139%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">Alpha7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F138161211795049561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=21355839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=121-129&author=M.+Ishikawaauthor=K.+Hashimoto&title=Alpha7+Nicotinic+Acetylcholine+Receptor+as+a+Potential+Therapeutic+Target+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia</span></div><div class="casAuthors">Ishikawa, Masatomo; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence suggests that the α7 subtype of nicotinic acetylcholine receptors (nAChRs) plays a role in the patho-physiol. of schizophrenia.  Deficits in auditory P50 evoked potential suppression in patients with schizophrenia are assocd. with decreased d. of α7 nAChRs in the brain.  Some agonists (e.g., DMXB-A and tropisetron) at α7 nAChRs can improve P50 deficits in patients with schizophrenia.  Together, these findings indicate that α7 nAChRs are a potential therapeutic target for schizophrenia.  Currently, a no. of agonists and allosteric modulators at α7 nAChRs are under development as potential therapeutic drugs.  In this article, we review recent topics on α7 nAChR agonists and α7 nAChR allosteric modulators as therapeutic drugs for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiPKBnCbTnLVg90H21EOLACvtfcHk0ljMPfS33tm3jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVSmsbk%253D&md5=4e16cc1e1aea2589a01ad722f760a8f1</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F138161211795049561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049561%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DAlpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520as%2520a%2520Potential%2520Therapeutic%2520Target%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=171-184&author=K.+Hashimotoauthor=K.+Koikeauthor=E.+Shimizuauthor=M.+Iyo&title=%CE%B17+Nicotinic+Receptor+Agonists+as+Potential+Therapeutic+Drugs+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic receptor agonists as potential therapeutic drugs for schizophrenia</span></div><div class="casAuthors">Hashimoto, Kenji; Koike, Kaori; Shimizu, Eiji; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Deficient inhibitory processing of the P50 auditory evoked potential is a measurable marker obsd. in schizophrenia.  Several lines of evidence suggest that α7 nicotinic receptors (α7 nAChRs) play a crit. role in P50 auditory sensory gating in the human brain.  Similar to schizophrenic patients, DBA/2 mice spontaneously exhibit a deficit in inhibitory processing of the P20-N40 auditory evoked potential, which is a rodent analog of the human P50 auditory evoked potential.  Agonists at α7 nAChRs improve deficient inhibitory processing of the P20-N40 auditory gating potential in DBA/2 mice.  In this article, we review the role of α7 nAChRs in the pathophysiol. of schizophrenia, and α7 nAChR agonists and indirect agonists (5-hydroxytryptamine-3 (5-HT3) receptor antagonists, pos. allosteric modulators (galantamine, 5-hydroxyindole, PNU-120596), FK960, FR236924) at α7 nAChRs as potential therapeutic drugs for the treatment of schizophrenia.  In addn., we also discuss the role of kynurenic acid as an endogenous antagonist of α7 nAChRs in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYcI0WdtDnLVg90H21EOLACvtfcHk0ljMPfS33tm3jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D&md5=69bc7ca07eb3b46da3bef6c9c8db956f</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3D%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonists%2520as%2520Potential%2520Therapeutic%2520Drugs%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ripoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronnec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span> </span><span class="NLM_article-title">Nicotinic Receptors and Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1185%2F030079904125004060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15265251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVyktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=1057-1074&author=N.+Ripollauthor=M.+Bronnecauthor=M.+Bourin&title=Nicotinic+Receptors+and+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors and schizophrenia</span></div><div class="casAuthors">Ripoll, Nadege; Bronnec, Marie; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1057-1074</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence of smoking is very high in nonschizophrenic subjects presenting various psychiatric disorders (35 to 54%).  However, the incidence of smoking is extremely high in schizophrenic patients: 80% to 90%, vs. 25% to 30% of the general population.  Various studies have demonstrated that the use of tobacco transiently restores the schizophrenic patient's cognitive and sensory deficits.  Smoking cessation also appears to exacerbate the symptoms of the disease.  Post-mortem binding studies have revealed a disturbance of nicotinic receptor expression, affecting the α7 and α4β2 subunits, in various cerebral areas.  Genetic linkage studies have also shown that the α7 subunit is involved in schizophrenia.  This review assesses the involvement of the nicotinic system in schizophrenia and suggests ways in which this system may participate in the pathophysiol. of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvoLWwOQISrVg90H21EOLACvtfcHk0lgNG2mNmsJbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVyktLk%253D&md5=23e174f0c6b1ccd4acbf0bb8ade6d530</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1185%2F030079904125004060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079904125004060%26sid%3Dliteratum%253Aachs%26aulast%3DRipoll%26aufirst%3DN.%26aulast%3DBronnec%26aufirst%3DM.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DNicotinic%2520Receptors%2520and%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2004%26volume%3D20%26spage%3D1057%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olincy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pender, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kongs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allensworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbe, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kem, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Proof-of-Concept Trial of an Alpha7 Nicotinic Agonist in Schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1001%2Farchpsyc.63.6.630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16754836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=630-638&author=A.+Olincyauthor=J.+G.+Harrisauthor=L.+L.+Johnsonauthor=V.+Penderauthor=S.+Kongsauthor=D.+Allensworthauthor=J.+Ellisauthor=G.+O.+Zerbeauthor=S.+Leonardauthor=K.+E.+Stevensauthor=J.+O.+Stevensauthor=L.+Martinauthor=L.+E.+Adlerauthor=F.+Sotiauthor=W.+R.+Kemauthor=R.+Freedman&title=Proof-of-Concept+Trial+of+an+Alpha7+Nicotinic+Agonist+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia</span></div><div class="casAuthors">Olincy, Ann; Harris, Josette G.; Johnson, Lynn L.; Pender, Vicki; Kongs, Susan; Allensworth, Diana; Ellis, Jamey; Zerbe, Gary O.; Leonard, Sherry; Stevens, Karen E.; Stevens, James O.; Martin, Laura; Adler, Lawrence E.; Soti, Ferenc; Kem, William R.; Freedman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">630-638</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor gene, CHRNA7, is assocd. with genetic transmission of schizophrenia and related cognitive and neurophysiol. sensory gating deficits.  Cognitive dysfunction is responsible for significant psychosocial disability in schizophrenia.  Nicotine, a low-potency agonist at the α7 receptor, has some pos. effects on neurophysiol. and neurocognitive deficits assocd. with schizophrenia, which suggests that more effective receptor activation might meaningfully enhance cognition in schizophrenia.  To det. if 3-[(2,4-dimethoxy) benzylidene]anabasine (DMXB-A), a natural alkaloid deriv. and a partial α7 nicotinic cholinergic agonist, significantly improves neurocognition, and to assess, by effects on P50 auditory evoked potential inhibition, whether its neurobiol. actions are consistent with activation of α7 nicotinic receptors.  Randomized, double-blind crossover trial of 2 drug doses and 1 placebo.  General clin. research center.  12 Persons with schizophrenia who did not smoke and were concurrently treated with antipsychotic drugs.  1 Person was withdrawn because of a transient decrease in white blood cell count.  Administration of DMXB-A.  Total scale score of the Repeatable Battery for the Assessment of Neuropsychol. Status and P50 inhibitory gating.  Significant neurocognitive improvement was found on the Repeatable Battery for the Assessment of Neuropsychol. Status total scale score, particularly for the lower DMXB-A dose compared with placebo.  Effects were greater than those of nicotine in a similar study.  Significant improvement in P50 inhibition also occurred.  Patients generally tolerated the drug well.  An α7 nicotinic agonist appears to have pos. effects on neurocognition in persons with schizophrenia.  Longer trials are needed to det. the clin. utility of this novel treatment strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNiy8qbdR6tbVg90H21EOLACvtfcHk0lgNG2mNmsJbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKgurc%253D&md5=f4589fdf1f448fc17063a182faf7eabf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.63.6.630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.63.6.630%26sid%3Dliteratum%253Aachs%26aulast%3DOlincy%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DL.%2BL.%26aulast%3DPender%26aufirst%3DV.%26aulast%3DKongs%26aufirst%3DS.%26aulast%3DAllensworth%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DZerbe%26aufirst%3DG.%2BO.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DK.%2BE.%26aulast%3DStevens%26aufirst%3DJ.%2BO.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DAdler%26aufirst%3DL.%2BE.%26aulast%3DSoti%26aufirst%3DF.%26aulast%3DKem%26aufirst%3DW.%2BR.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DProof-of-Concept%2520Trial%2520of%2520an%2520Alpha7%2520Nicotinic%2520Agonist%2520in%2520Schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2006%26volume%3D63%26spage%3D630%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kitagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesnes, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clody, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. L.</span><span> </span><span class="NLM_article-title">Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=542-551&author=H.+Kitagawaauthor=T.+Takenouchiauthor=R.+Azumaauthor=K.+A.+Wesnesauthor=W.+G.+Kramerauthor=D.+E.+Clodyauthor=A.+L.+Burnett&title=Safety%2C+Pharmacokinetics%2C+and+Effects+on+Cognitive+Function+of+Multiple+Doses+of+GTS-21+in+Healthy%2C+Male+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DH.%26aulast%3DTakenouchi%26aufirst%3DT.%26aulast%3DAzuma%26aufirst%3DR.%26aulast%3DWesnes%26aufirst%3DK.%2BA.%26aulast%3DKramer%26aufirst%3DW.%2BG.%26aulast%3DClody%26aufirst%3DD.%2BE.%26aulast%3DBurnett%26aufirst%3DA.%2BL.%26atitle%3DSafety%252C%2520Pharmacokinetics%252C%2520and%2520Effects%2520on%2520Cognitive%2520Function%2520of%2520Multiple%2520Doses%2520of%2520GTS-21%2520in%2520Healthy%252C%2520Male%2520Volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D542%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span>See Forum (formerly EnVivo) Pharmaceuticals Website: <a href="http://www.forumpharma.com/innovation-pipeline/a7-receptor-agonists.html" class="extLink">http://www.forumpharma.com/innovation-pipeline/a7-receptor-agonists.html</a>, accessed May 4, 2014.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Forum+%28formerly+EnVivo%29+Pharmaceuticals+Website%3A+http%3A%2F%2Fwww.forumpharma.com%2Finnovation-pipeline%2Fa7-receptor-agonists.html%2C+accessed+May+4%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gahring, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S. W.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptor Expression and Function on Nonneuronal Cells</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">E885</span><span class="NLM_x">–</span> <span class="NLM_lpage">E894</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=E885-E894&author=L.+C.+Gahringauthor=S.+W.+Rogers&title=Neuronal+Nicotinic+Acetylcholine+Receptor+Expression+and+Function+on+Nonneuronal+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGahring%26aufirst%3DL.%2BC.%26aulast%3DRogers%26aufirst%3DS.%2BW.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Expression%2520and%2520Function%2520on%2520Nonneuronal%2520Cells%26jtitle%3DAAPS%2520J.%26date%3D2006%26volume%3D7%26spage%3DE885%26epage%3DE894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayaraghavan, S.</span><span> </span><span class="NLM_article-title">Nicotinic Receptor Signaling in Nonexcitable Cells</span> <span class="citation_source-journal">J. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fneu.10114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12436417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Klsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=524-534&author=G.+Sharmaauthor=S.+Vijayaraghavan&title=Nicotinic+Receptor+Signaling+in+Nonexcitable+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor signaling in nonexcitable cells</span></div><div class="casAuthors">Sharma, Geeta; Vijayaraghavan, Sukumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-534</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The finding that neuronal nicotinic acetylcholine receptors (nAChRs) are present in non-neuronal cells both within and outside the nervous system raises some interesting issues.  The mechanisms underlying receptor signaling and its downstream consequences in these cells remain to be elucidated.  Factors controlling the release of acetylcholine and the extent of its diffusion are likely to be different for these cells than for traditional neuronal synapses.  Recent advances on the physiol. functions of some of these cell types have provided a better insight into possible functional roles for nAChRs in nonexcitable cells.  The presence of nAChRs on these cells also implies a broader scope for the actions of nicotine that needs to be considered from a clin. viewpoint.  Revealing the potential physiol. roles for nAChRs on nonexcitable cells is likely to provide a more complete understanding of cholinergic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-bxjyA9UnMLVg90H21EOLACvtfcHk0liAnJDCgEzJVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Klsb8%253D&md5=231fad2b31c4bb777de3cadc8227db76</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1002%2Fneu.10114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.10114%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DVijayaraghavan%26aufirst%3DS.%26atitle%3DNicotinic%2520Receptor%2520Signaling%2520in%2520Nonexcitable%2520Cells%26jtitle%3DJ.%2520Neurobiol.%26date%3D2002%26volume%3D53%26spage%3D524%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Receptors in Non-Neuronal Cells: New Modulators of Tobacco Toxicity?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0014-2999%2800%2900036-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10771024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFKjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2000&pages=279-294&author=B.+M.+Conti-Fineauthor=D.+Navaneethamauthor=S.+Leiauthor=A.+D.+J.+Maus&title=Neuronal+Nicotinic+Receptors+in+Non-Neuronal+Cells%3A+New+Modulators+of+Tobacco+Toxicity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?</span></div><div class="casAuthors">Conti-Fine, B. M.; Navaneetham, D.; Lei, S.; Maus, A. D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  The nicotinic acetylcholine receptors are prototypic ionotropic receptors that mediate fast synaptic transmission.  However, also non-excitable cells, and particularly the tegumental cells that line external and internal body surfaces, express acetylcholine receptors of neuronal type sensitive to nicotine.  Bronchial epithelial cells, endothelial cells of blood vessels, and skin keratinocytes express neuronal nicotinic receptors composed of α3, α5, β2, and β4 subunits, similar to those expressed in sympathetic ganglia, and neuronal nicotinic receptors composed of α7 subunits.  Neuronal nicotinic receptors in tegumental cells are involved in modulating cell shape and motility, and therefore in maintaining the integrity of the surfaces lined by those cells.  Neuronal nicotinic receptors in non-neuronal tissues may modulate other functions, including cell proliferation and differentiation.  Acetylcholine is synthesized, secreted, and degraded by a variety of cells, including the tegumental cells that express neuronal nicotinic receptors.  Thus, acetylcholine may function as a local hormone that is able to modulate cell functions that require fast adaptation to new conditions.  The presence of neuronal nicotinic receptors sensitive to nicotine in tissues known to be involved in tobacco toxicity, like bronchi and blood vessels, raises the possibility that they mediate some of the toxic effects of smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhBtISpa-YLVg90H21EOLACvtfcHk0lgw3JJEaK6ztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFKjs7c%253D&md5=66302d10e39477c6c18c284efffa651f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900036-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900036-4%26sid%3Dliteratum%253Aachs%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26atitle%3DNeuronal%2520Nicotinic%2520Receptors%2520in%2520Non-Neuronal%2520Cells%253A%2520New%2520Modulators%2520of%2520Tobacco%2520Toxicity%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D393%26spage%3D279%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wevers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maelicke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, H.</span><span> </span><span class="NLM_article-title">Expression of Alpha Subunit Genes of Nicotinic Acetylcholine Receptors in Human Lymphocytes</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1996&pages=171-174&author=C.+Hiemkeauthor=M.+Stolpauthor=S.+Reussauthor=A.+Weversauthor=S.+Reinhardtauthor=A.+Maelickeauthor=S.+Schlegelauthor=H.+Schroeder&title=Expression+of+Alpha+Subunit+Genes+of+Nicotinic+Acetylcholine+Receptors+in+Human+Lymphocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStolp%26aufirst%3DM.%26aulast%3DReuss%26aufirst%3DS.%26aulast%3DWevers%26aufirst%3DA.%26aulast%3DReinhardt%26aufirst%3DS.%26aulast%3DMaelicke%26aufirst%3DA.%26aulast%3DSchlegel%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DH.%26atitle%3DExpression%2520of%2520Alpha%2520Subunit%2520Genes%2520of%2520Nicotinic%2520Acetylcholine%2520Receptors%2520in%2520Human%2520Lymphocytes%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D214%26spage%3D171%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sato, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazuko, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, K.</span><span> </span><span class="NLM_article-title">Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1999&pages=17-20&author=K.+Z.+Satoauthor=T.+Fujiiauthor=Y.+Watanabeauthor=S.+Yamadaauthor=T.+Andoauthor=F.+Kazukoauthor=K.+Kawashima&title=Diversity+of+mRNA+Expression+for+Muscarinic+Acetylcholine+Receptor+Subtypes+and+Neuronal+Nicotinic+Acetylcholine+Receptor+Subunits+in+Human+Mononuclear+Leukocytes+and+Leukemic+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%2BZ.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DKazuko%26aufirst%3DF.%26aulast%3DKawashima%26aufirst%3DK.%26atitle%3DDiversity%2520of%2520mRNA%2520Expression%2520for%2520Muscarinic%2520Acetylcholine%2520Receptor%2520Subtypes%2520and%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Subunits%2520in%2520Human%2520Mononuclear%2520Leukocytes%2520and%2520Leukemic%2520Cell%2520Lines%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D266%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amella, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptor α7 Subunit is an Essential Regulator of Inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=384-388&author=H.+Wangauthor=M.+Yuauthor=M.+Ochaniauthor=C.+A.+Amellaauthor=M.+Tanovicauthor=S.+Susarlaauthor=J.+H.+Liauthor=H.+Wangauthor=H.+Yangauthor=L.+Ulloaauthor=Y.+Al-Abedauthor=C.+J.+Czuraauthor=K.+J.+Tracey&title=Nicotinic+Acetylcholine+Receptor+%CE%B17+Subunit+is+an+Essential+Regulator+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DAmella%26aufirst%3DC.%2BA.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DSusarla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptor%2520%25CE%25B17%2520Subunit%2520is%2520an%2520Essential%2520Regulator%2520of%2520Inflammation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D384%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Macklin, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human Vascular Endothelial Cells Express Functional Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9765366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVWjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=1998&pages=435-439&author=K.+D.+Macklinauthor=A.+D.+J.+Mausauthor=E.+F.+R.+Pereiraauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+Vascular+Endothelial+Cells+Express+Functional+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Human vascular endothelial cells express functional nicotinic acetylcholine receptors</span></div><div class="casAuthors">Macklin, Kevin D.; Maus, Arno D. J.; Pereira, Edna F. R.; Albuquerque, Edson X.; Conti-Fine, Bianca M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">435-439</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">ACh receptors sensitive to nicotine (nAChR) are present in human skin keratinocytes and in bronchial epithelial cells.  They are stimulated by ACh secreted by the same cells that express them, and they modulate cell motility and shape.  A variety of non-neuronal tissues, including endothelial cells, synthesize ACh, which raises the possibility that they are sensitive to nicotine.  We demonstrate here that endothelial cells that line blood vessels express functional nAChRs.  Their structure and ion-gating properties are similar to those of the nAChRs expressed by ganglionic neurons and by skin keratinocytes and bronchial epithelial cells.  In situ hybridization expts. using primary cultures of endothelial cells from human aorta demonstrated the presence in these cells of the subunits believed to contribute to ganglionic ACh receptors (AChRs) of the α3 subtype: α3, α5, β2 and β4.  Binding of radiolabeled epibatidine-a high-affinity specific ligand of certain neuronal AChRs, including the α3 subtypes-revealed the presence of approx. 900 specific binding sites per cell.  We assessed the presence of functional AChRs by patch-clamp expts.  Cultured human endothelial cells express ion channels that are opened by (+)-anatoxin-a and are blocked by dihydro-β-erythroidine.  These are specific agonist and antagonist, resp., of neuronal AChRs of the α3 subtype.  The ion-gating properties of the endothelial AChRs were similar to those of neuronal ganglionic AChRs.  The presence of AChRs sensitive to nicotine in endothelial cells may be related to the toxic effects of nicotine on the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jjBi9STJLrVg90H21EOLACvtfcHk0lgFeBRvwP6p0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVWjsrc%253D&md5=61f62a74b42c873c6042fc2c3ba1c12c</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacklin%26aufirst%3DK.%2BD.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520Vascular%2520Endothelial%2520Cells%2520Express%2520Functional%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D287%26spage%3D435%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karachunski, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macklin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human and Rodent Bronchial Epithelial Cells Express Functional Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=779-788&author=A.+D.+J.+Mausauthor=E.+F.+R.+Pereiraauthor=P.+I.+Karachunskiauthor=R.+M.+Hortonauthor=D.+Navaneethamauthor=K.+Macklinauthor=W.+S.+Cortesauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+and+Rodent+Bronchial+Epithelial+Cells+Express+Functional+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DKarachunski%26aufirst%3DP.%2BI.%26aulast%3DHorton%26aufirst%3DR.%2BM.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DMacklin%26aufirst%3DK.%26aulast%3DCortes%26aufirst%3DW.%2BS.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520and%2520Rodent%2520Bronchial%2520Epithelial%2520Cells%2520Express%2520Functional%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D779%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, A. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostlie, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaneetham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti-Fine, B. M.</span><span> </span><span class="NLM_article-title">Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1201-1209&author=Y.+Wangauthor=E.+F.+R.+Pereiraauthor=A.+D.+J.+Mausauthor=N.+S.+Ostlieauthor=D.+Navaneethamauthor=S.+Leiauthor=E.+X.+Albuquerqueauthor=B.+M.+Conti-Fine&title=Human+Bronchial+Epithelial+and+Endothelial+Cells+Express+%CE%B17+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPereira%26aufirst%3DE.%2BF.%2BR.%26aulast%3DMaus%26aufirst%3DA.%2BD.%2BJ.%26aulast%3DOstlie%26aufirst%3DN.%2BS.%26aulast%3DNavaneetham%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DS.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DConti-Fine%26aufirst%3DB.%2BM.%26atitle%3DHuman%2520Bronchial%2520Epithelial%2520and%2520Endothelial%2520Cells%2520Express%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Plummer, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuller, H. M.</span><span> </span><span class="NLM_article-title">Expression of the Alpha7 Nicotinic Acetylcholine Receptor in Human Lung Cells</span> <span class="citation_source-journal">Respir. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1186%2F1465-9921-6-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15807899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2M7pvVeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=29&author=H.+K.+Plummerauthor=M.+Dharauthor=H.+M.+Schuller&title=Expression+of+the+Alpha7+Nicotinic+Acetylcholine+Receptor+in+Human+Lung+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells</span></div><div class="casAuthors">Plummer Howard K 3rd; Dhar Madhu; Schuller Hildegard M</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We and others have shown that one of the mechanisms of growth regulation of small cell lung cancer cell lines and cultured pulmonary neuroendocrine cells is by the binding of agonists to the alpha7 neuronal nicotinic acetylcholine receptor.  In addition, we have shown that the nicotine-derived carcinogenic nitrosamine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is a high affinity agonist for the alpha7 nicotinic acetylcholine receptor.  In the present study, our goal was to determine the extent of alpha7 mRNA and protein expression in the human lung.  METHODS:  Experiments were done using reverse transcription polymerase chain reaction (RT-PCR), a nuclease protection assay and western blotting using membrane proteins.  RESULTS:  We detected mRNA for the neuronal nicotinic acetylcholine receptor alpha7 receptor in seven small cell lung cancer (SCLC) cell lines, in two pulmonary adenocarcinoma cell lines, in cultured normal human small airway epithelial cells (SAEC), one carcinoid cell line, three squamous cell lines and tissue samples from nine patients with various types of lung cancer.  A nuclease protection assay showed prominent levels of alpha7 in the NCI-H82 SCLC cell line while alpha7 was not detected in SAEC, suggesting that alpha7 mRNA levels may be higher in SCLC compared to normal cells.  Using a specific antibody to the alpha7 nicotinic receptor, protein expression of alpha7 was determined.  All SCLC cell lines except NCI-H187 expressed protein for the alpha7 receptor.  In the non-SCLC cells and normal cells that express the alpha7 nAChR mRNA, only in SAEC, A549 and NCI-H226 was expression of the alpha7 nicotinic receptor protein shown.  When NCI-H69 SCLC cell line was exposed to 100 pm NNK, protein expression of the alpha7 receptor was increased at 60 and 150 min.  CONCLUSION:  Expression of mRNA for the neuronal nicotinic acetylcholine receptor alpha7 seems to be ubiquitously expressed in all human lung cancer cell lines tested (except for NCI-H441) as well as normal lung cells.  The alpha7 nicotinic receptor protein is expressed in fewer cell lines, and the tobacco carcinogen NNK increases alpha7 nicotinic receptor protein levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPugvXjXbpPsSzjBFCN0BJfW6udTcc2eYbUCCNjClo2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7pvVeqsw%253D%253D&md5=37a6eee22b5bf0aa62020828773b4b97</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-6-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-6-29%26sid%3Dliteratum%253Aachs%26aulast%3DPlummer%26aufirst%3DH.%2BK.%26aulast%3DDhar%26aufirst%3DM.%26aulast%3DSchuller%26aufirst%3DH.%2BM.%26atitle%3DExpression%2520of%2520the%2520Alpha7%2520Nicotinic%2520Acetylcholine%2520Receptor%2520in%2520Human%2520Lung%2520Cells%26jtitle%3DRespir.%2520Res.%26date%3D2005%26volume%3D6%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amella, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">Nicotinic Acetylcholine Receptor α7 Subunit is an Essential Regulator of Inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=384-388&author=H.+Wangauthor=M.+Yuauthor=M.+Ochaniauthor=C.+A.+Amellaauthor=M.+Tanovicauthor=S.+Susarlaauthor=J.+H.+Liauthor=H.+Wangauthor=H.+Yangauthor=L.+Ulloaauthor=Y.+Al-Abedauthor=C.+J.+Czuraauthor=K.+J.+Tracey&title=Nicotinic+Acetylcholine+Receptor+%CE%B17+Subunit+is+an+Essential+Regulator+of+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOchani%26aufirst%3DM.%26aulast%3DAmella%26aufirst%3DC.%2BA.%26aulast%3DTanovic%26aufirst%3DM.%26aulast%3DSusarla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DUlloa%26aufirst%3DL.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DNicotinic%2520Acetylcholine%2520Receptor%2520%25CE%25B17%2520Subunit%2520is%2520an%2520Essential%2520Regulator%2520of%2520Inflammation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D384%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pavlov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czura, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14571320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlCksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=125-134&author=V.+A.+Pavlovauthor=H.+Wangauthor=C.+J.+Czuraauthor=S.+G.+Friedmanauthor=K.+J.+Tracey&title=The+Cholinergic+Anti-inflammatory+Pathway%3A+A+Missing+Link+in+Neuroimmunomodulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation</span></div><div class="casAuthors">Pavlov, Valentin A.; Wang, Hong; Czura, Christopher J.; Friedman, Steven G.; Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5-8</span>),
    <span class="NLM_cas:pages">125-134</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">North Shore-Long Island Jewish Research Institute</span>)
        </div><div class="casAbstract">A review.  This review outlines the mechanisms underlying the interaction between the nervous and immune systems of the host in response to an immune challenge.  The main focus is the cholinergic anti-inflammatory pathway, which we recently described as a novel function of the efferent vagus nerve.  This pathway plays a crit. role in controlling the inflammatory response through interaction with peripheral α7 subunit-contg. nicotinic acetylcholine receptors expressed on macrophages.  We describe the modulation of systemic and local inflammation by the cholinergic anti-inflammatory pathway and its function as an interface between the brain and the immune system.  The clin. implications of this novel mechanism also are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMRtAr1my92bVg90H21EOLACvtfcHk0lg_rlAfmeC4Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlCksr4%253D&md5=18c41ff029ff7891365eb48a4ae0f75f</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPavlov%26aufirst%3DV.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCzura%26aufirst%3DC.%2BJ.%26aulast%3DFriedman%26aufirst%3DS.%2BG.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Anti-inflammatory%2520Pathway%253A%2520A%2520Missing%2520Link%2520in%2520Neuroimmunomodulation%26jtitle%3DMol.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D125%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For reviews, see:</p></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">de Jonge, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulloa, L.</span><span> </span><span class="NLM_article-title">The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fsj.bjp.0707264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=17502850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1yls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=915-929&author=W.+J.+de+Jongeauthor=L.+Ulloa&title=The+alpha7+nicotinic+acetylcholine+receptor+as+a+pharmacological+target+for+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation</span></div><div class="casAuthors">de Jonge, W. J.; Ulloa, L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-929</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The physiol. regulation of the immune system encompasses comprehensive anti-inflammatory mechanisms that can be harnessed for the treatment of infectious and inflammatory disorders.  Recent studies indicate that the vagal nerve, involved in control of heart rate, hormone secretion and gastrointestinal motility, is also an immunomodulator.  In exptl. models of inflammatory diseases, vagal nerve stimulation attenuates the prodn. of proinflammatory cytokines and inhibits the inflammatory process.  Acetylcholine, the principal neurotransmitter of the vagal nerve, controls immune cell functions via the alpha7 nicotinic acetylcholine receptor (alpha7nAChR).  From a pharmacol. perspective, nicotinic agonists are more efficient than acetylcholine at inhibiting the inflammatory signaling and the prodn. of proinflammatory cytokines.  This 'nicotinic anti-inflammatory pathway' may have clin. implications as treatment with nicotinic agonists can modulate the prodn. of proinflammatory cytokines from immune cells.  Nicotine has been tested in clin. trials as a treatment for inflammatory diseases such as ulcerative colitis, but the therapeutic potential of this mechanism is limited by the collateral toxicity of nicotine.  Here, we review the recent advances that support the design of more specific receptor-selective nicotinic agonists that have anti-inflammatory effects while eluding its collateral toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLuWY2-j_xbVg90H21EOLACvtfcHk0lg_rlAfmeC4Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1yls70%253D&md5=fc0c155afc3dccd06c539314721b77cd</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707264%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJonge%26aufirst%3DW.%2BJ.%26aulast%3DUlloa%26aufirst%3DL.%26atitle%3DThe%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520as%2520a%2520pharmacological%2520target%2520for%2520inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D915%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tracey, K. J.</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fnri2566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19461672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1SktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tracey%2C+K.+J.Nature+Rev.+Immunol.+2009%2C+9%2C+418%E2%80%93428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Reflex control of immunity</span></div><div class="casAuthors">Tracey, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">418-428</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammation can cause damage and even death.  What controls this primitive and potentially lethal innate immune response to injury and infection.  Mol. and neurophysiol. studies during the past decade have revealed a pivotal answer: immunity is coordinated by neural circuits that operate reflexively.  The afferent arc of the reflex consists of nerves that sense injury and infection.  This activates efferent neural circuits, including the cholinergic anti-inflammatory pathway, that modulate immune responses and the progression of inflammatory diseases.  It might be possible to develop therapeutics that target neural networks for the treatment of inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRGUQHObttSLVg90H21EOLACvtfcHk0lgaFO9xNCXSQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1SktLk%253D&md5=61820f359748be5534a3a21dc640387e</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1038%2Fnri2566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2566%26sid%3Dliteratum%253Aachs%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D418%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hamano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwagaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishibori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span> </span><span class="NLM_article-title">Stimulation of α7 Nicotinic Acetylcholine Receptor Inhibits CD14 and the Toll-Like Receptor 4 Expression in Human Monocytes</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=358-364&author=R.+Hamanoauthor=H.+K.+Takahashiauthor=H.+Iwagakiauthor=T.+Yoshinoauthor=M.+Nishiboriauthor=N.+Tanaka&title=Stimulation+of+%CE%B17+Nicotinic+Acetylcholine+Receptor+Inhibits+CD14+and+the+Toll-Like+Receptor+4+Expression+in+Human+Monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamano%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%2BK.%26aulast%3DIwagaki%26aufirst%3DH.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DNishibori%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DN.%26atitle%3DStimulation%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Inhibits%2520CD14%2520and%2520the%2520Toll-Like%2520Receptor%25204%2520Expression%2520in%2520Human%2520Monocytes%26jtitle%3DShock%26date%3D2006%26volume%3D26%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">van Westerloo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giebelen, I. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florquin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daalhuisen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span> </span><span class="NLM_article-title">The Cholinergic Anti-inflammatory Pathway Regulates the Host Response During Septic Peritonitis</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">2138</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1086%2F430323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=15898001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFShs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=2138-2148&author=D.+J.+van+Westerlooauthor=I.+A.+J.+Giebelenauthor=S.+Florquinauthor=J.+Daalhuisenauthor=M.+J.+Brunoauthor=A.+F.+de+Vosauthor=K.+J.+Traceyauthor=T.+van+der+Poll&title=The+Cholinergic+Anti-inflammatory+Pathway+Regulates+the+Host+Response+During+Septic+Peritonitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis</span></div><div class="casAuthors">van Westerloo, David J.; Giebelen, Ilona A. J.; Florquin, Sandrine; Daalhuisen, Joost; Bruno, Marco J.; de Vos, Alex F.; Tracey, Kevin J.; van der Poll, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2138-2148</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background. The nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of tumor necrosis factor-α by endotoxin-stimulated macrophages.  This anti-inflammatory effect is mediated by an interaction between acetylcholine, the principal neurotransmitter of the vagus nerve, and cholinergic nicotinic acetylcholine receptors on macrophages.  Methods. the authors detd. the role of this "cholinergic anti-inflammatory pathway" during septic peritonitis induced in mice by i.p. injection of live Escherichia coli.  Septic peritonitis was preceded by inhibition of the cholinergic anti-inflammatory pathway by unilateral cervical vagotomy, by stimulation of this pathway by pretreatment of mice with nicotine, or by a combination of both interventions.  Results. Initial cytokine release during septic peritonitis was enhanced after previous vagotomy and was decreased after nicotine pretreatment, independently of the integrity of the vagus nerve.  Further study established that vagotomy before septic peritonitis resulted in an enhanced influx of neutrophils and a marked increase in proinflammatory cytokine levels and liver damage.  Conversely, nicotine pretreatment strongly decreased cell influx, proinflammatory cytokine levels, and liver damage, whereas bacterial clearance and survival were impaired.  Discussion. These data provide the first evidence, to the authors' knowledge, of an important role of the vagus nerve in regulating the innate immune response to a severe bacterial infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUlPngRpk2IbVg90H21EOLACvtfcHk0lgaFO9xNCXSQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFShs78%253D&md5=44a9d81735c0f20f475444ab5057c28c</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1086%2F430323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430323%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWesterloo%26aufirst%3DD.%2BJ.%26aulast%3DGiebelen%26aufirst%3DI.%2BA.%2BJ.%26aulast%3DFlorquin%26aufirst%3DS.%26aulast%3DDaalhuisen%26aufirst%3DJ.%26aulast%3DBruno%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BF.%26aulast%3DTracey%26aufirst%3DK.%2BJ.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26atitle%3DThe%2520Cholinergic%2520Anti-inflammatory%2520Pathway%2520Regulates%2520the%2520Host%2520Response%2520During%2520Septic%2520Peritonitis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D191%26spage%3D2138%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">de Jonge, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Zanden, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijlsma, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Westerloo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennink, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthoud, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uematsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Wijngaard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckxstaens, G. E.</span><span> </span><span class="NLM_article-title">Stimulation of the Vagus Nerve Attenuates Macrophage Activation by Activating the Jak2-STAT3 Signaling Pathway</span> <span class="citation_source-journal">Nature Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fni1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16025117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlSisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=844-851&author=W.+J.+de+Jongeauthor=E.+P.+van+der+Zandenauthor=F.+O.+Theauthor=M.+F.+Bijlsmaauthor=D.+J.+van+Westerlooauthor=R.+J.+Benninkauthor=H.-R.+Berthoudauthor=S.+Uematsuauthor=S.+Akiraauthor=R.+M.+van+den+Wijngaardauthor=G.+E.+Boeckxstaens&title=Stimulation+of+the+Vagus+Nerve+Attenuates+Macrophage+Activation+by+Activating+the+Jak2-STAT3+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway</span></div><div class="casAuthors">de Jonge, Wouter J.; van der Zanden, Esmerij P.; The, Frans O.; Bijlsma, Maarten F.; van Westerloo, David J.; Bennink, Roelof J.; Berthoud, Hans-Rudolf; Uematsu, Satoshi; Akira, Shizuo; van den Wijngaard, Rene M.; Boeckxstaens, Guy E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">844-851</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acetylcholine released by efferent vagus nerves inhibits macrophage activation.  Here the authors show that the anti-inflammatory action of nicotinic receptor activation in peritoneal macrophages was assocd. with activation of the transcription factor STAT3.  STAT3 was phosphorylated by the tyrosine kinase Jak2 that was recruited to the α7 subunit of the nicotinic acetylcholine receptor.  The anti-inflammatory effect of nicotine required the ability of phosphorylated STAT3 to bind and transactivate its DNA response elements.  In a mouse model of intestinal manipulation, stimulation of the vagus nerve ameliorated surgery-induced inflammation and postoperative ileus by activating STAT3 in intestinal macrophages.  The authors conclude that the vagal anti-inflammatory pathway acts by α7 subunit-mediated Jak2-STAT3 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR6EEpsubzdLVg90H21EOLACvtfcHk0lgGJTTAJ36vIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlSisb8%253D&md5=59cf7f4cb261379f4e163e3ceab88c6e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fni1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1229%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJonge%26aufirst%3DW.%2BJ.%26aulast%3Dvan%2Bder%2BZanden%26aufirst%3DE.%2BP.%26aulast%3DThe%26aufirst%3DF.%2BO.%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3Dvan%2BWesterloo%26aufirst%3DD.%2BJ.%26aulast%3DBennink%26aufirst%3DR.%2BJ.%26aulast%3DBerthoud%26aufirst%3DH.-R.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3Dvan%2Bden%2BWijngaard%26aufirst%3DR.%2BM.%26aulast%3DBoeckxstaens%26aufirst%3DG.%2BE.%26atitle%3DStimulation%2520of%2520the%2520Vagus%2520Nerve%2520Attenuates%2520Macrophage%2520Activation%2520by%2520Activating%2520the%2520Jak2-STAT3%2520Signaling%2520Pathway%26jtitle%3DNature%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D844%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Birtwistle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, K.</span><span> </span><span class="NLM_article-title">Does Nicotine Have Beneficial Effects in the Treatment of Certain Diseases?</span> <span class="citation_source-journal">Br. J. Nurs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9006184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADyaK2s7lvVyhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=1195-1202&author=J.+Birtwistleauthor=K.+Hall&title=Does+Nicotine+Have+Beneficial+Effects+in+the+Treatment+of+Certain+Diseases%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Does nicotine have beneficial effects in the treatment of certain diseases?</span></div><div class="casAuthors">Birtwistle J; Hall K</div><div class="citationInfo"><span class="NLM_cas:title">British journal of nursing (Mark Allen Publishing)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1195-202</span>
        ISSN:<span class="NLM_cas:issn">0966-0461</span>.
    </div><div class="casAbstract">Although tobacco smoking has long been associated with diseases of the lungs and cardiovascular system, numerous studies have demonstrated a negative association between tobacco smoking and ulcerative colitis, and the neurodegenerative diseases, Alzheimer's disease (AD) and Parkinson's disease (PD).  The evidence suggests that nicotine--the main pharmacologically active ingredient of tobacco--appears to be responsible for this effect.  Pure nicotine has no known carcinogenic properties and can be administered in numerous ways including transdermal patches and tablets.  As a therapeutic agent, its association with tobacco can be likened to morphine and opium smoking.  There is ample clinical evidence to suggest that nicotine could be beneficial in the treatment of some patients with diseases.  Pharmacologically, nicotine acts on cholinergic (nicotinic-specific) receptors which are depleted in AD and PD.  Nicotinic receptors also interact closely with several neurotransmitters including dopamine, which is implicated in both PD and Gilles de la Tourettes's syndrome.  There is no doubt that tobacco smoking can be harmful and no-one should be encouraged to smoke.  However, although nicotine has many harmful side-effects, it may have therapeutic value or at the very least be a useful tool for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYgUrsouWemxcr74wzj5o5fW6udTcc2eaaLYlQFDuYEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7lvVyhtA%253D%253D&md5=723f7a054eab2c62e6890bed4a976764</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirtwistle%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DK.%26atitle%3DDoes%2520Nicotine%2520Have%2520Beneficial%2520Effects%2520in%2520the%2520Treatment%2520of%2520Certain%2520Diseases%253F%26jtitle%3DBr.%2520J.%2520Nurs.%26date%3D1996%26volume%3D5%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rubin, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span> </span><span class="NLM_article-title">Smoking and Inflammatory Bowel Disease</span> <span class="citation_source-journal">Eur. J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1097%2F00042737-200012080-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10958212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FlsFCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=855-862&author=D.+T.+Rubinauthor=S.+B.+Hanauer&title=Smoking+and+Inflammatory+Bowel+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking and inflammatory bowel disease</span></div><div class="casAuthors">Rubin D T; Hanauer S B</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-62</span>
        ISSN:<span class="NLM_cas:issn">0954-691X</span>.
    </div><div class="casAbstract">It is well established that smoking cigarettes is associated with Crohn's disease (CD) and that non-smoking is associated with ulcerative colitis (UC).  Furthermore, there is convincing evidence that smoking cigarettes has a negative effect on the course of CD, and that smoking cigarettes may improve the disease severity or have a 'protective' effect in some patients with UC.  Despite these well-described associations, the mechanism by which cigarette smoking affects CD and UC is not known.  Researchers have studied the systemic effects, cellular and humoral immune effects, mucosal changes, and the intestinal permeability changes with inflammatory bowel disease (IBD) and smoking.  To date, none of these studies adequately explains the observed clinical patterns.  It has been assumed that nicotine is the active agent in these associations, but clinical trials of nicotine chewing gum and transdermal nicotine in UC have shown limited benefit, and have been complicated by significant side-effects.  Topical delivery systems for nicotine therapy are currently under development and await future clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRpsY2CvPbfRgd2Wuil24tfW6udTcc2eaaLYlQFDuYEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FlsFCltw%253D%253D&md5=833eb3fc739914b49feda1439cf63e15</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1097%2F00042737-200012080-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00042737-200012080-00004%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DD.%2BT.%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26atitle%3DSmoking%2520and%2520Inflammatory%2520Bowel%2520Disease%26jtitle%3DEur.%2520J.%2520Gastroenterol.%2520Hepatol.%26date%3D2000%26volume%3D12%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wolf, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashner, B. A.</span><span> </span><span class="NLM_article-title">Inflammatory Bowel Disease: Sorting Out the Treatment Options</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span><div class="note"><p class="first last">and 629–631.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.3949%2Fccjm.69.8.621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12184470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD38vislOnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2002&pages=621-626&author=J.+M.+Wolfauthor=B.+A.+Lashner&title=Inflammatory+Bowel+Disease%3A+Sorting+Out+the+Treatment+Options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease: sorting out the treatment options</span></div><div class="casAuthors">Wolf Jason M; Lashner Bret A</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">621-6, 629-31</span>
        ISSN:<span class="NLM_cas:issn">0891-1150</span>.
    </div><div class="casAbstract">An increasing array of treatments such as immunosuppressive drugs and tumor necrosis factor inhibitors can offer patients with ulcerative colitis and Crohn disease improved relief from symptoms with fewer adverse effects.  Several additional drugs have shown promise, including nicotine, antimicrobials, and heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQvGKtVttfRzslzEEsg76ufW6udTcc2eZrUaNiK3iylbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vislOnug%253D%253D&md5=e3c9d17fae9937053398085ef92fe919</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.3949%2Fccjm.69.8.621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.69.8.621%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DJ.%2BM.%26aulast%3DLashner%26aufirst%3DB.%2BA.%26atitle%3DInflammatory%2520Bowel%2520Disease%253A%2520Sorting%2520Out%2520the%2520Treatment%2520Options%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2002%26volume%3D69%26spage%3D621%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guinet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouri-Shirazi, M.</span><span> </span><span class="NLM_article-title">Nicotinic Environment Affects the Differentiation and Functional Maturation of Monocytes Derived Dendritic Cells (DCs)</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=45-55&author=E.+Guinetauthor=K.+Yoshidaauthor=M.+Nouri-Shirazi&title=Nicotinic+Environment+Affects+the+Differentiation+and+Functional+Maturation+of+Monocytes+Derived+Dendritic+Cells+%28DCs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuinet%26aufirst%3DE.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DNouri-Shirazi%26aufirst%3DM.%26atitle%3DNicotinic%2520Environment%2520Affects%2520the%2520Differentiation%2520and%2520Functional%2520Maturation%2520of%2520Monocytes%2520Derived%2520Dendritic%2520Cells%2520%2528DCs%2529%26jtitle%3DImmunol.%2520Lett.%26date%3D2004%26volume%3D95%26spage%3D45%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patton, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pross, S.</span><span> </span><span class="NLM_article-title">Nicotine Modulation of Cytokine Induction by LPS-Stimulated Human Monocytes and Coronary Artery Endothelial Cells</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.intimp.2005.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16332510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD2MnltFCnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=26-35&author=G.+W.+Pattonauthor=D.+A.+Powellauthor=A.+Hakkiauthor=H.+Friedmanauthor=S.+Pross&title=Nicotine+Modulation+of+Cytokine+Induction+by+LPS-Stimulated+Human+Monocytes+and+Coronary+Artery+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells</span></div><div class="casAuthors">Patton G W; Powell D A; Hakki A; Friedman H; Pross S</div><div class="citationInfo"><span class="NLM_cas:title">International immunopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    </div><div class="casAbstract">Nicotine, the major addictive component of tobacco, is an immunomodulator that impacts on many cells, including immune cells involved in inflammatory processes.  Nicotine also induces oxidative damage to the vascular endothelium and accentuates lipid peroxidation, resulting in vascular cell dysfunction.  Furthermore, vascular endothelial cells produce growth factors, such as cytokines and chemokines capable of stimulating and recruiting immune cells to atheromatous lesions.  In addition, bacterial products including lipopolysaccharides (LPS), a major component of Gram negative bacterial cell walls, activate gene expression resulting in inflammatory cytokine production causing further damage to the vasculature.  In the present study, the combined effects of nicotine and bacterial LPS on the expression of IL-6, IL-8, GRO-alpha and MCP-1 in cell lines of human coronary artery endothelial cells (HCAEC) and pulmonary monocytes (THP-1) were examined by quantitative real-time PCR and ELISA.  Results showed that nicotine suppressed the LPS induced production of IL-6 and IL-8 in both cell lines.  Since cytokines which alter homeostasis of both vascular endothelial and immune cells are critical for the atherogenic process, further studies are warranted to examine in detail the role of nicotine in terms of effects on inflammatory reactions, including those induced by bacterial infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaTQKW9iBlq8-crCu0nI_sfW6udTcc2ebNzQI3qQjTULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnltFCnsw%253D%253D&md5=29fcb24d379703ee391539d3af5385e4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2005.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2005.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DPatton%26aufirst%3DG.%2BW.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DHakki%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DPross%26aufirst%3DS.%26atitle%3DNicotine%2520Modulation%2520of%2520Cytokine%2520Induction%2520by%2520LPS-Stimulated%2520Human%2520Monocytes%2520and%2520Coronary%2520Artery%2520Endothelial%2520Cells%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2006%26volume%3D6%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mannino, D. M.</span><span> </span><span class="NLM_article-title">Chronic Obstructive Pulmonary Disease: Definition and Epidemiology</span> <span class="citation_source-journal">Respir. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1185</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14651759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADC%252BD3srntFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=1185-1191&author=D.+M.+Mannino&title=Chronic+Obstructive+Pulmonary+Disease%3A+Definition+and+Epidemiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic obstructive pulmonary disease: definition and epidemiology</span></div><div class="casAuthors">Mannino David M</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory care</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1185-91; discussion 1191-3</span>
        ISSN:<span class="NLM_cas:issn">0020-1324</span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) continues to cause a heavy health and economic burden in the United States and around the world.  Some of the risk factors for COPD are well known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions remain, such as why < 20% of smokers develop substantial airway obstruction.  There are several different definitions of COPD and the definitions depend on accurate diagnosis.  Small differences in the definition can have large effects on the estimates of COPD in the population.  In addition, newer measures, such as functional status or exercise capability, have emerged as important in determining the prognosis of COPD patients.  Furthermore, evidence continues to emerge that COPD represents several different disease processes, with potentially different interventions required.  In most of the world COPD prevalence and mortality are still increasing and will probably continue to rise in response to increases in smoking, particularly by women and adolescents.  Resources aimed at smoking cessation and prevention, COPD education, early detection, and better treatment will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcrpDbsElJIFWTCLT8lX9SfW6udTcc2ebNzQI3qQjTULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srntFOrsw%253D%253D&md5=84767538c0f22eb6c2da165cace04148</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMannino%26aufirst%3DD.%2BM.%26atitle%3DChronic%2520Obstructive%2520Pulmonary%2520Disease%253A%2520Definition%2520and%2520Epidemiology%26jtitle%3DRespir.%2520Care%26date%3D2003%26volume%3D48%26spage%3D1185%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sopori, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, M. J.</span><span> </span><span class="NLM_article-title">Nicotine-Induced Modulation of T-Cell Function: Implications for Inflammation and Infection</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=1998&pages=279-289&author=M.+L.+Soporiauthor=W.+Kozakauthor=S.+M.+Savageauthor=Y.+Gengauthor=M.+J.+Kluger&title=Nicotine-Induced+Modulation+of+T-Cell+Function%3A+Implications+for+Inflammation+and+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSopori%26aufirst%3DM.%2BL.%26aulast%3DKozak%26aufirst%3DW.%26aulast%3DSavage%26aufirst%3DS.%2BM.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DKluger%26aufirst%3DM.%2BJ.%26atitle%3DNicotine-Induced%2520Modulation%2520of%2520T-Cell%2520Function%253A%2520Implications%2520for%2520Inflammation%2520and%2520Infection%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D437%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sopori, M.</span><span> </span><span class="NLM_article-title">Effects of Cigarette Smoke on the Immune System</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1038%2Fnri803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12033743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2rs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=372-377&author=M.+Sopori&title=Effects+of+Cigarette+Smoke+on+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of cigarette smoke on the immune system</span></div><div class="casAuthors">Sopori, Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Although the health risks of tobacco smoking are well documented, there is increasing evidence that smokers have a lower incidence of some inflammatory and neurodegenerative diseases.  Many of the adverse and beneficial effects of smoking might result from the ability of cigarette smoke to suppress the immune system.  Nicotine, which is one of the main constituents of cigarette smoke, suppresses the immune system but might have therapeutic potential as a neuroprotective and anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_FwtswO3hbVg90H21EOLACvtfcHk0li1-2CVC6Y1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2rs7o%253D&md5=19a3e65f577022460d7e8530c749012a</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1038%2Fnri803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri803%26sid%3Dliteratum%253Aachs%26aulast%3DSopori%26aufirst%3DM.%26atitle%3DEffects%2520of%2520Cigarette%2520Smoke%2520on%2520the%2520Immune%2520System%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D2%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Floto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. G.</span><span> </span><span class="NLM_article-title">The Vagus Nerve, Macrophages, and Nicotine</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=1069-1070&author=R.+A.+Flotoauthor=K.+G.+Smith&title=The+Vagus+Nerve%2C+Macrophages%2C+and+Nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFloto%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BG.%26atitle%3DThe%2520Vagus%2520Nerve%252C%2520Macrophages%252C%2520and%2520Nicotine%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26spage%3D1069%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampognaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zongrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a Conformationally Restricted Analog of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000249r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4045-4050&author=G.+Mullenauthor=J.+Napierauthor=M.+Balestraauthor=T.+DeCoryauthor=G.+Haleauthor=J.+Macorauthor=R.+Mackauthor=J.+Lochauthor=E.+Wuauthor=A.+Koverauthor=P.+Verhoestauthor=A.+Sampognaroauthor=E.+Phillipsauthor=Y.+Zhuauthor=R.+Murrayauthor=R.+Griffithauthor=J.+Blosserauthor=D.+Gurleyauthor=A.+Machulskisauthor=J.+Zongroneauthor=A.+Rosenauthor=J.+Gordon&title=%28%E2%88%92%29-Spiro%5B1-azabicyclo%5B2.2.2%5Doctane-3%2C5%E2%80%B2-oxazolidin-2%E2%80%B2-one%5D%2C+a+Conformationally+Restricted+Analog+of+Acetylcholine%2C+Is+a+Highly+Selective+Full+Agonist+at+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm000249r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000249r%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DNapier%26aufirst%3DJ.%26aulast%3DBalestra%26aufirst%3DM.%26aulast%3DDeCory%26aufirst%3DT.%26aulast%3DHale%26aufirst%3DG.%26aulast%3DMacor%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSampognaro%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DR.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DMachulskis%26aufirst%3DA.%26aulast%3DZongrone%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529-Spiro%255B1-azabicyclo%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin-2%25E2%2580%25B2-one%255D%252C%2520a%2520Conformationally%2520Restricted%2520Analog%2520of%2520Acetylcholine%252C%2520Is%2520a%2520Highly%2520Selective%2520Full%2520Agonist%2520at%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4045%26epage%3D4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Van Maanen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoordeldonk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span> </span><span class="NLM_article-title">Stimulation of Nicotinic Acetylcholine Receptors Attenuates Collagen-Induced Arthritis in Mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fart.24177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19116908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=114-122&author=M.+A.+Van+Maanenauthor=M.+C.+Liebreauthor=T.+van+der+Pollauthor=G.+J.+La+Rosaauthor=D.+Elbaumauthor=M.+J.+Vervoordeldonkauthor=P.+P.+Tak&title=Stimulation+of+Nicotinic+Acetylcholine+Receptors+Attenuates+Collagen-Induced+Arthritis+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span></div><div class="casAuthors">van Maanen, Marjolein A.; Lebre, Maria C.; van der Poll, Tom; La Rosa, Gregory J.; Elbaum, Daniel; Vervoordeldonk, Margriet J.; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The parasympathetic nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of cytokines, including tumor necrosis factor α (TNFα), by activated macrophages.  The vagus nerve may exert antiinflammatory actions via a specific effect of its principal neurotransmitter, acetylcholine, on the α7 subunit of nicotinic acetylcholine receptors (α7nAChR) on macrophages.  The present study was undertaken to obtain insight into the role of the cholinergic antiinflammatory pathway in arthritis.  To inhibit the cholinergic antiinflammatory pathway, mice were subjected to unilateral cervical vagotomy or sham surgery, after which arthritis was induced with type II collagen.  In a sep. study, nicotine was added to the drinking water of mice with collagen-induced arthritis (CIA).  In addn., we investigated the effects of i.p. (IP)-injected nicotine and the specific α7nAChR agonist AR-R17779.  Clin. arthritis was exacerbated by vagotomy and ameliorated by oral nicotine administration.  Moreover, oral nicotine inhibited bone degrdn. and reduced TNFα expression in synovial tissue.  Both IP-injected nicotine and AR-R17779 ameliorated clin. arthritis and reduced synovial inflammation.  This was accompanied by a redn. of TNFα levels in both plasma and synovial tissue.  The effect of AR-R17779 was more potent compared with that of nicotine and was assocd. with delayed onset of the disease as well as with protection against joint destruction.  These data provide the first evidence of a role of the cholinergic antiinflammatory pathway in the murine CIA model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3s5iC-YbxFLVg90H21EOLACvtfcHk0liOog9VN49jrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D&md5=409abcd4db452578bab75b9a62cf2b04</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fart.24177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24177%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMaanen%26aufirst%3DM.%2BA.%26aulast%3DLiebre%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DLa%2BRosa%26aufirst%3DG.%2BJ.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DVervoordeldonk%26aufirst%3DM.%2BJ.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DStimulation%2520of%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Attenuates%2520Collagen-Induced%2520Arthritis%2520in%2520Mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompe, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordinou de Gouberville, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Hoeven, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoedemaekers, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickkers, P.</span><span> </span><span class="NLM_article-title">Effects if the α7 Nicotinic Acetylcholine Receptor Agonist GTS-21 on the Innate Immune Response in Humans</span> <span class="citation_source-journal">Shock</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=5-11&author=M.+Koxauthor=J.+C.+Pompeauthor=M.+C.+Gordinou+de+Goubervilleauthor=J.+G.+van+der+Hoevenauthor=C.+W.+Hoedemaekersauthor=P.+Pickkers&title=Effects+if+the+%CE%B17+Nicotinic+Acetylcholine+Receptor+Agonist+GTS-21+on+the+Innate+Immune+Response+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKox%26aufirst%3DM.%26aulast%3DPompe%26aufirst%3DJ.%2BC.%26aulast%3DGordinou%2Bde%2BGouberville%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BHoeven%26aufirst%3DJ.%2BG.%26aulast%3DHoedemaekers%26aufirst%3DC.%2BW.%26aulast%3DPickkers%26aufirst%3DP.%26atitle%3DEffects%2520if%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonist%2520GTS-21%2520on%2520the%2520Innate%2520Immune%2520Response%2520in%2520Humans%26jtitle%3DShock%26date%3D2011%26volume%3D36%26spage%3D5%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span>Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of TC-6987; <span class="NLM_publisher-name">Targacept</span>: <span class="NLM_publisher-loc">Winston-Salem, NC</span>, <span class="NLM_month">March</span><span class="NLM_day">27</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.targacept.com/newsroom/index.cfm?nid=Targacept%20Announces%20Top%2DLine%20Results%20from%20Two%20Exploratory%20Phase%202%20Studies%20of%20TC%2D6987&amp;newsyear=2012" class="extLink">http://www.targacept.com/newsroom/index.cfm?nid=Targacept%20Announces%20Top%2DLine%20Results%20from%20Two%20Exploratory%20Phase%202%20Studies%20of%20TC%2D6987&newsyear=2012</a>, accessed October 6, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Targacept+Announces+Top-Line+Results+from+Two+Exploratory+Phase+2+Studies+of+TC-6987%3B+Targacept%3A+Winston-Salem%2C+NC%2C+March27%2C+2012%3B+http%3A%2F%2Fwww.targacept.com%2Fnewsroom%2Findex.cfm%3Fnid%3DTargacept%2520Announces%2520Top%252DLine%2520Results%2520from%2520Two%2520Exploratory%2520Phase%25202%2520Studies%2520of%2520TC%252D6987%26newsyear%3D2012%2C+accessed+October+6%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTargacept%2520Announces%2520Top-Line%2520Results%2520from%2520Two%2520Exploratory%2520Phase%25202%2520Studies%2520of%2520TC-6987%26pub%3DTargacept%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speake, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yohannes, D.</span><span> </span><span class="NLM_article-title">Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7943</span><span class="NLM_x">–</span> <span class="NLM_lpage">7961</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007672" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7943-7961&author=A.+Mazurovauthor=J.+D.+Speakeauthor=D.+Yohannes&title=Discovery+and+Development+of+%CE%B17+Nicotinic+Acetylcholine+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm2007672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007672%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DSpeake%26aufirst%3DJ.%2BD.%26aulast%3DYohannes%26aufirst%3DD.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7943%26epage%3D7961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. H.</span><span> </span><span class="NLM_article-title">Selective α7 Nicotinic Acetylcholine Receptor Ligands</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F092986706777442011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16787204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1567-1584&author=A.+Mazurovauthor=T.+Hauserauthor=C.+H.+Miller&title=Selective+%CE%B17+Nicotinic+Acetylcholine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective α7 nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Mazurov, Anatoly; Hauser, Terry; Miller, Craig H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1567-1584</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand gated ion channels of broad distribution and structural heterogeneity.  Their functional diversity demonstrated involvement in a variety of neuronal processes (e.g., sensory gating and cognitive function) and generated great interest in them as targets for therapeutic intervention in a no. of neuropathol. conditions and diseases.  In order to control distinct nicotinic functions pharmacol., it is important to design ligands that selectively interact with distinct receptor subtypes in such a way as to maximize the therapeutic effect and minimize the adverse effects.  The α7 nAChR, a CNS subtype, has been the most intensively studied nAChR in recent years.  Selective α7 nAChR agonists have been developed as potential candidates for the treatment of schizophrenia, cognitive disorders (including Alzheimer's disease), and inflammation.  Despite early concerns that the rapid desensitization property of the α7 nAChR would limit their therapeutic potential, several have already been advanced to clin. trials (e.g., PH-399733, Pfizer; MEM 3454, Memory Pharmaceuticals/Roche).  Further development of allosteric modulators and pharmaceutically relevant antagonists might expand the therapeutic potential of compds. that target α7 nAChRs.  In this review we briefly describe the structure and function of the α7 nAChR and its in vitro and in vivo pharmacol., discuss the clin. relevance of these efforts, and review the current progress in α7 ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDkem3VpTTzrVg90H21EOLACvtfcHk0lg74EpLzRdaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D&md5=a7ce411b57d1e7b704bdce077563eea3</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.2174%2F092986706777442011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777442011%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1567%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljefors, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span> </span><span class="NLM_article-title">Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic Inspirations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4705</span><span class="NLM_x">–</span> <span class="NLM_lpage">4745</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040219e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4705-4745&author=A.+A.+Jensenauthor=B.+Frolundauthor=T.+Liljeforsauthor=P.+Krogsgaard-Larsen&title=Neuronal+Nicotinic+Acetylcholine+Receptors%3A+Structural+Revelations%2C+Target+Identifications%2C+and+Therapeutic+Inspirations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic Inspirations</span></div><div class="casAuthors">Jensen, Anders A.; Frolund, Bente; Liljefors, Tommy; Krogsgaard-Larsen, Povl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4705-4745</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Structures, drug targeting and therapeutic applications of Neuronal Nicotinic Acetylcholine Receptors are discussed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQuGlS_ZxYXbVg90H21EOLACvtfcHk0lg74EpLzRdaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlSgt78%253D&md5=267f469aca2e0f319da123669da5197b</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm040219e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040219e%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DFrolund%26aufirst%3DB.%26aulast%3DLiljefors%26aufirst%3DT.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26atitle%3DNeuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520Structural%2520Revelations%252C%2520Target%2520Identifications%252C%2520and%2520Therapeutic%2520Inspirations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4705%26epage%3D4745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=171-184&author=K.+Hashimotoauthor=K.+Koikeauthor=E.+Shimizuauthor=M.+Iyo&title=%CE%B17+Nicotinic+Receptor+Agonists+as+Potential+Therapeutic+Drugs+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic receptor agonists as potential therapeutic drugs for schizophrenia</span></div><div class="casAuthors">Hashimoto, Kenji; Koike, Kaori; Shimizu, Eiji; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Deficient inhibitory processing of the P50 auditory evoked potential is a measurable marker obsd. in schizophrenia.  Several lines of evidence suggest that α7 nicotinic receptors (α7 nAChRs) play a crit. role in P50 auditory sensory gating in the human brain.  Similar to schizophrenic patients, DBA/2 mice spontaneously exhibit a deficit in inhibitory processing of the P20-N40 auditory evoked potential, which is a rodent analog of the human P50 auditory evoked potential.  Agonists at α7 nAChRs improve deficient inhibitory processing of the P20-N40 auditory gating potential in DBA/2 mice.  In this article, we review the role of α7 nAChRs in the pathophysiol. of schizophrenia, and α7 nAChR agonists and indirect agonists (5-hydroxytryptamine-3 (5-HT3) receptor antagonists, pos. allosteric modulators (galantamine, 5-hydroxyindole, PNU-120596), FK960, FR236924) at α7 nAChRs as potential therapeutic drugs for the treatment of schizophrenia.  In addn., we also discuss the role of kynurenic acid as an endogenous antagonist of α7 nAChRs in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYcI0WdtDnLVg90H21EOLACvtfcHk0ljFTWk_i_TG9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSjsrg%253D&md5=69bc7ca07eb3b46da3bef6c9c8db956f</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3D%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonists%2520as%2520Potential%2520Therapeutic%2520Drugs%2520for%2520Schizophrenia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span> </span><span class="NLM_article-title">Design of Ligands for the Nicotinic Acetylcholine Receptors: The Quest for Selectivity</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568026043451438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=14754449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=299-334&author=W.+H.+Bunnelleauthor=M.+J.+Dartauthor=M.+R.+Schrimpf&title=Design+of+Ligands+for+the+Nicotinic+Acetylcholine+Receptors%3A+The+Quest+for+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21eR"><div class="casContent"><span class="casTitleNuber">21e</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ligands for the nicotinic acetylcholine receptors: The quest for selectivity</span></div><div class="casAuthors">Bunnelle, William H.; Dart, Michael J.; Schrimpf, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-334</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the last decade, nicotinic acetylcholine receptors (nAChRs) have emerged as important targets for drug discovery.  The therapeutic potential of nicotinic agonists depends substantially on the ability to selectively activate certain receptor subtypes that mediate beneficial effects.  The design of such compds. has proceeded in spite of a general shortage of data pertaining to subtype selectivity.  Medicinal chem. efforts have been guided principally by binding affinities to the α4β2 and/or α7 subtypes, even though these are not predictive of agonist activity at either subtype.  Nevertheless, a diverse family of nAChR ligands has been developed, and several analogs with promising therapeutic potential have now advanced to human clin. trials.  This paper provides an overview of the structure-affinity relationships that continue to drive development of new nAChR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG5dOTgvAdLbVg90H21EOLACvtfcHk0ljFTWk_i_TG9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVOiuw%253D%253D&md5=158b682f8eb51091cd9b03b74b65927d</span></div><a href="/servlet/linkout?suffix=cit21e&amp;dbid=16384&amp;doi=10.2174%2F1568026043451438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043451438%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDesign%2520of%2520Ligands%2520for%2520the%2520Nicotinic%2520Acetylcholine%2520Receptors%253A%2520The%2520Quest%2520for%2520Selectivity%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D299%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Romanelli, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, F.</span><span> </span><span class="NLM_article-title">Cholinergic Nicotinic Receptors: Competitive Ligands, Allosteric Modulators, and Their Potential Applications</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fmed.10037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12710018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21f&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=393-426&author=M.+N.+Romanelliauthor=F.+Gualtieri&title=Cholinergic+Nicotinic+Receptors%3A+Competitive+Ligands%2C+Allosteric+Modulators%2C+and+Their+Potential+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21fR"><div class="casContent"><span class="casTitleNuber">21f</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications</span></div><div class="casAuthors">Romanelli, M. Novella; Gualtieri, Fulvio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-426</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Discovery of the important role played by nicotinic acetylcholine receptors (nAChRs) in several CNS disorders has called attention to these membrane proteins and to ligands able to modulate their functions.  The existence of different subtypes at multiple levels has complicated the understanding of this receptor's physiol. role, but at the same time has increased the efforts to discover selective compds. to improve the pharmacol. characterization of this kind of receptor and to make the possible therapeutical use of its modulators safer.  This review focuses on the structure of new ligands for nAChRs, agonists, antagonists and allosteric modulators, and on their possible applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDvFmKJJTrLVg90H21EOLACvtfcHk0lhPza7foR64Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFGkt7w%253D&md5=166db6bdd8d5b7c809e2fcc98797b739</span></div><a href="/servlet/linkout?suffix=cit21f&amp;dbid=16384&amp;doi=10.1002%2Fmed.10037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10037%26sid%3Dliteratum%253Aachs%26aulast%3DRomanelli%26aufirst%3DM.%2BN.%26aulast%3DGualtieri%26aufirst%3DF.%26atitle%3DCholinergic%2520Nicotinic%2520Receptors%253A%2520Competitive%2520Ligands%252C%2520Allosteric%2520Modulators%252C%2520and%2520Their%2520Potential%2520Applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D393%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Astles, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F1568007023339256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=12769608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21g&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=337-348&author=P.+C.+Astlesauthor=S.+R.+Bakerauthor=J.+R.+Bootauthor=L.+M.+Broadauthor=C.+P.+Dellauthor=M.+Keenan&title=Recent+Progress+in+the+Development+of+Subtype+Selective+Nicotinic+Acetylcholine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21gR"><div class="casContent"><span class="casTitleNuber">21g</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Astles, P. C.; Baker, S. R.; Boot, J. R.; Broad, L. M.; Dell, C. P.; Keenan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion channels, which are found at the neuromuscular junction and in the central and peripheral nervous systems.  The channels can be assembled from fourteen known subunits.  The exact combination and function of all the channels are still not detd. but in the CNS certain combinations have been identified which appear to modulate the release of specific neurotransmitters.  Non-specific nAChR agonists like nicotine and epibatidine, have been shown to have interesting pharmacol. but their clin. value is limited by their undesirable side effects.  Selective ligands for different receptor subtypes have been reported and these compds. are probably the best tools for detg. the function of the subtypes.  The expectation is that some receptor subtype selective nAChR ligands will be clin. useful for the treatment of a broad range of CNS disorders.  The development of stable cell lines functionally expressing specific combinations of subunits has greatly improved our understanding of ligand specificity.  There have also been advances in the modeling of the ligand binding site, thanks to the discovery of a homologous snail ACh binding protein the x-ray structure of which was detd. in 2001.  These techniques should lead to rapid advances in the development of truly subtype selective ligands.  In this review we describe recent progress in the area and describe the first 1000 fold selective low mol. wt. ligands from the Astra-Zeneca group.  We also comment on the first subtype specific channel modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7blv1UIcybVg90H21EOLACvtfcHk0lhPza7foR64Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D&md5=dc305ccf03024133de5219453a82cb88</span></div><a href="/servlet/linkout?suffix=cit21g&amp;dbid=16384&amp;doi=10.2174%2F1568007023339256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339256%26sid%3Dliteratum%253Aachs%26aulast%3DAstles%26aufirst%3DP.%2BC.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DKeenan%26aufirst%3DM.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Subtype%2520Selective%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span> </span><span class="NLM_article-title">Exploring the Nature of Molecular Recognition in Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.2174%2F0929867003374660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=10828287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21h&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltVGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=749-800&author=J.+D.+Schmitt&title=Exploring+the+Nature+of+Molecular+Recognition+in+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21hR"><div class="casContent"><span class="casTitleNuber">21h</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the nature of molecular recognition in nicotinic acetylcholine receptors</span></div><div class="casAuthors">Schmitt, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">749-800</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 224 refs.  Nicotinic acetylcholine receptors (nAChRs) are the subject of ever increasing interest because of their presumed involvement in the etiol. of numerous clin. disorders.  Unfortunately, the absence of at.-level structural data, as well as the pharmacol. complexity of these receptors leaves many fundamental questions unanswered.  An understanding of how ligands interact with the receptor and, in-turn, how these interactions lead to pharmacol. effect is vital in the advancement of nAChR-based therapeutics.  We will first explore physico-chem. themes that are evidenced to be of particular importance in nAChR mol. recognition; these are- π-cation interaction, conformational entropy and stereochem.  The second objective of this review is an interpretive encapsulation of the extensive and disparate body of structure-activity data that now exists for nAChRs.  Finally, this review will advocate a re-investigation of distance geometry based methods as well as the need for addnl. approaches in nicotinic receptor pharmacophore generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodugV1iwAXWLVg90H21EOLACvtfcHk0lhOmM9_Axe2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltVGitLg%253D&md5=cb5cec41c69141cc29012aa2376468ad</span></div><a href="/servlet/linkout?suffix=cit21h&amp;dbid=16384&amp;doi=10.2174%2F0929867003374660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867003374660%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26atitle%3DExploring%2520the%2520Nature%2520of%2520Molecular%2520Recognition%2520in%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D749%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Meyer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.-l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fiebre, C. M.</span><span> </span><span class="NLM_article-title">3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) Selectively Activates Rat α7 Receptors and Improves Memory-Related Behaviors in a Mecamylamine-Sensitive Manner</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">768</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-8993%2897%2900536-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9369300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK2sXlsleltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=768&publication_year=1997&pages=49-56&author=E.+M.+Meyerauthor=E.+T.+Tayauthor=R.+L.+Papkeauthor=C.+Meyersauthor=G.-l.+Huangauthor=C.+M.+de+Fiebre&title=3-%5B2%2C4-Dimethoxybenzylidene%5Danabaseine+%28DMXB%29+Selectively+Activates+Rat+%CE%B17+Receptors+and+Improves+Memory-Related+Behaviors+in+a+Mecamylamine-Sensitive+Manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner</span></div><div class="casAuthors">Meyer, Edwin M.; Tay, Ee Tein; Papke, Roger L.; Meyers, Craig; Huang, Guang-ling; de Fiebre, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">768</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The α7 nicotinic receptor agonist 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB; GTS-21) was investigated for its ability to: (1) activate a variety of nicotinic receptor subtypes in Xenopus oocytes; (2) improve passive avoidance and spatial Morris water task performances in mecamylamine-sensitive manners in bilaterally nucleus basalis lesioned rats; and (3) elevate high-affinity [3H]acetylcholine (ACh) and high-affinity α-[125I]bungarotoxin binding in rat neocortex following 2 wk of daily injections.  DMXB (100 μM) activated α7 homo-oligomeric receptors, without significant activity at α2-, α3- and α4-contg. subtypes.  Mecamylamine blocked rat α7 receptors weakly if co-administered with agonist, but much more potently when pre-applied.  Bilateral ibotenic acid lesions of the nucleus basalis interfered with passive avoidance and spatial memory-related behaviors.  DMXB (0.5 mg/kg, i.p.) improved passive avoidance behavior in lesioned animals in a mecamylamine-sensitive manner.  DMXB (0.5 mg/kg 15 min before each session) also improved performance in the training and probe components of the Morris water task.  DMXB-induced improvement in the probe component but not the training phase was mecamylamine-sensitive.  [3H]ACh binding was elevated after 14 days of daily i.p. injections with 0.2 mg/kg nicotine but not after 1 mg/kg DMXB.  Neither drug elevated high-affinity α-[125I]bungarorotoxin binding over this interval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM55sLnGyIOrVg90H21EOLACvtfcHk0lhOmM9_Axe2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsleltLc%253D&md5=bb3c4d49046f80910eca0d0c52fe9418</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2897%2900536-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252897%252900536-2%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%2BM.%26aulast%3DTay%26aufirst%3DE.%2BT.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DG.-l.%26aulast%3Dde%2BFiebre%26aufirst%3DC.%2BM.%26atitle%3D3-%255B2%252C4-Dimethoxybenzylidene%255Danabaseine%2520%2528DMXB%2529%2520Selectively%2520Activates%2520Rat%2520%25CE%25B17%2520Receptors%2520and%2520Improves%2520Memory-Related%2520Behaviors%2520in%2520a%2520Mecamylamine-Sensitive%2520Manner%26jtitle%3DBrain%2520Res.%26date%3D1997%26volume%3D768%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abreo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlik, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9506884" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK28Xntlyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=817-25&author=M.+A.+Abreoauthor=N.-H.+Linauthor=D.+S.+Garveyauthor=D.+E.+Gunnauthor=A.-M.+Hettingerauthor=J.+T.+Wasicakauthor=P.+A.+Pavlikauthor=Y.+C.+Martinauthor=D.+L.+Donnelly-Robertsauthor=D.+J.+Andersonauthor=J.+P.+Sullivanauthor=M.+Williamsauthor=S.+P.+Arnericauthor=M.+W.+Holladay&title=Novel+3-Pyridyl+Ethers+with+Subnanomolar+Affinity+for+Central+Neuronal+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors</span></div><div class="casAuthors">Abreo, Melwyn A.; Lin, Nan-Horng; Garvey, David S.; Gunn, David E.; Hettinger, Anne-Marie; Wasicak, James T.; Pavlik, Patricia A.; Martin, Yvonne C.; Donnelly-Roberts, Diana L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-25</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence indicating the therapeutic potential of cholinergic channel modulators for the treatment of central nervous system (CNS) disorders as well as the diversity of brain neuronal nicotinic acetylcholine receptors (nAChRs) have suggested an opportunity to develop subtype-selective nAChR ligands for the treatment of specific CNS disorders with reduced side effect liabilities.  The synthesis of a novel series of 3-pyridyl ether compds. was reported which possess subnanomolar affinity for brain nAChRs and differentially activate subtypes of neuronal nAChRs.  The synthesis and structure-activity relationships for the leading members of the series are described, including A-85380, which possesses ca. 50 pM affinity for rat brain [3H]-(-)-cytisine binding sites and 163% efficacy compared to nicotine to stimulate ion flux at human α4β2 nAChR subtype, and A-84543, which exhibits 84-fold selectivity to stimulate ion flux at human α4β2 nAChR subtype compared to human ganglionic type nAChRs.  Computational studies indicate that a reasonable superposition of a low energy conformer of A-85380 with (S)-nicotine and (-)-epibatidine can be achieved.  An example compd. are (S)-3-[(1-methyl-2-pyrrolidinyl)methoxy]pyridine and (S)-3-(1-methyl-2-azetidinylmethoxy)pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQJNpsnACwLbVg90H21EOLACvtfcHk0lhOmM9_Axe2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlyltw%253D%253D&md5=5deeea6b10b0c4efe2fdd92b617a5430</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm9506884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9506884%26sid%3Dliteratum%253Aachs%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DHettinger%26aufirst%3DA.-M.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DPavlik%26aufirst%3DP.%2BA.%26aulast%3DMartin%26aufirst%3DY.%2BC.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DNovel%25203-Pyridyl%2520Ethers%2520with%2520Subnanomolar%2520Affinity%2520for%2520Central%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D817%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guendisch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilotta, M. C.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Phenylcarbamate Derivatives as Ligands for Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4953-4962&author=D.+Guendischauthor=M.+Andraeauthor=L.+Munozauthor=M.+C.+Tilotta&title=Synthesis+and+Evaluation+of+Phenylcarbamate+Derivatives+as+Ligands+for+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuendisch%26aufirst%3DD.%26aulast%3DAndrae%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DTilotta%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Phenylcarbamate%2520Derivatives%2520as%2520Ligands%2520for%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4953%26epage%3D4962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">+)-3-[2-(Benzo[<i>b</i>]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as Potent Agonists for the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3781-3784&author=R.+Tatsumiauthor=K.+Seioauthor=M.+Fujioauthor=J.+Katayamaauthor=T.+Horikawaauthor=K.+Hashimotoauthor=H.+Tanaka&title=%2B%29-3-%5B2-%28Benzo%5Bb%5Dthiophen-2-yl%29-2-oxoethyl%5D-1-azabicyclo%5B2.2.2%5Doctane+as+Potent+Agonists+for+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%252B%2529-3-%255B2-%2528Benzo%255Bb%255Dthiophen-2-yl%2529-2-oxoethyl%255D-1-azabicyclo%255B2.2.2%255Doctane%2520as%2520Potent%2520Agonists%2520for%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3781%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bodnar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span> </span><span class="NLM_article-title">Discovery and Structure–Activity Relationship of Quinuclidine Benzamides as Agonists of α7 Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049363q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=905-908&author=A.+L.+Bodnarauthor=L.+A.+Cortes-Burgosauthor=K.+K.+Cookauthor=D.+M.+Dinhauthor=V.+E.+Groppiauthor=M.+Hajosauthor=N.+R.+Higdonauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=J.+K.+Myersauthor=B.+N.+Rogersauthor=T.+M.+Wallauthor=M.+L.+Wolfeauthor=E.+Wong&title=Discovery+and+Structure%E2%80%93Activity+Relationship+of+Quinuclidine+Benzamides+as+Agonists+of+%CE%B17+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1021%2Fjm049363q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049363q%26sid%3Dliteratum%253Aachs%26aulast%3DBodnar%26aufirst%3DA.%2BL.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Quinuclidine%2520Benzamides%2520as%2520Agonists%2520of%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span> </span><span class="NLM_article-title">2-(Arylmethyl)-3-Substituted Quinuclidines as Selective α7 Nicotinic Receptor Ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2073-2077&author=A.+Mazurovauthor=J.+Klucikauthor=L.+Miaoauthor=T.+Y.+Phillipsauthor=A.+Seamansauthor=J.+D.+Schmittauthor=T.+A.+Hauserauthor=R.+T.+Johnsonauthor=C.+Miller&title=2-%28Arylmethyl%29-3-Substituted+Quinuclidines+as+Selective+%CE%B17+Nicotinic+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DT.%2BY.%26aulast%3DSeamans%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BT.%26aulast%3DMiller%26aufirst%3DC.%26atitle%3D2-%2528Arylmethyl%2529-3-Substituted%2520Quinuclidines%2520as%2520Selective%2520%25CE%25B17%2520Nicotinic%2520Receptor%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2073%26epage%3D2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+L.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=L.+A.+Cortes-Burgosauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-Azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+Agonist+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor%2C+for+the+Potential+Treatment+of+Cognitive+Deficits+in+Schizophrenia%3A+Synthesis+and+Structure%E2%80%93Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24e&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-Azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520Agonist%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%252C%2520for%2520the%2520Potential%2520Treatment%2520of%2520Cognitive%2520Deficits%2520in%2520Schizophrenia%253A%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetman, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinholt, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hester, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structure–Activity Relationship, and in Vivo Activity of Azabicyclic Aryl Amides as α7 Nicotinic Acetylcholine Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8219-8248&author=D.+P.+Walkerauthor=D.+G.+Wishkaauthor=D.+W.+Piotrowskiauthor=S.+Jiaauthor=S.+C.+Reitzauthor=K.+M.+Yatesauthor=J.+K.+Myersauthor=T.+N.+Vetmanauthor=B.+J.+Margolisauthor=E.+J.+Jacobsenauthor=B.+A.+Ackerauthor=V.+E.+Groppiauthor=M.+L.+Wolfeauthor=B.+A.+Thornburghauthor=P.+M.+Tinholtauthor=L.+A.+Cortes-Burgosauthor=R.+R.+Waltersauthor=M.+R.+Hesterauthor=E.+P.+Seestauthor=L.+A.+Dolakauthor=F.+Hanauthor=B.+A.+Olsonauthor=L.+Fitzgeraldauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=M.+Hajosauthor=W.+E.+Hoffmannauthor=K.+S.+Liauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=E.+H.+F.+Wongauthor=B.+N.+Rogers&title=Design%2C+Synthesis%2C+Structure%E2%80%93Activity+Relationship%2C+and+in+Vivo+Activity+of+Azabicyclic+Aryl+Amides+as+%CE%B17+Nicotinic+Acetylcholine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DVetman%26aufirst%3DT.%2BN.%26aulast%3DMargolis%26aufirst%3DB.%2BJ.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DAcker%26aufirst%3DB.%2BA.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DTinholt%26aufirst%3DP.%2BM.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHester%26aufirst%3DM.%2BR.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DB.%2BA.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLi%26aufirst%3DK.%2BS.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Azabicyclic%2520Aryl%2520Amides%2520as%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8219%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Clark, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span> </span><span class="NLM_article-title">An Orthogonal Protection Strategy for the Synthesis of 2-Substituted Piperazines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3065</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=3057-3065&author=R.+B.+Clarkauthor=D.+Elbaum&title=An+Orthogonal+Protection+Strategy+for+the+Synthesis+of+2-Substituted+Piperazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BB.%26aulast%3DElbaum%26aufirst%3DD.%26atitle%3DAn%2520Orthogonal%2520Protection%2520Strategy%2520for%2520the%2520Synthesis%2520of%25202-Substituted%2520Piperazines%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D3057%26epage%3D3065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hooper, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsunomiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Scope and Mechanism of Palladium-Catalyzed Amination of Five-Membered Heterocyclic Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2861</span><span class="NLM_x">–</span> <span class="NLM_lpage">2873</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0266339" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvF2ltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=2861-2873&author=M.+W.+Hooperauthor=M.+Utsunomiyaauthor=J.+F.+Hartwig&title=Scope+and+Mechanism+of+Palladium-Catalyzed+Amination+of+Five-Membered+Heterocyclic+Halides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scope and Mechanism of Palladium-Catalyzed Amination of Five-Membered Heterocyclic Halides</span></div><div class="casAuthors">Hooper, Mark W.; Utsunomiya, Masaru; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2861-2873</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Detailed studies have been conducted to det. the activity of palladium catalysts for the amination of five-membered heterocyclic halides and to det. the factors that control the scope of this reaction.  Palladium-catalyzed aminations of the electron-rich furanyl, thiophenyl, and indolyl halides and of the related 2-halogenated thiazoles, benzimidazole, and benzoxazole have been shown to occur with a subset of amines.  Various combinations of palladium precursors and PtBu3 were tested as catalysts for reaction of 3-bromothiophene with N-methylaniline, and the fastest reactions occurred with the Pd(I) dimer, [PdBr(PtBu3)]2.  The fastest aminations of thiazoles, benzimidazoles, and benzoxazoles occurred with the combination of palladium trifluoroacetate and PtBu3 as catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aQmjLVtO6LVg90H21EOLACvtfcHk0lgBBpVk0RPjrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvF2ltLs%253D&md5=3fb8603411fc1099b4fd2e3c2f9e86f9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo0266339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0266339%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DM.%2BW.%26aulast%3DUtsunomiya%26aufirst%3DM.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DScope%2520and%2520Mechanism%2520of%2520Palladium-Catalyzed%2520Amination%2520of%2520Five-Membered%2520Heterocyclic%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D2861%26epage%3D2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Available from ChemPacific Corporation, Baltimore, MD.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">van Maanen, M. A.; Papke, R. L.; Koopman, F. A.; Koepke, J.; Bevaart, L.; Clark, R.; Lamppu, D.; Elbaum, D.; LaRosa, G. J.; Tak, P. P.; Vervoordeldonk, M. J.</span><span> </span><span class="NLM_article-title">Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induce arthritis in mice</span>. <div class="note"><p class="first last">Submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=van+Maanen%2C+M.+A.%3B+Papke%2C+R.+L.%3B+Koopman%2C+F.+A.%3B+Koepke%2C+J.%3B+Bevaart%2C+L.%3B+Clark%2C+R.%3B+Lamppu%2C+D.%3B+Elbaum%2C+D.%3B+LaRosa%2C+G.+J.%3B+Tak%2C+P.+P.%3B+Vervoordeldonk%2C+M.+J.+Two+novel+%CE%B17+nicotinic+acetylcholine+receptor+ligands%3A+in+vitro+properties+and+their+efficacy+in+collagen-induce+arthritis+in+mice.+Submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMaanen%26aufirst%3DM.%2BA.%26atitle%3DTwo%2520novel%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%253A%2520in%2520vitro%2520properties%2520and%2520their%2520efficacy%2520in%2520collagen-induce%2520arthritis%2520in%2520mice" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct Profiles of α7 nAChR Postive Allosteric Modulation Revealed by Structurally Divers Chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=715-724&author=J.+H.+Gr%C3%B8nlienauthor=M.+H%C3%A5kerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+Profiles+of+%CE%B17+nAChR+Postive+Allosteric+Modulation+Revealed+by+Structurally+Divers+Chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520Profiles%2520of%2520%25CE%25B17%2520nAChR%2520Postive%2520Allosteric%2520Modulation%2520Revealed%2520by%2520Structurally%2520Divers%2520Chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">A Structural Basis for Drug-Induced Long QT Syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12329</span><span class="NLM_x">–</span> <span class="NLM_lpage">12333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1073%2Fpnas.210244497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=11005845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12329-12333&author=J.+S.+Mitchesonauthor=J.+Chenauthor=M.+Linauthor=C.+Culbersonauthor=M.+C.+Sanguinetti&title=A+Structural+Basis+for+Drug-Induced+Long+QT+Syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A structural basis for drug-induced long QT syndrome</span></div><div class="casAuthors">Mitcheson, John S.; Chen, Jun; Lin, Monica; Culberson, Chris; Sanguinetti, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12329-12333</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the HERG K+ channel gene cause inherited long QT syndrome (LQT), a disorder of cardiac repolarization that predisposes affected individuals to lethal arrhythmias.  Acquired LQT is far more common and is most often caused by block of cardiac HERG K+ channels by commonly used medications.  It is unclear why so many structurally diverse compds. block HERG channels, but this undesirable side effect now is recognized as a major hurdle in the development of new and safe drugs.  Here we use alanine-scanning mutagenesis to det. the structural basis for high-affinity drug block of HERG channels by MK-499, a methanesulfonanilide antiarrhythmic drug.  The binding site, corroborated with homol. modeling, is comprised of amino acids located on the S6 transmembrane domain (G648, Y652, and F656) and pore helix (T623 and V625) of the HERG channel subunit that face the cavity of the channel.  Other compds. that are structurally unrelated to MK-499, but cause LQT, also were studied.  The antihistamine terfenadine and a gastrointestinal prokinetic drug, cisapride, interact with Y652 and F656, but not with V625.  The arom. residues of the S6 domain that interact with these drugs (Y652 and F656) are unique to eag/erg K+ channels.  Other voltage-gated K+ (Kv) channels have lle and Val (lle) in the equiv. positions.  These findings suggest a possible structural explanation for how so many commonly used medications block HERG but not other Kv channels and should facilitate the rational design of drugs devoid of HERG channel binding activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczBuinwjCZrVg90H21EOLACvtfcHk0lgBBpVk0RPjrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVSnsro%253D&md5=595505ebd987ee7a4af280016c03ea35</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.210244497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.210244497%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DA%2520Structural%2520Basis%2520for%2520Drug-Induced%2520Long%2520QT%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D12329%26epage%3D12333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">Assays at Cerep were performed according to previously described procedures with the noted exceptions. α4β2:</p></div><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_contrib-group">Pabereza, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]cytisine binding to nicotinic cholinergic receptors in brain</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=9-12&author=L.+A.+Paberezaauthor=S.+Dhawanauthor=K.+J.+Kellar&title=%5B3H%5Dcytisine+binding+to+nicotinic+cholinergic+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPabereza%26aufirst%3DL.%2BA.%26aulast%3DDhawan%26aufirst%3DS.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3D%255B3H%255Dcytisine%2520binding%2520to%2520nicotinic%2520cholinergic%2520receptors%2520in%2520brain%26jtitle%3DMol.%2520Pharmacol.%26date%3D1991%26volume%3D39%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">α1β1γδ:</p></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1471-4159.1986.tb08516.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=3701338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaL28XkvFaks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=1936-1941&author=R.+J.+Lukas&title=Characterization+of+curaremimetic+neurotoxin+binding+sites+on+membrane+fractions+derived+from+the+human+medulloblastoma+clonal+line%2C+TE671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671</span></div><div class="casAuthors">Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1936-41</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Studies were conducted on curaremimetic neurotoxin binding to the nicotinic acetylcholine  [51-84-3] receptor present on membrane fractions derived from the human medulloblastoma clonal line, TE671.  High-affinity binding sites (KD = 2 nM for 1-h incubation at 20°) and low-affinity binding sites (KD = 40 nM) for 125I-labeled α-bungarotoxin  [11032-79-4] are present in equal quantities (60 fmol/mg membrane protein).  The kinetically detd. dissocn. const. for high-affinity binding of toxin is 0.56 nM (k1 = 6.3 · 10-3 min-1 nM-1; k-1 = 3.5 · 10-3 min-1) at 20°.  Nicotine  [54-11-5], d-tubocurarine  [57-95-4], and acetylcholine are among the most effective inhibitors of high-affinity toxin binding.  The quantity of toxin binding sites and their affinity for cholinergic agonists is sensitive to redn., alkylation, and(or) oxidn. of membrane sulfhydryl residues.  High-affinity toxin binding sites that have been subjected to reaction with the sulfhydryl reagent dithiothreitol are irreversibly blocked by the nicotinic receptor affinity reagent bromoacetylcholine  [17139-54-7].  High-affinity toxin binding is inhibited in the presence of either of 2 polyclonal antisera or a monoclonal antibody raised against nicotinic acetylcholine receptors from fish elec. tissue.  Taken together, these results indicate that curaremimetic neurotoxin binding sites on membrane fractions of the TE671 cell line share some properties with nicotinic acetylcholine receptors of peripheral origin and with toxin binding sites on other neuronal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4MXeyhaVG7Vg90H21EOLACvtfcHk0ljjZ-WeWCE1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XkvFaks74%253D&md5=cd35020c5445171bc033fefdafeacfa2</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1986.tb08516.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1986.tb08516.x%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520curaremimetic%2520neurotoxin%2520binding%2520sites%2520on%2520membrane%2520fractions%2520derived%2520from%2520the%2520human%2520medulloblastoma%2520clonal%2520line%252C%2520TE671%26jtitle%3DJ.%2520Neurochem.%26date%3D1986%26volume%3D46%26spage%3D1936%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">5-HT<sub>3</sub>:</p></div><div class="NLM_citation" id="rightTab-cit31c"><span><span class="NLM_contrib-group">Hope, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-As) subunit stably expressed in HEK 293 cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1476-5381.1996.tb15529.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=8818349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31c&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK28Xks1Ghsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1237-1245&author=A.+G.+Hopeauthor=J.+A.+Petersauthor=A.+M.+Brownauthor=J.+J.+Lambertauthor=T.+P.+Blackburn&title=Characterization+of+a+human+5-hydroxytryptamine3+receptor+type+A+%28h5-HT3R-As%29+subunit+stably+expressed+in+HEK+293+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31cR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-As) subunit stably expressed in HEK 293 cells</span></div><div class="casAuthors">Hope, Anthony G.; Peters, John A.; Brown, Angus M.; Lambert, Jeremy J.; Blackburn, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1237-1245</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">A cloned cDNA encoding a human 5-hydroxytryptamine3 receptor type A subunit (h5-HT3R-As) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high d. of the recombinant receptor was selected.  Membrane homogenates prepd. from transfected but not untransfected, cells exhibited a homogeneous and saturable population (Bmax = 4.49 pmol mg-1 protein) of sites that bound the radiolabeled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pKD = 8.87).  Kinetic studies (at 37°) revealed rapid assocn. (k+1 = 4.76 × 108 M-1 min-1) and dissocn. (k-1 = 0.21 min-1) of the radioligand.  Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > m-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS.  In electrophysiol. recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 μM) evoked transient inward current responses that reversed in sign at a potential of -1.0 mV.  Such responses were antagonized in a reversible manner by granisetron (1 nM).  The construction of a stable cell line expressing a high d. of recombinant human 5-HT3 receptors which display appropriate pharmacol. and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphoHkEVXGW9bVg90H21EOLACvtfcHk0ljjZ-WeWCE1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xks1Ghsbc%253D&md5=103e1995ab3c9fad24b272e017028c98</span></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15529.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15529.x%26sid%3Dliteratum%253Aachs%26aulast%3DHope%26aufirst%3DA.%2BG.%26aulast%3DPeters%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DLambert%26aufirst%3DJ.%2BJ.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DCharacterization%2520of%2520a%2520human%25205-hydroxytryptamine3%2520receptor%2520type%2520A%2520%2528h5-HT3R-As%2529%2520subunit%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D118%26spage%3D1237%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">This assay was performed using [<sup>3</sup>H]BRL-43694 at 0.5 nM as the ligand. hERG:</p></div><div class="NLM_citation" id="rightTab-cit31d"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31d&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=G.+Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31dR"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0ljjZ-WeWCE1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit31d&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DG.%2BQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Cytochrome P450 all isoforms:</p></div><div class="NLM_citation" id="rightTab-cit31e"><span><span class="NLM_contrib-group">Dierks, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. E.</span><span> </span><span class="NLM_article-title">A method for the simulataneus evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><div class="note"><p class="first last">The cytochrome P450 assays were performed as described with single substrates rather than a substrate cocktail. The substrates used are: 1A2, ethoxyresorufin; 2C9, diclofenac; 2C19, <i>S</i>-mephenytoin; 2D6, bufuralol; 3A4, midazolam.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=23-29&author=E.+A.+Dierksauthor=K.+R.+Stamsauthor=H.-K.+Limauthor=G.+Corneliusauthor=H.+Zhangauthor=S.+E.+Ball&title=A+method+for+the+simulataneus+evaluation+of+the+activities+of+seven+major+human+drug-metabolizing+cytochrome+P450s+using+an+in+vitro+cocktail+of+probe+substrates+and+fast+gradient+liquid+chromatography+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DStams%26aufirst%3DK.%2BR.%26aulast%3DLim%26aufirst%3DH.-K.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26atitle%3DA%2520method%2520for%2520the%2520simulataneus%2520evaluation%2520of%2520the%2520activities%2520of%2520seven%2520major%2520human%2520drug-metabolizing%2520cytochrome%2520P450s%2520using%2520an%2520in%2520vitro%2520cocktail%2520of%2520probe%2520substrates%2520and%2520fast%2520gradient%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hide, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrä, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohsaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, Y.</span><span> </span><span class="NLM_article-title">Microglial α7 Nicotinic Acetylcholine Receptors Drive a Phospholipase C/IP3 Pathway and Modulate the Cell Activation toward a Neuroprotective Role</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1002%2Fjnr.20850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=16652343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlOqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1461-1470&author=T.+Suzukiauthor=I.+Hideauthor=A.+Matsubaraauthor=C.+Hamaauthor=K.+Haradaauthor=K.+Miyanoauthor=M.+Andr%C3%A4author=H.+Matsubayashiauthor=N.+Sakaiauthor=S.+Kohsakaauthor=K.+Inoueauthor=Y.+Nakata&title=Microglial+%CE%B17+Nicotinic+Acetylcholine+Receptors+Drive+a+Phospholipase+C%2FIP3+Pathway+and+Modulate+the+Cell+Activation+toward+a+Neuroprotective+Role"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role</span></div><div class="casAuthors">Suzuki, Tomohisa; Hide, Izumi; Matsubara, Akiyo; Hama, Chihiro; Harada, Kana; Miyano, Kanako; Andra, Matthias; Matsubayashi, Hiroaki; Sakai, Norio; Kohsaka, Shinichi; Inoue, Kazuhide; Nakata, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1461-1470</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Microglia perform both neuroprotective and neurotoxic functions in the brain, with this depending on their state of activation and their release of mediators.  Upon P2X7 receptor stimulation, for example, microglia release small amts. of TNF, which protect neurons, whereas LPS causes massive TNF release leading to neuroinflammation.  Here we report that, in rat primary cultured microglia, nicotine enhances P2X7 receptor-mediated TNF release, while suppressing LPS-induced TNF release but without affecting TNF mRNA expression via activation of α7 nicotinic acetylcholine receptors (α7 nAChRs).  In microglia, nicotine elicited a transient increase in intracellular Ca2+ levels, which was abolished by specific blockers of α7 nAChRs.  However, this response was independent of extracellular Ca2+ and blocked by U 73122, an inhibitor of phospholipase C (PLC), and xestospongin C, a blocker of the IP3 receptor.  Repeated expts. showed that currents were not detected in nicotine-stimulated microglia.  Moreover, nicotine modulation of LPS-induced TNF release was also blocked by xestospongin C.  Upon LPS stimulation, inhibition of TNF release by nicotine was assocd. with the suppression of JNK and p38 MAP kinase activation, which regulate the post-transcriptional steps of TNF synthesis.  In contrast, nicotine did not alter any MAP kinase activation, but enhanced Ca2+ response in P2X7 receptor-activated microglia.  In conclusion, microglial α7 nAChRs might drive a signaling process involving the activation of PLC and Ca2+ release from intracellular Ca2+ stores, rather than function as conventional ion channels.  This novel α7 nAChR signal may be involved in the nicotine modification of microglia activation towards a neuroprotective role by suppressing the inflammatory state and strengthening the protective function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2gUrBM0HirrVg90H21EOLACvtfcHk0lgCBw2p8CWvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlOqt74%253D&md5=ad2973479343f0d0e3e472c27bd7a13f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20850%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHide%26aufirst%3DI.%26aulast%3DMatsubara%26aufirst%3DA.%26aulast%3DHama%26aufirst%3DC.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DAndr%25C3%25A4%26aufirst%3DM.%26aulast%3DMatsubayashi%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DKohsaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DNakata%26aufirst%3DY.%26atitle%3DMicroglial%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptors%2520Drive%2520a%2520Phospholipase%2520C%252FIP3%2520Pathway%2520and%2520Modulate%2520the%2520Cell%2520Activation%2520toward%2520a%2520Neuroprotective%2520Role%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1461%26epage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Chojnacka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horenstein, N. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a Conditionally-Silent Agonist of the α7 Nicotinic Acetylcholine Receptor</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4145</span><span class="NLM_x">–</span> <span class="NLM_lpage">4149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.bmcl.2013.05.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=23746476" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4145-4149&author=K.+Chojnackaauthor=R.+L.+Papkeauthor=N.+A.+Horenstein&title=Synthesis+and+evaluation+of+a+Conditionally-Silent+Agonist+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DChojnacka%26aufirst%3DK.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DHorenstein%26aufirst%3DN.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520Conditionally-Silent%2520Agonist%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4145%26epage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Thomsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span> </span><span class="NLM_article-title">The alpha7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysacharide-induced TNF-alpha release from microglia</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1016%2Fj.jneuroim.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=22884467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2nt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2012&pages=65-72&author=M.+S.+Thomsenauthor=J.+D.+Mikkelsen&title=The+alpha7+nicotinic+acetylcholine+receptor+ligands+methyllycaconitine%2C+NS6740+and+GTS-21+reduce+lipopolysacharide-induced+TNF-alpha+release+from+microglia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia</span></div><div class="casAuthors">Thomsen, Morten S.; Mikkelsen, Jens D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The anti-inflammatory properties of, particularly the α7, nicotinic acetylcholine receptors (nAChRs) in the peripheral immune system are well documented.  There are also reports of anti-inflammatory actions of nicotine in the CNS, but it is unclear, whether this is due to activation or inhibition of nAChRs.  Here the authors investigate the mechanisms behind α7 nAChR-mediated modulation of TNF-α release.  The authors show that α7 nAChR agonists or pos. allosteric modulators do not affect LPS-induced release of the pro-inflammatory cytokine TNF-α from cultured microglia.  This suggests that classical activation of, i.e., ion-flux through, the α7 nAChR does not reduce TNF-α release from activated microglia.  Contrarily, the α7 nAChR antagonist methyllycaconitine and the weak (< 10%) agonist NS6740 reduced LPS-induced TNF-α release, indicating that α7 nAChR antagonism conveys anti-inflammatory properties on microglia.  The effect of methyllycaconitine or NS6740 was not due to changes in MAPK signaling.  These results suggest that the anti-inflammatory effects of nicotine seen in vivo are not due to classical activation of the α7 nAChR, and further suggest that antagonism of α7 nAChRs may reduce neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Yn3hEYZ7OrVg90H21EOLACvtfcHk0lgCBw2p8CWvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2nt7zN&md5=954f106f0919ba3c2353b7533b29d2ba</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%2520methyllycaconitine%252C%2520NS6740%2520and%2520GTS-21%2520reduce%2520lipopolysacharide-induced%2520TNF-alpha%2520release%2520from%2520microglia%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D251%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Br. J. Phamacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1111%2Fj.1476-5381.2009.00426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=19845675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSkurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1486-1494&author=C.+A.+Briggsauthor=J.+H.+Gr%C3%B8nlienauthor=P.+Curzonauthor=D.+B.+Timmermannauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=P.+Kerrauthor=D.+A.+Andersonauthor=J.+Malyszauthor=T.+Dyhringauthor=G.+M.+Olsenauthor=D.+Petersauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Role+of+channel+activation+in+cognitive+enhancement+mediated+by+%CE%B17+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Role of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors</span></div><div class="casAuthors">Briggs, Clark A.; Gronlien, Jens Halvard; Curzon, Peter; Timmermann, Daniel B.; Ween, Hilde; Thorin-Hagene, Kirsten; Kerr, Paige; Anderson, David J.; Malysz, John; Dyhring, Tino; Olsen, Gunnar M.; Peters, Dan; Bunnelle, William H.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1486-1494</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Several agonists of the α7 nicotinic acetylcholine receptor (nAChR) have been developed for treatment of cognitive deficits.  However, agonist efficacy in vivo is difficult to reconcile with rapid α7 nAChR desensitization in vitro; and furthermore, the correlation between in vitro receptor efficacy and in vivo behavioral efficacy is not well delineated.  The possibility that agonists of this receptor actually function in vivo as inhibitors via desensitization has not been finally resolved.  Exptl. approach: Two structurally related α7 nAChR agonists were characterized and used to assess the degree of efficacy required in a behavioral paradigm.  Key results: NS6784 activated human and rat α7 nAChR with EC50s of 0.72 and 0.88 μM, and apparent efficacies of 77 and 97% resp.  NS6740, in contrast, displayed little efficacy at α7 nAChR (<2% in oocytes, ≤8% in GH4C1 cells), although its agonist-like properties were revealed by adding a pos. allosteric modulator of α7 nAChRs or using the slowly desensitizing α7V274T receptor.  In mouse inhibitory avoidance (IA) memory retention, NS6784 enhanced performance as did the 60% partial agonist A-582941.  In contrast, NS6740 did not enhance performance, but blocked effects of A-582941.  Conclusions and implications: Collectively, these findings suggest that a degree of α7 nAChR agonist efficacy is required for behavioral effects in the IA paradigm, and that such behavioral efficacy is not due to α7 nAChR desensitization.  Also, a partial agonist of very low efficacy for this receptor could be used as an inhibitor, in the absence of α7 nAChR antagonists with favorable CNS penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo32atdw4MkkLVg90H21EOLACvtfcHk0lgCBw2p8CWvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSkurvO&md5=9fe212784ed34e2ba5b96f88bc1011f5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00426.x%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DKerr%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BA.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DOlsen%26aufirst%3DG.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DRole%2520of%2520channel%2520activation%2520in%2520cognitive%2520enhancement%2520mediated%2520by%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DBr.%2520J.%2520Phamacol.%26date%3D2009%26volume%3D158%26spage%3D1486%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Assayag, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, Y.</span><span> </span><span class="NLM_article-title">Bronchodilatory and Anti-Inflammatory Effects of ASM-024, a Nicotinic Receptor Ligand Developed for the Treatment of Asthma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e86091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e86091&author=E.+I.+Assayagauthor=M.-J.+Beaulieuauthor=Y.+Cormier&title=Bronchodilatory+and+Anti-Inflammatory+Effects+of+ASM-024%2C+a+Nicotinic+Receptor+Ligand+Developed+for+the+Treatment+of+Asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssayag%26aufirst%3DE.%2BI.%26aulast%3DBeaulieu%26aufirst%3DM.-J.%26aulast%3DCormier%26aufirst%3DY.%26atitle%3DBronchodilatory%2520and%2520Anti-Inflammatory%2520Effects%2520of%2520ASM-024%252C%2520a%2520Nicotinic%2520Receptor%2520Ligand%2520Developed%2520for%2520the%2520Treatment%2520of%2520Asthma%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De86091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><div class="note"><p class="first last">The ovalbumin challenge procedure was adapted from</p></div><span class="NLM_contrib-group">Hamelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvin, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography</span> <span class="citation_source-journal">Am. J. Resp. Crti. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5004599&amp;key=10.1164%2Fajrccm.156.3.9606031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5004599&amp;key=9309991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5004599&amp;key=1%3ACAS%3A280%3ADyaK2svlsFOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1997&pages=766-775&author=E.+Hamelmannauthor=J.+Schwarzeauthor=K.+Takedaauthor=A.+Oshibaauthor=G.+L.+Larsenauthor=C.+G.+Irvinauthor=E.+W.+Gelfand&title=Noninvasive+Measurement+of+Airway+Responsiveness+in+Allergic+Mice+Using+Barometric+Plethysmography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography</span></div><div class="casAuthors">Hamelmann E; Schwarze J; Takeda K; Oshiba A; Larsen G L; Irvin C G; Gelfand E W</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3 Pt 1</span>),
    <span class="NLM_cas:pages">766-75</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">To study the mechanisms and kinetics underlying the development of increased airway responsiveness (AR) after allergic sensitization, animal models have been invaluable.  Using barometric whole-body plethysmography and increases in enhanced pause (Penh) as an index of airway obstruction, we measured responses to inhaled methacholine in conscious, unrestrained mice after sensitization and airway challenge with ovalbumin (OVA).  Sensitized and challenged animals had significantly increased AR to aerosolized methacholine compared with control animals.  AR measured as Penh was associated with increased IgE production and eosinophil lung infiltration.  In a separate approach we confirmed the involvement of the lower airways in the response to aerosolized methacholine using tracheotomized mice.  Increases in Penh values after methacholine challenge were also correlated with increased intrapleural pressure, measured via an esophageal tube.  Lastly, mice demonstrating AR using a noninvasive technique also demonstrated increased pulmonary resistance responses to aerosolized methacholine when measured using an invasive technique the following day in the same animals.  The increases in Penh values were inhibited by pretreatment of the mice with a beta 2-agonist.  These data indicate that measurement of AR to inhaled methacholine by barometric whole-body plethysmography is a valid indicator of airway hyperresponsiveness after allergic sensitization in mice.  The measurement of AR in unrestrained, conscious animals provides new opportunities to evaluate the mechanisms and kinetics underlying the development and maintenance of airway hyperresponsiveness and to assess various therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-tCkOZh2wflVwdslNBF-tfW6udTcc2eYveXyib8og4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svlsFOksg%253D%253D&md5=75a577fc5fbe44e26cd8ec900f8e490a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.156.3.9606031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.156.3.9606031%26sid%3Dliteratum%253Aachs%26aulast%3DHamelmann%26aufirst%3DE.%26aulast%3DSchwarze%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DOshiba%26aufirst%3DA.%26aulast%3DLarsen%26aufirst%3DG.%2BL.%26aulast%3DIrvin%26aufirst%3DC.%2BG.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DNoninvasive%2520Measurement%2520of%2520Airway%2520Responsiveness%2520in%2520Allergic%2520Mice%2520Using%2520Barometric%2520Plethysmography%26jtitle%3DAm.%2520J.%2520Resp.%2520Crti.%2520Care%2520Med.%26date%3D1997%26volume%3D156%26spage%3D766%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Investigation of the Molecular Mechanism of the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator PNU-120596 Provides Evidence for Two Distinct Desensitized States</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=1013-1032&author=D.+K.+Williamsauthor=J.+Wangauthor=R.+L.+Papke&title=Investigation+of+the+Molecular+Mechanism+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor+Positive+Allosteric+Modulator+PNU-120596+Provides+Evidence+for+Two+Distinct+Desensitized+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DInvestigation%2520of%2520the%2520Molecular%2520Mechanism%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Positive%2520Allosteric%2520Modulator%2520PNU-120596%2520Provides%2520Evidence%2520for%2520Two%2520Distinct%2520Desensitized%2520States%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D1013%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Brieden, W.; Roduit, J.-P.</span><span> </span><span class="NLM_article-title">Process for Preparing 2-Piperazinecarboxylic Acid Derivatives</span>. United States Patent 5,856,485,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=W.+Brieden&author=J.-P.+Roduit&title=Process+for+Preparing+2-Piperazinecarboxylic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrieden%26aufirst%3DW.%26atitle%3DProcess%2520for%2520Preparing%25202-Piperazinecarboxylic%2520Acid%2520Derivatives%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><div class="note"><p class="first last">Compounds were prepared from 2-aminophenols as described in</p></div><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiokawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span> </span><span class="NLM_article-title">Orally Active Benzoxazole Derivative as 5-HT3 Receptor Partial Agonist for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7075</span><span class="NLM_x">–</span> <span class="NLM_lpage">7079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050209t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7075-7079&author=S.+Yoshidaauthor=S.+Shiokawaauthor=K.+Kawanoauthor=T.+Itoauthor=H.+Murakamiauthor=H.+Suzukiauthor=Y.+Sato&title=Orally+Active+Benzoxazole+Derivative+as+5-HT3+Receptor+Partial+Agonist+for+Treatment+of+Diarrhea-Predominant+Irritable+Bowel+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050209t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050209t%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DShiokawa%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DOrally%2520Active%2520Benzoxazole%2520Derivative%2520as%25205-HT3%2520Receptor%2520Partial%2520Agonist%2520for%2520Treatment%2520of%2520Diarrhea-Predominant%2520Irritable%2520Bowel%2520Syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7075%26epage%3D7079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><div class="note"><p class="first last">The 2-chlorobenzothiazoles were prepared from 2-haloanilines as described in</p></div><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span> </span><span class="NLM_article-title">A convenient synthesis of 2-mercapto- and 2-chlorobenzothiazoles</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=727-730&author=L.+Zhuauthor=M.+Zhangauthor=M.+Dai&title=A+convenient+synthesis+of+2-mercapto-+and+2-chlorobenzothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthesis%2520of%25202-mercapto-%2520and%25202-chlorobenzothiazoles%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2005%26volume%3D42%26spage%3D727%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-8"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm5004599">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37606"></div></div></div></div></div><hr /></hr><p class="last">Binding assay data on panel of 55 receptors, ion channels, and transporters for compounds (<b><i>R</i></b>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b>. Activity inhibition data on panel of 11 enzymes for compounds (<i><b>R</b></i>)-<b>18</b> and (<b><i>R</i></b>)-<b>47</b>.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5004599/suppl_file/jm5004599_si_001.pdf">jm5004599_si_001.pdf (437.82 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5004599&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5004599%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5004599" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                687KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679963fe8e311252","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
